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SECTION ONE 
LOCAL ANAESTHETICS 
Unlike other drugs, anaesthetics are not usually used 
to cure or to lessen the distressful symptoms of an illness 
but rather are to be regarded as chemicals which place the 
patient into a state of aloofness and non-resistance to a 
surgical insult (Takman and Camougis, 1970). 
A local anaesthetic (LA) interrupts the transmission 
of impulses in peripheral pain conducting nerves on which it 
acts directly. The resulting block may be partial or 
complete: though it should always be reversible. This 
requirement for reversibility precludes the use, as local 
anaesthetics, of compounds such as phenol that cause long-
lasting nerve blockade due to irreversible nerve damage. 
Similarly compounds such as ethyl chloride whose action 
relies on local cooling are not strictly local anaesthetics 
though they do have a local anaesthetic-like action. The 
phenolics, however, raise an interesting dilemma. Their 
tissue damaging effects are concentration dependent and the 
induced anaesthesia is reversible when the agent is applied 
at very low concentrations. This conflict in action, local 
anaesthesia versus local toxicity, is one of the more 
difficult problems in the selection of a compound for use as 
a local anaesthetic. 
1 • 1 • 1 Historical Review 
Though this thesis is primarily concerned with local 
anaesthetics (LAs) as antibacterial agents, it is appropriate 
- 3 -
to briefly outline the development of LAs. 
The first LA to be discovered was cocaine, an alkaloid 
contained in large amounts (0.6 to 1.8%) in the leaves of 
Erythroxylon coca , a shrub growing in the Andes Mountains. 
Long before the time of Columbus, the Indians of south 
America were aware of the special properties of these leaves, 
which they used as a stimulant. 
Niemann (1860) succeeded in isolating and purifying 
cocaine, and noted that it has a bitter taste and produce~ a 
numbing effect on the tongue, making it almost devoid of 
sensation. The molecular formula of cocaine (C 17 H21 NO~) 
was determined by Lessen (1865), who also showed its 
structure as benzoylmethylecgonine. Von Anrep (1880) 
studied its pharmacological actions. He observed that the 
skin became insensitive when cocaine was infiltrated 
subcutaneously, and recommended that· the alkaloid be used 
clinically as a LA. This suggestion, however, was not acted 
upon, and credit for the introduction of cocaine into 
clinical use as a LA is usually given to Karl Koller. 
Koller (1884) exhaustively investigated the possibility of 
using cocaine to relieve pain in ophthalmic procedures. He 
showed that a drop of a 2% cocaine solution rendered 
the cornea and conjunctiva of the frog and the guinea pig 
insensitive to mechanical, chemical, and electrical 
stimulation. He repeated these experiments on himself, on 
his colleagues, and finally on his patients and demonstrated 
that cocaine was useful in relieving pain. Thus in 1884 the 
first practical LA was introduced into therapeutics. 
The ensuing acceptance of cocaine as a LA was 
immediate, and in this way the history of local anaesthesia 
- 4 -
differs sharply from that of general anaesthesia. Halstedt 
and Hall (1884) introduced LAs into dental practice and then 
by demonstrating that cocaine could stop transmission in 
nerve trunks, laid the foundation for nerve block anaesthesia 
in general surgery. 
The curiosity and interest aroused by the various 
pharmacological properties of cocaine led to chemical 
manipulations of the molecule even before its structure had 
been ascertained. Thus the identification of ester functions 
in the largely unknown cocaine structure prompted uses of 
alcohols (other than methanol) and acids (other than benzoic 
acid) in the preparation of analogues and homologues from the 
hydrolysis products of cocaine (e.g. Merck, 1885; Einhorn, 
1888). This chemical search resulted in the synthesis of 
procaine (Einhorn and Uhlfelder, 1904, 1909), which today is 
still widely employed. Clinical investigations still 
continue, however, because no available local anaesthetic is 
free of undersirable properties. 
1.1. 2 Pharmacology of Local Anaesthetics 
In addition to blocking conduction in nerve axons in 
the peripheral nervous systems, LAs interfere with the 
function of all organs within which the conduction or 
transmission of impulses occurs. Thus, they have effects 
on the central nervous system (CNS), the ne~muscular 
junction, the autonomic ganglia, and all forms of muscle 
fibre (Ritchie and Cohen, 1975). 
Following absorption, LAs may cause stimulation of the 
CNS, producing restlessness and tremor that may proceed the 
chronic convulsions. Central stimulation is followed by 
- 5 -
depression and drowsiness, respiratory failure and coma 
(Takman and Camougis, 1970; Holroyd, 1978). 
Also LAs act on the cardiovascular system. The 
primary site of action is the myocardium, where decreases in 
electrical excitability, conduction rate and force of 
contraction occur (Ritchie and Cohen, 1975; Holroyd, 1978). 
The LAs also affect transmission at the neuromuscular 
junction. Harvey (1939) observed that the close intra-
arterial injection of as little as 0.2 mg of procaine into 
the eat's tibialis anterior muscle reduced twitches and 
tetanic responses evoked by maximal motor-nerve volleys, as 
well as the response of the muscle to injected acetylcholine. 
The muscle, however, responded normally to direct electrical 
stimulation. Hirst and Nood (1971) suggested that procaine 
also diminishes the release of acetylcholine by the motor-
nerve endings. 
1.1.3 Sites of Application of Local Anaesthetics 
Today LAs have wide clinical applications in dentistry, 
medicine, and veterinary science. The several locations at 
which a local anaesthetic may be applied (Nade, 1978; Holroyd,1978; 
Crossland, 1980; BOIITlllan and Rand, 19 8 0) are shown in Fig. 1.l • 
Surface or Topical Anaesthesia: The LA is applied in the 
form of a solution, ointment, cream or powder directly to the 
site at which anaesthesia is required. The method is 
restricted to mucous or damaged skin surfaces. Application 
of LA to unbroken skin will not normally show any effect. 
Topical anaesthesia proper is used to relieve pain or itching 
- 6 -
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in, for example, haemorrhoids, or to anaesthetise the 
cornea. 
The LAs mainly used for surface anaesthesia are 
amethocaine (tetracaine), benzocaine, cocaine, lignocaine 
(lidocaine), and prilocaine. 
Local or Infiltration Anaesthesia: A solution of the LA is 
injected subcutaneously at one or more sites in and around 
the area which is to be incised by the surgeon. The object 
is to ensure blockade of the finer nerve endings which 
supply the region. Infiltration anaesthesia is used for 
minor operations. It is also employed in the treatment of 
rheumatoid arthritis and muscular rheumatism. The LA is 
infiltrated around the joint or into the fibrositic 
nodules. 
Lignocaine, mepivacaine, prilocaine and procaine are 
the compounds mainly used in this sort of anaesthesia. 
Conduction or Regional Nerve Block Anaesthesia: The LA is 
injected as close as possible to the main nerve trunk in a 
limb supplying the area in which anaesthesia is required. 
Conduction in both motor and sensory fibres is blocked, 
enabling operations to be carried out on the limb. Higher 
concentrations of LA than are used in infiltration 
anaesthesia are required to produce anaesthesia by nerve 
block, because the fibres in the nerve trunk are consider-
ably thicker than the fine nerve terminals encountered in 
the skin. 
Epidural or Extradural Anaesthesia: It is a special 
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form of regional nerve block in which the solution is 
injected into the epidural space, and comes into contact 
with the dura covering the roots of spinal nerves. Some of 
the drug penetrates the dura, enters the subarachnoid space 
and anaesthetises the nerve roots. The rest of the solution 
diffuses outside the dura and reaches the paravertebral 
space causing additional blockade at this point. In Caudal 
anaesthesia, an epidural injection is made through the 
sacral hiatus. 
For regional nerve block and epidural anaesthesia, the 
compounds mainly used are bupivacaine, lignocaine, 
mepivacaine, prilocaine and procaine. 
Spinal or Subarachnoid Anaesthesia: The LA solution is 
injected into the subarachnoid space so that it reaches the 
roots of spinal nerves. The technique is used to induce 
anaesthesia in parts of the body up to the thoracic region. 
Abdominal or pelvic operations can then be carried out while 
the patient remains conscious. 
1 • 1 • 4 Properties Desirable in Local Anaesthetics 
An ideal LA should combine several properties. It 
should be inexpensive, stable in solutions and capable of 
being sterilized by heat. In administration it should not 
be irritating to the tissue to which it is applied, nor 
should it cause any permanent damage to nerve structure; 
most LAs in common use fulfil these requirements. Systemic 
toxicity should be low, as the LA is eventually absorbed 
from its site of application. The LAs therapeutic index is 
of obvious importance in the evaluation of the efficacy and 
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safety of these drugs. Anaesthesia should be of rapid 
onset and must last long enough to allow time for surgery, 
yet not so long as to need an extended period of recovery. 
Sometimes, for example, in the control of chronic pain, a 
LA action lasting for days or even weeks is required. 
Unfortunately, the available compounds employed for 
anaesthesia of such long duration, have high local toxicity. 
1.1. 5 Chemistry and Structure - Activity Relationships 
Three years had elapsed after the introduction of 
cocaine as a LA when the first effort to correlate structure 
to activity was made. Filehne (1887), suggested that the 
effect was associated with .the benzoic acid moiety of cocaine 
and that the ecgonine portion was of only slight importance 
(Fig. 1.2). 
9 CH2-~H -CH-C-O CH3 
N-CH3 CH-o-80 
CJ 
CH2-IH -~H-C-OH 
N-CH3 CH-OH 
I 
cocaine ecgonine 
Fig. 1.2 Structure of cocaine and ecgonine 
The benzoic acid hypothesis was soon criticized 
(Poulsson, 1890). It was pointed out that benzoyl-ecgonine 
was inactive and that many analogoues of cocaine with other 
organic acids possess considerable anaesthetic potency 
(Stockman, 1885-1886). 
The toxicity of several compounds related to cocaine 
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was found to be practically identical (Ehrlich, 1890) ~hile 
only a few of them, which were esters of acids closely 
related to benzoic acid, were potent LAs. Later Ehrlich and 
Einhorn (1894) suggested that the ability to induce 
anaesthesia is a common property residing in widely differ-
ing organic compounds. The term "anaesthesiophor" introduced 
by Ehrlich (1890) has since been used widely to indicate the 
structural fragments of a molecule to which the LA effect 
could be assigned. 
In an homologous series, LA parameters such as potency 
or duration usually increase with increasing molecular weight 
for the lower members until a maximum is reached. Further 
increase of number of carbon atoms decreases the anaesthetic 
effect (Abreu et al., 1955; Bftchi, Cordes and Perlia, 
0 
1964; Ekenstam, 1966; Aberg et al., 1977). 
Miescher (1932) demonstrated that effective LAs possess 
certain general structural characteristics and noted: 
(1) Compounds with LA activity are oxygen-containing 
substituents that are bonded to either higher aliphatic 
and hydroaromatic groups or equally to electro-
negative groups, such as alkylene and trichloromethyl 
groups (narcotics), aromatic and unsaturated hetero-
cyclic rings (e.g. benzoic acid, p-aminobenzoic acid, 
cinnamic acid, and quinoline-4-carboxylic acid 
derivatives). 
(2) The carbonyl group exhibits a particularly 
satisfactory effect in the form of the ester group 
(procaine series), keto group (Falicaine series) and 
as the amide group in an a-position to an unsaturated 
ring (cinchocaine series). 
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(3) In general, an increase in the local anaesthetic 
activity can be reached by: 
(a) introducing higher alkyl groups in the form 
of side chains, 
(b) introducing alkoxy groups which improve 
the lipid solubility, 
(c) introducing basic substituents which improve 
the basicity of compound as a whole, and 
(d) accumulation of aromatic and heterocyclic 
rings • 
• Lofgren (1948) also gave a generally all-inclusive 
formulation of these relationships. His own results and 
his study of the literature led him to the conclusion, that 
almost all useful LA molecules can be arranged according to 
the following scheme: 
lipophilic part~ intermediate chain~ hydrophilic part 
which usually can be expressed as: 
. 
aromatic portior ~ intermediate chain ~ amine portion 
Most of these compounds can, according to this point of 
view, be subsumed under the simple structure outlined in 
Table 1.1. 
Aromatic radicals are primarily phenyl with different 
kinds of substitued phenyl groups, as well as 2-alkoxyquino-
line groups. The connecting chain contains a hetero atom 
(0, N, or S) in an ether, alcohol, ketone, ester, amide, 
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Table 1.1 Chemical Structure of Local Anaesthetics 
Lipophilic Intermediate Hydrophilic 
I· Aromatic radical ~nnecting chain --i Amine group ! 
~i g!-.e~CnH 2 n +1 
0CH2)n-
OCH2)n-
v -9,-0{ CH 2 )2-3 -0 
-~-s-{ c~)2-3-
o . 
- Y,-NH-(CH2) 2-J-
0 
-NH-C (CH) -
•• , \ 2 2-3 
0 
-NH- q-o{cH2) 2_3 -
0 
" }-( CH2)2-3-
-o 
( :i· 1 1 ,\ K=H, -NH2• -NHR· -oH. -oR. -CH3• -c1J 
.. (After Buchi, et al, 1964) 
-0 
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amine or thio ester linkage. The amino group can be 
secondary or tertiary in nature and may carry alkyl, 
hydroxy alkyl, or aralkyl groups, or can be pyrrolidino, 
piperidine, pipecolino, or morpholino radicals. 
Doerge (1971) mentioned some general examples which 
show that a change of structure changed the activity. 
(a) The most desirable position of the amino group on 
the aromatic ring is para to a carboxy group. 
(b) The introduction of a methylene group (CH 2 ) as in 
phenylacetic acid, will decrease the activity. The 
following structure (I) is practically inactive 
(c) The carboxyl group must be conjugated with an aryl 
group. Therefore the following structure (II) has 
no LA activity. 
(II) 
than are the esters of benzoic acid, p-hydroxybenzoic 
acid and p-alkoxybenzoic acid. 
Similar observations were made by Brrchi and Perlia 
(1972) ~ho illustrated the relative importance of the LAs 
chemical constitution, by eliminating individual molecular 
functions and assessing LA effectiveness (Table 1.2). 
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Table 1.2 Influence of Chemical Change on Local Anaesthetic 
Activity of Procaine (+ = Active; - = Non-Active). 
H2N-Q-g-o-CH~CH2-'N (c2HJ2 
"\N-Q-go-CH2CH2- NH-C2H5 
"\N-Q-go-CH2CH2-NH2 
"\N-Q-g-o-CH2 CH2-H 
H-Q-g-o-CH2CH2 N(~s)2 
H2N-Q-g-oH 
CH 3CH2CH2~-0-CH2CH2- N (C2H* 
0 
" 
LA Activity 
Surface Regional 
+ ++ 
(+) + (+) 
(+) + 
++ 
+ 
(After Buchi and Perlia, 1972) 
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1.1 • 6 Mechanism of Action as Local Anaesthetics 
The LAs in the form of the unprotonated amine tend 
to be only slightly soluble and unstable in solution. 
Therefore, they are generally marketed in the form of their 
water-soluble salts, usually the hydrochlorides. In as much 
as the LAs are weak bases the salt solutions are quite acid, 
a condition that fortunately increases their stability and 
that of any accompanying vasoconstrictor substance with which 
LAs are often formulated. It has been predicted, that 
previous alkalinization of an anaesthetic solution (Gros, 
1910; Fosdick et al., 1930; de Jong,1969), or the use of a 
salt of a weak acid such as the borate or carbonate salt of 
the LA (Bignon,. 1892), will increase its clinical efficacy. 
However, objective tests have failed to substantiate this 
point (Ritchie and Ritchie, 1968), and more alkaline 
preparations have the disadvantage of being relatively 
unstable. 
The most useful LAs are secondary or tertiary amines 
which will exist as uncharged or positively charged ions 
depending on the pH of the solution and on the dissociation 
constant (pK ) of the compound. The ionization of a typical 
a 
LA may be depicted as follows: 
+ 
+ H 
The more alkaline the solution, the greater is the 
proportion of anaesthetic in the uncharged form. 
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The pKa's of most LAs in common use lie between 8.0 and 
9.0, so that only 5 to 20% will be in the form of 
unprotonated amine at the physiological pH. This fraction, 
although small, is important because the drug usually has to 
diffuse through connective tissue and other cellular 
membranes to get to its site of action. It is generally 
agreed that it can do so only in the form of uncharged amine 
with its high oil/water partition coefficient (de Jong, 1969; 
Narahashi et al., 1970; Holroyd, 1978). 
There is every indication that LAs act on any part of 
the nervous system and on every part of nerve fibre 
(Vandam, 1960; Hsia and Boggs, 1975; strichartz, 1976). 
Their main site of action, however, is the membrane (Straub, 
1956; Shanes, 1958; Takman and Camougis, 1970; Seeman, 1972; 
Lee,· 1976) and there is seemingly little direct action of 
physiological importance on the axoplasm (Ritchie and cohen, 
1975). Those axoplasmic effects, such as effect on the giant 
axons of squid that do occur may be secondary to the membrane 
action (de Jong, 1969). 
LAs block impulse conduction by interfering with the 
movement of sodium ions and to a lesser extent potassium ions 
through the membrane (Vandam, 1960, Rothstein, 1968; de Jong, 
1969; Ritchie, 1975). 
Many different types of drugs, such as certain hie-
toxins, alcohols, the volatile and gaseous general anaes-
thetics, organic acids and bases, and certain substituted 
quaternary ammonium ions can block conduction of the nervous 
impulse (Ritchie, 1975). Because of the diversity of these 
molecular structures, Ritchie (1975) suggested that more 
than one mechanism is involved in the production of nerve 
block. However, Staiman and Seeman (1975) have shown that 
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the effects of mixtures of LAs are close to being additive, 
suggesting a single mode of action for the wide range of LA 
molecules. Only one group, however, has emerged as being 
clinically useful in producing local anaesthesia, namely 
certain aromatic amines (such as lignocaine, procaine, 
cocaine, amethocaine). 
Numer.ous theories have been proposed for the mode of 
action of LAs. They may be summarized as follows (Bllchi and 
Perlia, 1972; Ritchie, 1975; Lee, 1976; 1979; Boggs et al., 
1976). Local anaesthetics may: 
(1) interfere with chemicals involved in nerve con-
duction; 
(2) alter the density of fixed charges on the 
surface of the membrane; 
(3) cause an expansion of some region of the 
membrane that is critical for conduction; 
(4) react with some specific receptor in the 
nerve membrane; 
(5) cause protein perturbation; 
(6) close the sodium channel by changing the 
lipid molecules surrounding it from the gel, 
to the fluid, liquid crystalline phase. 
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SECTION TWO 
GENERAL CONCEPTS OF ANTIMICROBIAL ACTIVITY 
It would be quite wrong to discuss the antibacterial 
activity of any chemical compounds without considering the 
structure of their likely targets. In this project, LAs are 
being considered as antibacterial agents and their target is 
thus the components of the bacterial cell. 
1.2.1. Structure of Bacterial Cell 
Bacteria are prokaryotic and unicellular. The 
essential features of a very "generalised" bacterial cell 
are shown in Fig. 1.3. 
Three fundamental divisions of the bacterial cell 
occur in all species: cell wall, cell or cytoplasmic 
membrane, and cytoplasm. Two types of thread like appendages 
may be found growing from bacterial cells, namely, flagella 
and fimbriae or pili (including the sex or F-pilus). 
Surface adherants (capsules, slime and extracellular 
substances) can be seen in some bacteria (Hugo, 1977; Murray, 
1978). 
Flagella are threads of protein often 12-15~m long 
which start as a small but complex basal organ at the 
cytoplasmic membrane. They are responsible for the movement 
of motile bacteria (Murray, 1978; Stanier et al., 1980). 
Pili are organs of attachment. They are responsible 
for haemagglutination in bacteria and also for inter cell 
adhesiveness giving rise to clumping. The sex or F-pilus is 
part of a primitive genetic exchange system in some bacterial 
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Fig. 1.3 Diagram of a dividing rod-shaped bacterium to 
illustrate anatomical relations of various structures: as, 
adhesion sites cap, capsule; cyt, cytoplasm containing ribo-
somes; F,flagella with 'hook' attachment to Fbc, the 
flagellar basal complex, f, fimbriae (common pili); g, 
inclusion granules and ribosome-free cytoplasm; i, simple 
membrane intrusion; m, mesoseme ; n, nucleoplasms; PM, 
plasma membrane; p, polar membrane; pe, periplasmic space; 
RS, regularly structured outer wall layer (s); S, septum; 
sm, stacked membranes; w, cell wall. 
(After Murray, 1978). 
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species. Through them part of the genetic material may be 
passed from one cell to another, thus giving rise to a 
simple form of sexual reproduction. 
some species of bacteria accumulate material as a 
coating of varying degrees of looseness. If the material 
is reasonably discrete it is called a capsule; if loosely 
bound to the surface it is called slime. Their function is 
likely to be protective for both the Gram-positive and Gram-
negative bacteria (Meadow, 1978). 
According to Schott and Young (1972) the nature of the 
exterior surface of bacteria (the cell wall) is of 
considerable interest because it is the first region of the 
cell with which nutrient, antibacterial agents or any other 
substances come to contact. 
Bacterial cell walls, especially those of Gram-positive 
organisms, are fairly robust structures which protect the 
cell from osmotic lysis. Mitchell and Moyle (1959) found 
that solute concentrations in Staphylococcus aureus 
cells were capable of generating an osmotic pressure of 
about 20 atmospheres. such a high pressure is capable of 
bringing about the osmotic lysis of the cytoplasmic 
membrane and it is the cell wall with its great tensile 
strength which prevent this. 
The main difference between Gram-negative and Gram-
positive bacteria lies in the composition of the cell enve-
lope (cell membrane + cell wall). It consists of a basic 
structure of alternating N-acetylglucosamine and N-acetyl-
3-0-1-carboxylethyl-glucosamine molecules, giving a 
polysaccharide backbone. This is then cross-linked by 
peptide chains, the nature of which is different in each 
species. 
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This basic peptidoglycan (murein) , is attached by 
covalent links to teichoic acid molecules (in the case of 
Gram-positive bacteria, Fig. 1.4), or lipoprotein molecules 
and a layer of lipopolysaccharide (in the case of Gram-
negative bacteria, Fig. 1.5). 
In Gram-negative bacteria the complex outer layers 
beyond the murein sacculus must protect the organism to a 
certain extent from the action of toxic chemicals and may 
act as a crude "outer membrane" (Brown, 1975). 
In addition, periplasmic spaces within the cell 
envelope may constitute chemical defence zones in which 
enzymes such as penicillinases may be found (Stanier et.al, 
19 80) • 
The cell membrane is a very delicate structure found 
beneath and in some places, firmly attached to the cell wall. 
It is the site for very many physiological processes and is, 
therefore, prone to damage induced by chemicals. 
Chemically the bacterial membrane is similar to other 
biological membranes (Salton, 1971). It consists of 
phospholipid and protein, though carbohydrates, may also be 
present (Weibull, 19571 Salton, 19671 Estrugo et al., 19721 
Hugo, 1977). 
A "unit membrane" structure was proposed by Danielli 
and Davson (1935), and in various modifications still forms 
the basis for many membrane models (Fig. 1.6(a , b)). This 
model as modified by Robertson (1962), proposes a three 
layered structure1 protein-lipid-protein. The two lipid 
monolayers occupy the middle layer with their hydrocarbon 
chains faced end-to-end and their hydrophilic ends pointing 
outwards contacting protein dense layer. This triple-layer 
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Fig 1.4 Diagram of Gram-positive cell envelope. +,Free 
cation; ® bound cation; - Free anion; e bound anion; e--e, 
adhesion point due to ionic bound; ii;, hydrophobic zone; 
~ , cross linking polypeptide in the peptidoglycan; --
polysaccharide; ~ , enzymatically active protein;~, teichoic 
and teichuronic acid polymers; ~ , phospholipid; bp, binding 
protein; em, cytoplasmic membrane enzyme which synthesizes 
macromolecular components of the cell wall; ec, cytoplasmic 
membrane enzyme whose function is directed to the cytoplasm; 
ep, periplasmic enzyme; es, surface enzyme; ps, permease; s, 
structural protein of cytoplasmic membrane; cc, capsular carbo-
hydrate; cp, capsular protein. 
(After costerton, 1977). 
DETAIL OF 
MEMBRANE 
ARCHITECTURE 
+ 
I 
I 
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Fig. 1.5 Diagram of Gram-negative cell envelope. 
PRESSURE 
+ 1 Free cation; @,bound cation ;-,Free anion ;9,bound anion; 
9-Ql,adhesion point due to ionic bond;. :::,hydrophobic zone; 
)~,covalent bond;~,cross linked polypeptide;--,polysaccharide; 
~,enzymatically active protein;~,lipopolysaccharide;~, 
phospholipid; bp, binding protein; s and p,protein components of 
membranes; em, cytoplasmic membrane enzyme which synthesizes 
macromolecular components of the cell wall; ec,cytoplasmic membrane 
enzyme whose function is directed to the cytoplasm; ep,periplasmic 
enzyme; es,surface enzyme; ps,permease; pl and lp,protein and 
lipid components of lipoprotein bridges between outer membrane and 
peptidoglycan wall. After costerton et al (1974). 
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Fig 1.6: Models of membrane structure 
(a) After Danielli and Davson (1935) 
(b) After Stoeckenius and Engelman (1969) 
(c) After Singer and Nicolson (1972) 
(b) 
(c) 
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sandwich is thus posed between internal and external 
environments and passage from one to the other would 
involve transport through: protein, lipid and protein. The 
hydrophobic layer, or core, would f=m an osmotic barrier, 
protein could form binding sites and/or enzymes involved in 
transport processes. This membrane model has been subjected 
to much study and criticism; the arguments have been 
assembled and reviewed by Stoeckenius and Engelman (1969). 
The modern theory of the structure of cell membrane is 
of a phospholipid bilayer, in which protein molecules are 
embedded. This is thought to be common to a variety of 
membrane ranging from the cytoplasmic membrane of prokar-
yotes, to those of erythrocytes and mitochondria (Singer and 
Nic.olson, 1972; Fig. 1.6(c)), though some chemical 
differences are apparent in the components of membranes from 
different sources. 
Certain enzymes and especially the electron transport 
chain which are located in the membrane are responsible for 
transport systemswhich utilise: electrochemical potential 
of the proton to power it. Salton (1971), listed the follow-
ing as membrane associated enzymes: succinate, malate and 
lactate dehydrogenases, cytochromes, cytochrome oxidase, 
NADH oxidase , mannosyldiglyceride synthetase and ATPase. 
Also permeases, the group of enzymes implicated in the active 
transport of metabolites are located in the membrane (Cohn 
and Monad, 1957) • In addition the plasma membrane is 
intimately involved in the biosynthesis of all cellular 
elements external to it, such as cell-wall mucopeptides, 
lipopolysaccharidesand teichoicacids,and it apparently 
ensures the equal partitioning of the genome among daughter 
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cells at division (Harold, 1970). 
Despite the complexity of some microbial envelopes, 
the plasma membrane appears to be in all cases the main 
osmotic barrier between internal and external media of the 
cell. The barrier is permeable to water. Other substances 
cross the membrane as a result of specific mechanisms, which 
fall into three classes (Harold, 1970; Gale et al., 1972; 
Franklin and Snow, 1975): 
Passive diffusion: In this case the substance diffuses 
into the organism by passing down a concentration or 
electrical gradient. This process obeys the laws of 
diffusion and is normally terminated when the concentration 
of substance outside the cell is balanced by the concentra-
tion inside the cell. The substance must be sufficiently 
soluble in the hydrophobic medium of the membrane to allow 
it to shuttle across the barrier. 
Facilitated diffusion: This occurs when substances 
which are insoluble in the hydrophobic barrier of the cell 
membrane react with a carrier within the membrane. The 
carrier-substance complex is then shuttled across the 
membrane, following which the complex is broken down and the 
substance released into the cell (Fig. 1.7). 
Active transport: In this case, uptake is by carrier-
mediated transport which unlike facilitated diffusion cannot 
pass across the membrane in the absence of a source of 
energy (Fig. 1.8). Inhibition of energy generation or 
coupling results in immediate and direct inhibition of 
transport. 
The nature of the coupling of energy production to 
transport is still a matter for debate. There are three 
major hypotheses: 
outside 
Fig 1.7 
outside 
Fig 1.8 
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membrane inside 
Facilitated diffusion: Metabolite (M) 
binds to mobile carrier (C) at the outer 
face of the membrane. The CM complex 
diffusesthrouah the membrane and dissociates 
at-the inner surface, releasing M into the 
cell interior. 
(After Harrison and Lunt, 1975). 
membrane inside 
Active transport: the permease model: 
Metabolite (M) binds to permease (P) at 
the outer face of the membrane. The PM 
complex diffuses through the membrane 
and at the inner surface P is phosphorylated 
by the 'high energy' compound (H-P), resulting 
in a modified permease (PP) and in release of 
M. Alternatively the permease can act as a 
facilitated diffusion carrier as shown in the 
upper part of the scheme. 
(After Harrison and Lunt, 1975). 
(a) 
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Chemical coupling hypothesis: Electron transfer 
leads to the formation of a covalent high-energy 
intermediate that serves as a precursor of ATP 
(Slater, 1966). 
(b) Conformational coupling hypothesis: This is a 
variant of the chemical coupling hypothesis. It 
proposes that conformational changes in membrane 
proteins are mediated by ATP and are responsible for 
driving translocation processes (Green et al., 1968 ; 
Young et al., 1971). 
(c) The Chemiosmotic - coupling hypothesis: (Mitchell, 
1967; 1968; 1970). Which proposes that, the membrane 
is impermeable to H+ and OH, that the electron 
transport system in the membrane sets up a proton 
gradient across the membrane, and that the proton 
gradient then provides the source of energy to drive 
transport processes (Fig. 1.9). 
Mitchell's chemiosmotic theory is substantiated 
by the finding that uncoupling agents such as 2,4-dinitro-
phenol (DNP) act as specific conductors of protons across 
bacterial, mitochondrial, and artificial membranes, thereby 
modifying part of the proton motive force across the membrane 
(Mitchell, 1961; 1970), and that these uncouplers are able 
to discharge transport processes (Hamilton, 1968). 
The cytoplasm, which is a semifluid material, contains 
all the remaining components necessary for the life of the 
cell. These include those enzymes that are not present in 
membrane, reserves of food material, structures involved in 
the synthesis of protein (ribosomes and associated m-RNA and 
t-RNA) and the genetic material responsible for the 
inheritable character of the cell (DNA). 
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Fig 1.9 Active transport: The chemiosmotic model: The 
electron transport chain (ET chain), produces a 
transmembrane gradient. Proton Symport (PS) 
combines with metabolite (M) and protons (H). 
Protons run down their concentration gradient and 
power the active uptake of M. Uncoupler (UC) 
short-circuits the proton return and diminishes 
the power source. Under these conditions PS 
can still function as a facilitated diffusion 
carrier as shown in the lower part of the 
diagram. 
(After Harrison and Lunt, 1975). 
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1.2.2 Drug-Cell Interaction 
The first apparent interaction of a drug with the '~hole 
cell is when the compound is adsorbed onto the cell surface. 
The uptake of the drugs by cells have been measured by many 
workers as an initial study of their mode of action. Many 
drugs are readily taken up by bacteria, the amount adsorbed 
increasing with increasing drug concentration. The extent 
of adsorption of any drug by bacteria is likely to be 
governed by three principles factors, namely: drug 
concentration, bacterial cell numbers, and the time that the 
drug and the cell are in contact. 
The drug-cell adsorption isotherm may show a point of 
inflection or change in slope, corresponding to a paritcular 
biological response (e.g. Salt and Wiseman, 1968), and the 
overall shape of the isotherm may give some indication of 
the interaction involved in the uptake process. 
Giles et al. (1960) and Giles and Smith (1974) 
classified isotherms obtained for adsorption from solution 
into four basic patterns. According to the nature of slope 
of the initial portion of the curve, the isotherms are 
grouped as s, L, H and c types, plus an additional special 
case, the z shape. Numerous workers have made use of this 
system to interpret drug cell interactions. Some example 
of the adsorption of antibacterial substances by micro-
organisms that have been reported in literature are: uptake 
of cetrimide by Staphylococcus aureus and Escherichia coli 
(Salton, 1951), chlorhexidine by Staph. aureus and E. coli 
(Hugo & Longworth, 1964), cetyltrimethylammonium bromide 
(CTAB) by E. coli (Salt and Wiseman, 1968, 1970), benzyl and 
phenethyl alcohols by E. coli (Lang and Rye, 1972), some p-
hydroxybenzoate esters by E. coli (Lang and Rye, 1973u3-and 4-
' 
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chlorophenol by Pseudomonas aeruginosa (Gilbert and Brown,1978) 
Following adsorption, secondary processes will occur 
leading to the inhibition of the reproductive and metabolic 
process of the cell. Wilson et al. (1975), summarized the 
target for antibacterial attack in the bacterial cell as in 
Fig. 1.10. 
Hugo (1976) included essentially the same targets for 
chemical inactivation of the bacterial cell in three groups: 
1) the cell wall, 2) the cytoplasmic membrane and 3) the 
cytoplasmic contents. Cytoplasmic membrane, includes the 
membrane itself and membrane associated enzymes. Within 
the cytoplasm, targets (both soluble and insoluble) include 
the ribosomes, the nucleic acids, cytoplasmic enzymes and 
general cytoplasm proteins which may be coagulated. 
The wall is a prime target for chemical inactivation. 
Any drug which impairs the structure or synthesis of the 
cell wall (e.g. the penicillins) will indirectly facilitate 
membrane damage. Division may be impaired as may enzyme 
function (Hugo, 1976). Lysis of the cell often follows 
cell wall damage (Huge, 1967). 
Chemicals may cause damage to the cell membrane and 
its associated biochemical processes without any direct 
effect on the cell wall. This would include: 
a) induction of leakage, so that small molecular 
weight substances such as amino acids, purines, 
pyrimidines, sugars and cations, especially K+, 
leave the cell, 
b) the inhibition of membrane enzymes especially 
adenosine triphosphatase (ATPase), and 
c) the attenuation of the membrane electrochemical 
potential set up by the extrusion of H+ during 
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Targets for antibacterial attack in 
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1: active enzyme centre 
2: allosteric changes in enzymes 
3: DNA 
4: the ribsome system responsible-for 
protein synthesis 
5: the cell membrane 
6: the cell wall 
(After Wilson et al, 1975) 
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metabolism. 
Membrane damage has been detected after treating cells 
with many different compounds. For example, early studies 
of haemolysis showed that it could be induced by simple 
detergents (Schulman and Rideal, 1937; Pethica and 
Schulman, 1953), and by analogy Kuhn and Bielig (1940) 
suggested that quaternary ammonium compounds (QACs) because 
of their ability to dissociate conjugated proteins, might 
act on the bacterial membrane (a lipo-protein conjugate) 
and damage it in a manner resembling haemolysis. 
Many other drugs have been shown to promote leakage 
from bacterial cells. For example, leakage from: 
P.aeruginosa by polymyxin (Newton, 1953); E. coli and 
Staph. aureus by chlorhexidine (Hugo and Longworth, 1964 ; 
1965); Micrococcus lysodeikticus by chlorhexidine (Rye and 
Wiseman, 1964; 1965); E.coli by chlorhexidine (Rye and 
Wiseman, 1966); E. coli by CTAB (Salt and Wiseman, 1968); 
E.coli by novobiocin (Morris and Russell, 1970); 
E. coli and Staph. aureus by Fentichlor (Hugo and Bloomfield, 
1971a); Staph. aureus by Triton X45 and Triton X100 
(Lamikanra and Allwood, 1977a). 
Many enzymes are attached to membrane. Membrane-
bound ATPase has been implicated in the utilization of the 
trans-membrane pH and proton gradient to power energy 
dependent transport in microbial cells as postulated in 
Mitchell's chemiosmotic theory. Harold et al (1969) 
showed that chlorhexidine and DI09, inhibited this 
enzyme in Streptococcus faecalis. 
The membrane-bound electron transport chain of 
Bacillus megaterium was shown to be inhibited by hexa-
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chlorophene (Frederick et al , 1974). 
Several workers have shown that a group of chemicals 
will atte.nuate the membrane electrochemical potential 
generated by metabolism and, as a result, inhibit anabolic 
reactions dependent on it. These are uncoupling agents, 
some of which are also used as disinfectants. The classical 
uncoupling drug is 2,4-dinitrophenol. Its action as an 
uncoupler and an inhibitor of substrate uptake has been known 
for many years (Harold, 1970; Gale,et al, 1972). Similarly 
Hugo and Bloomfield(1971b) demonstrated that bacteriostatic 
concentrations of Fentichlor inhibited energy dependent 
uptake of substrates by E.coli and Staph. aureus. Later 
Bloomfield (1974) showed that Fentichlor was able to 
dissipate the membrane pH gradient in Staph. aureus. 
High concentrations of many antimicrobial agents, 
have been shown to cause protein precipitation. This 
observation led Hugo (1967) to ascribe rapid antibacterial 
induced cell death, to general protein precipitation. In 
rapid cell death, subtle long term effects like the leakage 
of cytoplasmic material tend to be masked by the dramatic 
precipitation of protein which is observed. 
There are two types of proteins, structural and 
enzymic. Both are characterised by the specifity of their 
structure and anything that disturbs the delicate balance 
of charges on the surface of the structure will bring about 
rapid denaturation. Enzymic proteins have highly specific 
contoured surfaces which carry more charges than those on 
9tructural proteins. For this reason, they are more prone 
to precipitation than the more stable structural proteins. 
Precipitation has been observed microscopically, by 
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light scattering techniques and by the effect of drug on 
cell free extract (Hugo and Longworth, 1964; 1965; 1966; 
Hugo, 1967; Hugo and Daltrey, 1974; Silva et al., 1976). 
A number of antibacterial dyestuffs belonging to the 
acridine series have been shown to impair the function of 
bacterial nucleic acids. Dyes such as proflavine fit, or 
intercalate, into the double-stranded DNA helix and thereby 
prevent its function (Franklin and Snow, 1975). 
Although the ribosomes are a target for many 
antibiotics (e.g. Vazquez, 1966; Modolell and Davis, 1970; 
Cundliffe, 1972), they are not normally a specific target 
for chemical disinfectants. 
1.2.3 Antimicrobial Activity of Local Anaesthetics 
Complications, including infection, following the 
clinical use of local anaesthetics have been reported 
(Massey Dawkins, 1969). The common use of LAs during 
dental procedures has led to concern over the possible 
introduction of microorganisms along the path of the needle 
during infiltration (Streitfeld and Zinner, 1958; 
Winther and Praphailong, 1969; Zaidi and Healy, 1977) and 
this has given rise to much discussion over the need for 
disinfection of the oral mucosa at the site of injection 
(Streitfeld and Zinner, 1958; Davis, 1961; Winther and Khan,. 
1971). 
LAs are frequently administered topically before 
samples for microbiological evaluation are obtained from 
certain sensitive area of the body. These areas include the 
cornea, the upper respiratory tract including the sinuses, 
and areas of the urinogenital tracts. In such cases, it is 
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essential that the LA administered should not interfere 
with the growth of organisms present in the sample. 
That LAs possess antibacterial properties was first 
suggested by Jonnesco (1909)., though it ·was not until 
Schlegel and Swan (1954), described the inhibition of growth 
of two organisms by 0.2% benoxinate that more specific 
information began to be available. Over the next few years 
it became apparent that LAs may interfere with the growth of 
microorganisms in clinical specimens (Murphy et al., 1955; 
Erlich, 1961; Conte and Laforet, 1962) and that antimicro-
bial effectiveness related to both LA and cell type (Hughes 
and Stewart, 1957). 
It has been commented that the antituberculous 
effects of amethocaine may be related to its chemical 
similarity to p-aminosalicylic acid (PAS) and p-aminobenzoic 
acid (PAB) (Conte and Laforet, 1962). However, no solid 
data is available to document such a suggestion. 
Kleinfeld and Ellis (1966) showed that amethocaine, 
benoxinate, and cocaine displayed inhibitory activity against 
staphylococcus albus, P.aeruginosa and Candida albicans. 
They also observed that proparacaine had only fungicidal 
action against c.albicans. These authors warned against the 
use of such topical anaesthetics before obtaining material 
for culture from ophthalmologic infections (Kleinfeld and 
Ellis, 1967). They also suggested that certain factors could 
influence the growth inhibitory effect of anaesthetic. These 
were, notably, LA dilution by tears or other body fluids, 
contact time, the number and type of organisms present, and 
the presence of viscous secretion which could protect the 
organism from contact with the anaesthetic. 
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Schmidt and Rosenkranz (1970) showed that both 
lignocaine and procaine inhibited the growth of most 
pathogenic bacterial and fungal isolates. Their results 
showed that Gram-negative bacteria were especially sensitive 
to the drugs, while species of c. albicans were resistant to 
concentration of drugs used topically (MIC > 2%) • Since 
neither lignocaine nor procaine selectively inhibited the 
synthesis of DNA, RNA or protein, they suggested that the 
basis of action of these agents may involve the cell wall or 
cytoplasmic membrane. 
They also mentioned that the use of LAs prior to the 
obtaining material for culture may account for frequent 
failure to recover etiologic agent. This is supported by 
evidence of the inhibition of two species of Pseudomonas by 
a fluoresein-anaesthetic solution, (Stewart, 1972). 
El.Nakeeb and Farouk ("1973) studied th~ effect of six 
LAs on the growth of Staph. aureus. Their results showed 
that amethocaine (tetracaine) , cinchocaine (dibucaine) and 
benzocaine have the highest activity followed by butacaine, 
lignocaine and procaine which were practically inactive in 
the concentration used. Both amethocaine and cinchocaine 
were considered to be bactericidal and benzocaine bacterio-
static. Later (1975, 1976), the same authors studied the 
activity of an admixture of these drugs with some preser-
vatives and found that LAs has synergistic, additive, or 
antagonistic combinations when evaluated against Staph. 
aureus, B. megaterium, E.coli, P.aeruginosa, and Sacharomyces 
cerevisiae. However, incubation of lignocaine (2%) with 
seven different antibiotics resulted in no change in 
antibacterial activity when measured by agar diffusion 
bioassay (Barza et al., 1974). 
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Of the agents used by l'leinstein et al (1975), 
amethocaine and hexylcaine displayed the highest level of 
broad spectrum antimicrobial activity. Benoxinate showed 
almost no activity and procaine only limited antifungal 
activity. 
Leung and Rawal (1977) investigated the mechanism of 
action of amethocaine against P.aeruginosa. They 
speculated that amethocaine acts on the phospholipids of 
the cell envelope possibly by inhibiting the binding of 
divalent cations to the anionic sites on the phospholipids. 
such a speculation was supported by their obGervation that 
Mg++ antoganizes the lytic and bactericidal action of 
amethocaine on P. aeruginosa. 
Observation of cellular lysis, leakage of 
intracellular material (260 nm absorbing materials), 
dehydrogenase activity, and a higher sensitivity of 
spheroplasts than of whole cells to amethocaine led them to 
the conclusion that amethocaine acts by damaging the cell 
membrane. They also found that the lytic action of 
lysozyme was potentiated by amethocaine, and they related 
this to the enhance permeability of the cell envelope. 
Zaidi and Healy (1977) confirmed that amethocaine 
is bactericidal for some common hospital pathogens, and 
suggested its use for extradural and caudal anaesthesia, 
and in other situations where there is a risk of infection. 
Cizmarik and Trupl (1978) studied the antimicrobial 
effect of heptacaine and two key synthetic intermediary 
products. Their results.indicated that heptacaine and one 
of the intermediate (2-heptyloxyaniline) have antimicrobial 
activity. They concluded that, some microorganisms seem 
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to split heptacaine enzymatically to the intermediate which 
is the actual antimicrobial agent. 
Silva et al (1979) described the effects that some 
LAs induced on Gram-positive bacterial cells. These 
effects included growth inhibition, reduction in the number 
of viable cells, lysis of protoplasts, permeability changes, 
characteristic ultrastructural alterations, and inhibition 
of membrane-bond enzymic activities. The quick and exten-
sive K+ efflux induced in treated bacteria led them to 
the conclusion that the cell membrane is directly 
affected by the anaesthetics and that membrane permeability 
is primarily disturbed. They also found a correlation 
between the activity of four drugs (chlorpromazine, 
nupercaine, amethocaine and procaine) and their lipid 
solubilities as indicated by octanol - water partition 
coefficients. 
Salt and Traynor (1979) showed that LAs induce 
increases in the turbidity of non-growing bacterial 
cultures, and suggested a similarity between their mode 
of action and that of quaternary ammonium compounds. They 
found a close correlation between the deduced critical 
micelle concentration (CMC) for amethocaine and that 
concentration in excess of which large induced increases 
in culture turbidity were detected. They concluded that, 
the uptake of amethocaine by E.coli may occur preferent-
ially when the molecules are in the micellar state. 
1.2.4 Aim of the Project 
The aim of this project was to review the current 
information on antimicrobial activity of local anaesthetics, 
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to evaluate their antibacterial effectiveness and their 
probable site(s) of antibacterial action. 
Four commonly used local anaesthetics were chosen 
for evaluation and comparison, to represent the two major 
LA types. Amethocaine and Procaine represent the ester 
linked compounds and Cinchocaine and Lignocaine the amides. 
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SECTION ONE 
MATERIALS 
2. 1 • 1 Organisms 
The organisms used during investigation in this 
project were obtained from either The National Collection 
of Type Cultures (NCTC), London or The National Collection 
of Industrial Bacteriology (NCIB), Aberdeen. These were: 
Escherichia coli (E.coli) NCTC 9001 
Pseudomonas aeruginosa(P.aeruginosa) NCTC 6749 
Bacillus megaterium (B.megaterium) NCIB 8291 
Klebsiella aerogenes (K.aerogenes) NCIB 8267 
2.1.2 Media and Associated Solutions 
Preliminary shaken culture experiments were 
performed to determine the composition of most suitable 
synthetic growth medium for the range of organisms used. 
Also the pH of the buffer and its capacity was chosen in 
such a way to be suitable for both bacteria and local 
anaesthetics. From these,the growth medium (2.1.2 vi) was 
·selected. 
( i) Trace elements solution (Cruickshank, 
Fe so4.1H20. O.Sg 
zn so4.1H20 O.Sg 
Mn so4.3H2o O.Sg 
H2 S04 0 .1N 10 ml 
Distilled water to 1000 ml 
Sterilized by filtration. 
1970) 
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(ii) Vitamin-free casamino acid solution 10g.100ml- 1 
sterilized by autoclave. 
(iii) Vitamin solution: 
Nicotinic acid. 
Thiamine hydrochloride 
Distilled water to 1000 ml 
sterilized by filtration. 
1.0g 
1.0g 
(iv) carbohydrate solutions (aqueous) 
(a) D-Glucose 201 (w/v) (unless otherwise 
stated) 
(b) D-Glucose and D-Galactose 31 W/v) 
sterilized by autoclave. 
( v) Mineral salts solution 
Mg Clz.6Hz0 
3.00g 
0.20g 
0.20g 
9.25gl 0.2 M phosphate 
S.S?g pH 6.4 - 6.5 KzHP04 
Distilled water to 1000ml 
sterilized by autoclave. 
(vi) Growth medium 
buffer 
Mineral salts solution 100ml 
Trace elements solution O.Sml 
Vitamin-free casamino acid solution 0.2ml 
Vitamin solution 0.1ml 
D-Glucose (201 solution) 1.5ml 
(vii) Carbohydrate free medium (CFM) 
Growth medium from which the carbohydrate 
solution had been omitted. 
(viii) 
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Low phosphate medium (LPM) 
Growth medium in which phosphate buffer had been 
replaced by: 
Potassium chloride 
Sodium citrate 
Citric acid 
-1 0.074g·l 
12
•
57g · 1-
1}citrate 
1 51 . 1-1 buffer 
• g pH 6.2 
and contained very low phosphate as impurities. 
(ix) Medium of variable magnesium content 
Growth medium with or without added carbohydrate 
in which the amount of magnesium chloride was 
varied. 
{X) Maintenance (solid) medium 
Growth medium solidified by the addition of agar 
(Oxoid No.3) 1.5% w/ v. 
(xi) Tryptone soya agar 
(xii) 
Tryptone soya broth 
Agar No.3 (Oxoid) 
Distilled water to 1000ml 
sterilized by autoclave. 
Acetate veronal buffer (AVB) 
Basic mixture 
N HCl (TQ) 
distilled water 
5 •. Oml 
7.0ml 
13.0ml 
0.25ml 
30g 
15g 
CaC1 2 (1M) 
Mg Cl2 (1M) 0.25ml 
pH adjucted to 6.1 
2. 1 • 3 
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Basic mixture consists of: 
sodium acetate 
sodium barbitone 
Sodium chloride 
distilled "!ater to 1000ml 
19.43g 
29.43g 
34.0g 
Reagents 
( i} Dye solubilization 
sundan Black B B.D.H. Chemicals Ltd. 
Poole, England. 
(ii} Pentose estimation (Mejbaum, 1939} 
FeC1 3 0.10g 
Orcinol 0.30g 
cone. HCl to 100ml 
(iii} voltammetric determination of inorganic 
phosphate (Fogg & Bsebsu, 1981} 
Acidic molybdate solution, 2% wfv: 35 ml of 
analytical-reagent grade concentrated 
sulphuric acid was added to 200 ml of water. 
5.0g of ammonium molybdate was dissolved in 
the resulting solution, and diluted to 250 ml 
with water when cooled. 
(iv} Dehydrogenase activity 
Triphenyltetrazolium chloride (TTC} 
Fisons, Loughborough, England. 
2 .1. 4 
- 47 -
Local Anaesthetics 
(i) Amethocaine hydrochloride (B.P.). Tetracaine 
hydrochloride (Eur.P., u.s.P.), 2-
Dimethylaminoethyl p-N-butylaminobenzoate 
hydrochloride. M.wt = 300.8 
Fig 2. 1 a 
A gift from Glaxo Group Research, Ware Ltd 
and purchased from Sigma Chemicals eo. Ltd. 
London, England. 
(ii) Cinchocaine hydrochloride (B.P.). Dibucaine 
hydrochloride (U.S.N.F.); 2-Butoxyquinoline-
4-carboxylic acid diethylaminoethylamide 
hydrochloride. M.wt. = 379.9 
, HCI 
Fig.2.1b 
A gift from Glaxo Group Research, Ware Ltd. 
Samples were also purchased from Sigrna 
Chemicals Co. Ltd. London, England. 
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(iii) Lignocaine hydrochloride (B.P.). Lidocaine 
hydrochloride (Eur.P., u.s.P.), a-Diethylamine-
2 , 6 -dimethylacetanilide hydrochloride. 
M.wt. = 270.8 
• H Cl 
Fig. 2.1c 
Gift from Johnson and Johnson, Slough, Bucks; 
Boots eo. Ltd. Nottingham, England and 
" " Astra Sodertalje, Sweden. 
( iv) Procaine hydrochloride (B.P., Eur. P.) .2-
Diethylaminoethyl p-aminobenzoate 
hydrochloride. M.wt. = 272.8 
, H Cl 
Fic:f.2 .1d 
Purchased from Sigma Chemicals Co. Ltd. 
London, England, or a gift from Boots eo. Ltd. 
Nottingham, England. 
Stock solutions of LAs were prepared with 
sterile minimal salts solution or appropriate 
medium. 
2. 1 • 5 
2 .1. 6 
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Antimicrobial Agents 
Ampicillin B.P. 
Chloramphenicol 
Puromycin 
Cetylpyridinium bromide 
Beecham Research Labs. 
Sigma Chemicals Co.Ltd. 
Sigma Chemicals Co.Ltd. 
B.D.H. Chemicals Ltd. 
stock solutions of antimicrobial agents wereprepared 
with sterile minimal salts solution, or appropriate 
medium. 
Miscellaneous 
(i) General chemicals were of Analar grade, 
unless otherwise stated • 
(ii) Radiotracers and associated materials: 
( iii) 
32 p -orthophosphate (Radiochemical Centre, 
Amersham, Buckinghamshire, England). 
Liquid scintillator KL 372(Koch-Light 
Laboratories, Ltd. Colnbroack, Bucks., 
England). 
Materials for electron microscopy: 
Glutaraldehyde (E.M. Grade) (B.D.H. Chemicals 
Ltd., Poole, England). 
Silver dag (Agar Aids) 
Round glass cover-slips, 13mm (Chance 
Propper Ltd.). 
Aluminium stubs , 15mm (Agar Aids) 
Copper grids, 200 and 400. mesh (Agar Aids) 
Gold palladium wire (Agar Aids) 
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Embedding medium: 
Araldite (Polaron Equip. Ltd. \vatford) 
GY 212 27ml 
Hardener (Polaron) HY 964 23ml 
Accelerator (N-Benzyl-dimethylamine-
Polaron) 1ml 
(iv) Materials for coulter counter: 
Polystyrene Beads (0.8 ~m), Dow Chemical Co. 
Michigan, u.s.A. 
Isoton II, Azide free electrolyte solution. 
Coulter Electronics Ltd., Luton, England. 
Formaldehyde (Formalin) Fisons, Loughborough, 
England. 
(v) Solvent for extraction: 
Chloroform (Spectroscopic grade) Fisons, 
Loughborough, England. 
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SECTION TWO 
GENERAL PROCEDURES 
2. 2. 1 Sterilization of Solutions and Equipment 
All solutions were sterilized either by standard 
autoclaving (at 121°c and 15lb.in2 for 15 min),or by 
membrane filtration using Nuflow 0.45 Millipore filters. 
In most cases, equipment was sterilized by standard 
autoclaving. In some instances, however, equipment (e.g. 
pipettes) was sterilized in a dry air oven at 150°C for 
2 hr. 
2.2.2 Cultivation of Organisms: All cultures were 
available as freeze dried speciments from standard collections. 
( i) Maintenance of cultures: Master cultures on 
growth medium slopes were stored at 2-4°c and subcultured 
at 3 month intervals. Cell sub-masterswere stored in the 
dark at 15-20°c on growth medium agar slopes. These were 
subcultured at 7-14 day intervals. Cultures were subjected 
to monthly routine microscopic and streak-plating exami-
nations. 
(ii) Cultivation and preparation of cell suspensions: 
Daily slope subcultures from sub-master slopes were 
prepared, and after overnight incubation at 37°C, the cells 
washed from the surface with growth medium to cleated 
conical flasks (1 litre) containing approximately 200ml 
sterilized growth medium. Such cultures were incubated in 
a Gallenkamp orbital incubator at 37°c with a rate of ea 
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170 rev. . -1 m1.n When an optical density of 0.6-0.7 (at 
650nm, 1cm path) using a Pye Unicam SP 500 series II UV and 
visible spectrophotometer, was reached, the cells were 
harvested by centrifugation at 5000 R.P.M. (4500g) in a HSE 
Mistral 6L centrifuge for 15 minutes. The supernatant fluid 
was decanted off and the cells washed with, and then 
resuspended in, fresh carbohydrate free medium (CFM). The 
optical density of this suspension was adjusted to the 
required value (usually 0.600 at 650nm, lcm path) by the 
addition of medium. 
Alteinatively, if dense cell suspensions were 
required, cells were grown on the surface of solidified 
medium in 1 litre-Roux bottles, containing approximately 
200ml sterilized solid growth medi.um at 37°C, for 12-15 hr. 
Cells were then harvested into a sample of the appropriate 
medium and agar fragments removed by low speed centrifuging 
(130g; 10 min). The cell suspension was carefully 
decanted and subjected to a further centrifuging process 
(4500g; 15 min). The supernatant was discarded and the cells 
washed with and finally resuspended in the required medium. 
The final optical density (650nm; 1cm) of such a suspension 
was typically adjusted to give a cell concentration, as 
required, in the range 7.6 x 10 9 - 10 cells.ml-1 • 
2.2.3 Determination of Dry Weight 
Membrane filters(0,45 ~m porosity) were washed with 
distilled water and dried at 95°C for 10 min. The filters 
were stored until use in a calcium chloride desiccator. 
100ml volumes of bacterial suspensions were filtered through 
weighed membranes. The cells were washed on the membrane, 
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which were then dried to constant weight. The cell weight 
was found by difference. 
2.2.4 Determination of Total Cell Numbers 
The actual number of individual bacteria per ml of a 
suspension was 
chamber (depth 
determined by means 
1 2 o.l mm, 400 mm ) • 
of a Hawksley counting 
One loop of a suspension 
of diluted bacteria was transfered to the platform of the 
Hawksley slide and covered with a coverslip. The liquid was 
then spread over the platform. The slide was allowed to 
stand for 5min,after which it was examined under a micro-
scope with a total magnification of X400. The number of 
organism in 50-100 small squares were counted (between 2 and 
10), and the mean number of organisms per small square was 
calculated. From these the count per ml of the original 
suspension was determined. 
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SECTION THREE 
SPECIFIC EXPERIMENTAL METHODS 
2.3.1 Assessment of Growth Inhibition 
(i) Tube dilution method 
Equal volumes (5ml) of bacterial cell suspensions 
in CFM or appropriate medium and drug solutions of different 
concentration were mixed in sterile capped test tubes and 
maintained at 22°c for 10 min, after which 0.15ml 20% 
glucose solution was added to each tube. The tubes were 
incubated at 37°C for 36-48 hr and the optical density 
(650nm: 1cm) measured. 
(ii) Direct assessment method 
Suspensions (20ml) containing the test compound and 
bacterial cells in CFM were incubated at 37°c in 100ml 
conical flasks in a Gallenkamp shaking water bath. After 
10 min contact time, sufficient glucose (0. 30ml) was added to 
promote active cell growth. The optical density of samples 
of each culture was measured (650nm: 1cm) at 10 or 15 min 
intervals after which the samples were returned to the 
appropriate flask. Optical density measurement was continued 
for approximately 2 hr. 
(iii) The effect of local anaesthetics on the growth 
and sze distribution of division inhibited 
cell suspensions 
The method based on that of Rye and Wiesman (1968) 
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was used. Equal volumes of cell suspension in CFH and of 
solution of the drug were mixed and shaken at 37°C in a 
water bath. After 10 min contact time, glucose {2mg.ml-1) 
and sufficient ampicillin to produce a final concentration 
of 2.0 ~g.ml- 1 were added. {This concentration of ampicillin 
was determined by prior experimentation, and suppresses cell 
division without drastically affecting the growth rate). 
Shake incubation was continued and growth of the cells was 
followed spectrophotometrically. 
At set time intervals 0.1ml samples were removed from 
each culture and diluted with Isoton diluent, containing 
0.2% formaldehyde, to facilitate counting an.d sizing with a 
Coulter electronic particle counter, model ZB, (Coulter 
Electronics Ltd. Harpenden, Herts., England). The counter 
was fitted with a 30 ~ orifice tube and was calibrated with 
polystyrene beads of0.8 ~m mean diameter. The size 
distributions were obtained by making counts with a two 
threshold unit window and with lower threshold setting at 
two unit intervals. 
(iv) Reversibility of growth inhibition 
20ml volumes of drug-cell mixtures were incubated 
for approximately 1 hr as described under 'Direct assess-
ment method (2.3.1. ii). The cultures were then subjected 
to one of the following: (a) the cells were centrifuged 
down (4500g, 10 min, 4°C) washed with and then resuspended 
in 20ml fresh growth medium at 37°C or (b) diluted SO-SO 
. 0 
with fresh growth medium at 37 c. In each case shake 
incubation was continued and cultures optical density 
monitored for a further 2 hr. 
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(v) Diau xic grmvth curves in the presence of anti-
microbial agents 
Two different techniques were employed:-
(a) Drug added before the carbohydrates. 
(b) Drug added just before diauXic lag phase. 
(a) To each 10 ml of cells suspended in CFM, 
an equal volume of antimicrobial drug 
solution was added to give the required 
final concentration. One flask was left 
without drug, so as to act as a control. 
The flasks were incubated in a shaking 
water bath at 37°c and after 10 min, 0.10ml 
. w/ 
of glucose-galactose (3% v) solution, was 
added to promote active cell growth. 
Samples were removed at about 10 min inter-
vals from the shaking flasks and the 
optical density read at 650nm (1cm). 
(b) To each flasks containing bacterial cell 
suspensions in CFM, 0.10ml of a mixture of 
glucose-galactose (3%w/v) was added to 
promote active cell growth. The exact 
time of onset of the diauxic lag had been 
determined by prior experimentation and at 
this time, equal volumes of antibacterial 
drug solutions were added to give the 
required concentrations. Samples were 
removed at about 10 min intervals through-
out the continuance of the experiment. 
Optical density were measured at 650nm (1cm). 
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2.3.2 Viable Counting 
A set of sterile capped test tubes containing equal 
volumes (5ml) of different concentration of the test solution 
were prepared. 5ml of bacterial cells suspended in CFM 
(optical density 0.60 at 650nm) were added to each tube. 
After 10 min contact time at 22°c, cell suspensions were 
serially diluted, to obtain a countable colonies. From the 
last three sets of tubes, duplicate 0.2ml samples were 
added separately to three pairs of petri dishes. This was 
repeated for each different concentration of the drug. To 
each petri dish, 10-15ml tryptone soya agar (previously 
melted and cooled to ea. 50°C) was added and the samples 
were incubated at 37°c. After 24 hr the colonies were 
counted. 
The experiment was repeated varying the medium 
composition the number of bacterial cells initially 
present and the contact time. 
Preliminary experiments showed that use of tryptone 
soya broth or Ringer solution, with or without Tween 80 as 
a diluent, for the inactivation of LAs did not alter 
significantly the number of colonies counted, therefore, 
minimal salts solution was used as a diluent. 
2.3.3 Leakage of Intracellular Materials 
(i) Effect of LAs on 32P labelled bacterial cells 
A method similar to that described by Rye and 
Wiseman (1966) was used. 32P labelled bacterial cells were 
prepared by addition of 1 ~Ci of 32P orthophosphate to 
washed growing cells briefly resuspended in LPM at 37°C, 
followed 90 seconds later by addition of 5ml of 0.1M 
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potassium dihydrogen orthophosphate. After 1.0 min the 
labelled cell suspension was centrifuged (5 min, 7000g) 
washed with and then suspended in CFM. The optical density 
was adjusted to 0.60 with more CFM. 
Equal volumes (2.5 ml) of suitable concentration of 
drug in CFM and of labelled cell suspension were mixed and 
maintained at 22°c. After 10 min contact time, the cells 
were removed by centrifuging at 4500g for 10 min and 1ml of 
the supernatant (duplicate) was added to 10 ml of liquid 
32 
scintilator. The P content of the supernatant of these 
samples was determined by counting for 10 min, using a 
liquid scintilation counter (LKB lvallac 1215 Back Beta). 
32P content of the cold trichloroacetic acid 
soluble fraction (metabolic pool) was determined by mixing 
equal volumes of bacterial cell suspensions with 10% 
trichloroacetic acid and maintaining the reaction mixture 
at 4°C for 30 min. The radioactivity in the supernatant 
was measured as above. 
(ii) Voltammetric determination of inorganic 
phosphate 
Orthophosphate can be determined voltammetrically at 
a glassy carbon electrode in dilute sulphuric acid solution 
(pH2) as 12-molybdophosphate or molybdenum blue, which give 
anodic waves at +0.14 v or+0.30 V vs. s.c.E. (saturated 
calomel electrode) respectively (Fogg and Bsebsu, 1981). 
(7.6 X 
Equal quantities 
9 -1 10 .ml ) and LA 
(2.5ml) of cell suspensions 
solutions in LPM were mixed and 
maintained at 22°C for 10 min. Cells were then removed by 
centrifuging at 7000g for 15 min (MSE Mistral-super speed) 
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and the supernatants collected for assay. 
Aliquots of standard orthophosphate solution 
( 1 0- 4_ 1 0- 5 M) or samples of supernatant were transfered to 
a series of 50 ml volumetric flasks. To each flask Sml of 
acidic molybdate solution (2% w/v) was added and the volume 
of each made up to approximately 20ml with distilled water. 
The solutions were left to stand for 15 min, then diluted 
to 50ml with more distilled water. Each solution was 
transfered to a votammetric cell and deoxygenated for 5 min 
with nitrogen gas. A clean dried glassy carbon electrode 
was then placed in the solution for 10 seconds, after which 
the cell circuit was closed. The initial potential was 
set at OV and a differential pulse mode was selected. The 
circuit was left closed for 20 seconds to stabilise the 
current and a differential pulse voltammogram between OV 
and + 0.3V was obtained. 
The electrode was cleaned between scans by washing 
with 1M solution of sodium hydroxide and then with 
distilled water before drying. 
Conditions set up for the polarographic analyser 
(PAR 174, Princeton Applied Research): a sweep rate of 
5 mvs-1 and a pulse height of 50 mV and a pulse frequency 
of 0.5 s were used. 
(iii) Estimation of pentoses 
When pentoses are heated with concentrated HCl, 
furfural is formed which condenses with orcinol in the 
presence of ferric ions to give a blue green colour 
(Mejbaum, 1939) 
Equal volumes (2.5ml) of the LA solutions and of 
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bacterial cells suspended in CFM were mixed to give final 
10 9 -1 cell concentrations of 3.8 x cells.ml • After 15 min 
or after other set time intervals at 22°C or 1°C the cells 
were removed by centrifuging at 7000g for 15 min at 4°c 
and 1.0ml samples of the supernatants were added to 1.0ml 
of reagent for pentoseestimation in test tubes. The tubes 
were heated in a boiling water bath for 20 min. The 
contents of each tube were then diluted with an equal 
volume of distilled water and the optical density 
measured at 675nm. D-ribose was used as the standard 
for a calibration curve. 
(iv) Release of 260nm absorbing material 
Equal volumes (5ml) of LA solutions and of cell 
suspensions were mixed to give the final cell concentration 
of 3.8 x 109 cells.ml-1 • After 30 min contact time at 
22°c, the cells were removed by centrifugation (7000g, 
15 min, 4°C). As the supernatant containedboth the non-
adsorbed LA (Amax = 220 - 320 nm) and the leaked material 
(Amax = 260 nm), the direct measurement of 260nm absorbing 
material would not have realistically reflected the 
concentration of leaked cellular constituents. To 
facilitate the assessment of 260nm absorbing materials 
leaked from the cells, the liquid/liquid extraction 
procedure of Beckett, Patki and Robinson (1959) was 
employed. The supernatant solution was shaken with portions 
of a water immiscible solvent, (chloroform of spectro-
scopic grade) to remove all the LA from the aqueous phase. 
The optical density (260nm) of aqueous phase after 
complete extraction was measured. 
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2.3.4 Uptake of Local Anaesthetics by Bacterial Cells 
Preliminary experiments determined that a suspension 
of at least 3.8 x 10 10 E.coli per ml was required to get 
measurable uptake. 
10 ml of double strength LA was prepared and equal volumes 
(5ml) was added to two sets of tubes; one containing equal 
volumes of CFM and the other bacterial cell suspension. Both 
sets were allowed to stand at 37°C with occasional shaking for 
a period of 30 min. 
After centrifugation of the set containing bacteria at 
7000g (4°C for 15 min), the supernatant of each tube was 
divided into two portions. The optical density of one 
portion was measured at the appropriate A of the LA. This 
max 
gave the optical density of the mixture of LA remaining 
after uptake, plus any leaked material. The second portion 
was extracted as described earlier (2.3.3 iv) and the optical 
density of this layer was measured at the appropriate Amax· 
The difference between the two measurement corresponds to the 
optical density of LA remaining in the supernatant after 
uptake has taken place by bacteria (c'). The difference 
between the optical density of set containing no bacteria (c) 
and (c'), after correction for the cell volume (see 3.4) will 
give uptake of LA by bacteria. 
2.3.5 Determination of the Critical Micelle Concentration 
(C~1C) 
This was achieved using two different methods: 
(i) Dye solubilization 
The solubilization of Sudan Black B by solution of LA 
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in CFM and doubled distilled water was studied by the 
equilibrating with the solutions an excess of solid dye 
( 1 Omg dye in 1 Oml solution) while they \vere shaking for 1 hr 
at 22°C. The mixture was centr~fuged at 4500g for 40 min to 
remove the undissolved dye. The maximum absorption wave 
length of one of the coloured supernatant was assessed using 
an SP 800 Ultraviolet Spectrophotometer (300 - 700 nm) and 
then the optical density (absorbance) of all supernatants was 
measured at that maximum wavelength. 
Preliminary experiments showed that the use of Sudan 
Black instead of Victoria Blue (Salt and Traynor, 1979) gave 
a sharper end point, probably due to the slight water 
solubility of the latter dye. 
(ii) Surface tension measurement 
The surface tension of solutions containing different 
concentrations of LAs in CFM or doubled distilled water was 
" measured using a Du Nouy Tensiometer, ring method (Harkins 
and Jordan, 1930). 
2.3.6 LAS' Partition Coefficien.ts !K 
0 /w) 
Technique used was based on the method described by 
Lang and Rye (1972). Equal volumes (20ml) of known 
concentrations of the LAs in CFM and either chloroform, 
n-heptane or octanol were mixed and continuously shaken 
at 22°C for 6 hr. Each container was then allowed to stand 
for ~ hr. In each cases two phases were separated and the 
concentration of LA remaining in the aqueous phase determined 
by measuring the optical density at the wavelength of 
maximum absorbance of the particular drug. From these 
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measurements the partition coefficient of the drug between 
these organic solvents and the aqueous medium were calculated. 
2.3.7 Measurement of Turbidity Changes 
(i) Standard technique for non-growing bacterial cells 
To a set of test tubes containing equal volumes (5ml) 
of different concentrations of local anaesthetics in the 
appropriate medium, equal volumes (5ml) of bacterial cell 
suspensions were added. After 10 min contact time or at 
other set times at 22°C, the optical density of samples of 
each suspension was measured at 650nm (1 cm). 
(ii) Effect of LAs on the turbidity of isolated cell 
envelope and cytoplasmic constituent preparations 
a) Preparation of isolated cell envelope and cytoplasmic 
constituents: 
Cell suspensions of E. coli in CFM were sonicated 
(Salton, 1960), for about 8 min in an ice-cooled vessel at 
a rate of 9 microns (peak to peak) in a MSE Ultrasonic 
disintegrator (Model 60W). Intact cells were removed from 
• • the sonicated by centrifugation (2000g for 10 min). The 
supernatant liquid was decanted and recentrifuged (10,000g 
for 15 min) 1 a force sufficient to bring down isolated cell 
walls (Rogers, 1963). The pellet, consisting of isolated cell 
envelopes , was washed three times with 1% w;v sodium 
chloride as recommended by Salton and Horne (1951) to remove 
adhering cytoplasmic contents and suspended in CFM. The 
supernatant fluid obtained in this instance was a suspension 
of intracellular material. It was diluted with CFM such that 
the cytoplasmic constituents contained in 1ml of solution 
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were derived from about 0.24 mg dry weight of cells. 
b) Effect of LAs: To a set of test tubes containing 
5ml of different concentrations of LA, equal volumes of 
either cell envelope preparation or cytoplasmic constituents 
were added. The mixtures were maintained at 22°c for 10 min 
after which the optical density of samples from each tube was 
measured at 650nm (1cm). 
(iii) Effect of LAs on the turbidity of lipid depleted. 
cells and cell free lipid dispersions 
a) Preparation of lipid extracted cells and isolation 
of total lipids: 
Large volumes of E.coli cells which were grown in 
liquid growth medium were centrifuged (4500g, 15 min) to 
isolate th~ cells which were then subjected to an extraction 
procedure based on the method of Shaw and Dinglinger (1969) 
for the extraction of total lipid. The cells were first 
freeze dried (Chem Lab Instruments Ltd) and then suspended 
in chloroform:methanol (2:1, vfv) and shaken for 48 hr at 
22°c. After filtration, the pellet (lipid extracted cells) 
was washed with and then suspended in CFM to give required 
density. The bulk of the solvent, containing extracted 
lipids was removed under vacuum using rotatory evaporator 
" (Rotavapor-R Buchi Switzerland) and the extracted lipids were 
b) Effect of LAs: Two sets of test tubes contain 
equal volume of different concentrations of LA in CFM were 
prepared. To the first set, equal volumes of lipid 
extracted cells in CFM (OD = 0.6, 650nm) were added and to 
the second set equal volumes of the lipid emulsion 
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(ultrasonicated) in CFM. After 10 min at 22°c the optical 
density of samples for each set was assessed at 650nm. 
2.3.8 Effect of Local Anaesthetics on Respiration 
(i) The use of triphenyltetrazolium chloride (TTC) 
The optical density of a dense E.coli cell suspension 
in either 0.2M phosphate buffer (pH 6.4) or CFM was adjusted 
so that when added to the reaction mixture, a dry weight of 
-1 9 -1 
ea 1.20mg ml (3.8 x 10 cells ml ) was achieved. 
The dehydrogenase activity of cell suspensions was 
established under aerobic conditions, by the triphenyl-
tetrazolium chloride method of Hugo (1954). Into a series 
of sterile universal bottles, 2.5ml of phosphate buffer or 
CFM containing different concentrations of LA, 1.0ml of TTC 
(0.1% w/v) 1 0.5ml of cell suspension and 1.0ml of 0.02M 
substrate (D-glucose, sodium succinate, sodium malate or 
sodium lactate) were added. Several sets were prepared to 
facilitate sampling. Also bottles containing neither LA nor 
substrate were prepared to be used as blanks. All the 
bottles were shaked in a water bath at 37°C. At various 
time intervals one control (no LA), one blank and one of the 
concentrations of LA were removed. The reaction mixture was 
acidified with 5ml of glacial acetic acid and the triphenyl-
formazan produced by the reduction of TTC by dehydrogenases, 
Fig. 2.2, was extracted using several 5ml quantities of 
toluene (Fahmy and Walsh, 1952). The cells were removed by 
centrifugation and the optical density of toluene solution 
containing the formazan determined spectrophotometrically at 
490nm (1 cm). Values obtained were corrected for the actual 
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volumes of toluene used. 
Fig 2.2 Formation of triphenylformazan (red) from TTC 
(colourless) 
(ii) Measurement of oxygen uptake (Warburg Manometry) 
Studies on respiration were performed using standard 
manometric techniques (Umbreit, Burris and Stauffer, 1964) 
in an atmosphere of air at 100 oscillations/min (Warburg 
Apparatus, B.Braun Melsungen, made in w. Germany). 
Experiments were carried out using cells prepared as 
earlier described (2.2.2 ii) and employing the following 
procedure: 
(1) The following materials were placed in the main corn-
partment of clean, dry, l'larburg flasks equipped with 
a centre well: 1.5ml LA solution at required 
concentration in CFM and O.Sml of 0.03M substrate 
(either D-glucose or sodium succinate). 
(2) 0.2ml of 20% KoH was placed into the centre well, 
with a fluted filter strip. 
(3) O.Sml of cell suspension was put into the side arm 
(final concentration, 3.8 x 10 8 organisms. ml- 1). 
(4) After the attachment joint on the manometer and the 
side arm plug were greased and the plug inserted into 
the side arm, the flask was attached to the manometer. 
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(5) The flask was placed in a constant temperature bath 
(37°C) and the contents of the flask were allowed to 
equilibrate with shaking. 
(6) Manometer fluid was adjusted to the reference point 
on. closed side of manometer with stop-cock open. 
(7) contents of the side arm were added to the main 
compartment. 
(8) The stop-cock was closed and manometer readings 
taken every 10-15 min for 2 hr. 
The flask constant was found using the nomogram of 
Dixon (1951). 
2.3.9 Electron Microscopy 
(i) Scanning electron microscopy (SEM) 
cells of E. coli were shake-incubated at 37°c in the 
presence of different concentrations of LA for 15 min 
(Initial cell concentration approximately 3.8 x 10 6 cells 
ml- 1 ). Glutaraldehyde (E.M. grade) was then added to cell 
culture to give final concentration of 1.5% (v/v). After 
2 min, the cells were removed by centrifugation at 3000g 
for 15 min at 4°C, then resuspended in 2ml of glutaraldehyde 
(5%v/v) for 16 hrat 4°C. The cells were removed by 
centrifugation, washed 3 times with and finally resuspended 
in distilled water to give the required density (faint 
opalescence)• One drop from each of these suspensions was 
allowed to air dry on a 13mm round microscope cover slips 
and then dehydrated over ea c12 under partial vacuum for 
12-18 hr. The cover slips were fixed to 15mm aluminium 
stubs using quick drying silver cement (DAG) and coated in 
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an Edwards high vacuum unit, with gold palladium to give a 
coating film of ea 10nm thickness. The samples were examined 
in an ISI-Alpha- 9 Scanning Electron Microscope with a beam 
0 
angle of 45 and a voltage of 15KV. Magnifications ranged 
from X30 to X30,000. Images of typical cell groups were 
produced on the screen of a cathode ray tube and photographed 
on 35mm film (ILFORD FP4 or HP5). 
(ii) Transmission electron microscopy (TEM) 
Suspensions of E.coli in CFM were left at 22°C in the 
presence of different concentrations of LA for 15 min 
(final cell concentration about 3.8 x 10 6 cells.ml-1). Cells 
were prepared for electron microscopy as follows: 
(1) The cells were fixed by adding glutaraldehyde (E.M. 
grade) to give final concentration of 1.5% (v/v) for 
2 min. 
(2) The cells were removed by centrifugation (4°C, 3000g, 
15 min) 
(3) The pellet obtained was resuspended in 2ml 
glutaraldehyde (5% v/v) for 16 hr at 4°c. 
(4) The cells were harvested by centrifugation, and 
washed 3 times with acetate veronal buffer. 
(5) The pellets were suspended in molten (45-50°C) 
3% purified agar and when set the agar was cut into 
small cubes (1mm). 
(6) The agar cubes were refixed in glutaraldehyde 
(1.5% V/v) for 1 hr. 
(7) The cubes were washed with A.V.B. for 15 min and 
stained in uranyl acetate (2% vfv in AVB) for 25 min. 
(8) To stain the agar, the agar cubes were left in 
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methylene blue for 2 min. 
(9) The agar cubes were left in series of ethanol 
concentration range of 25, 50, 75 and 100% for 
15, 20, 30 and 60 min respectively, in order to be 
dehydrated. 
(10) To clear the alcohol, the cubes were left in propylene 
oxide - ethanol in the ratio of 50:50 and then 
100:0 for 15 and 2 x 20 min respectively. 
(11) To embed the cells in resin, the agar cubes were left 
in mixtures of propyleneo*ide- embedding agent of the 
ratio 1:1, 1:3·and.0:1 respectively at room 
temperature, each one for about 12 hr. 
(12) The agar cubes in embedding mixture were left at 60°G 
for 1 hr (to get rid of any propyleneoxide residue). 
(13) The agar cubes were then embedded in capsules 
(Taab Laboratories Reading) and kept at 60°C for 
48 hr. 
(14) Section were cut using a Reichert - Jung ultra-
microtome equipped with glass knives (angle 55°) 
and the sections (80-100nm) collected on copper 
grids (200 or 400 mesh). 
(15) The sections were observed under the AEI, EM6B 
Electron microscope (Associated Electrical 
Industries Ltd., Manchester, England), using an 
accelerating voltage of 60KV. The microscope was 
fitted with a 70mm roll film camera and electron 
micrographs were recorded directly on Agfa Rapidoline 
Ortho FO 71P film. 
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RESULTS 
3.1 Growth Inhibition 
(i) Tube dilution and direct assessment techniques 
The minimum inhibitory concentrations (MICs) of 
amethocaine, procaine, cinchocaine and lignocaine determined 
for the four different bacteria using the tube dilution 
method are shown in Table 3.1. All bacteria were more 
sensitive to the inhibitory action of amethocaine and 
cinchocaine than to that of procaine and lignocaine. MIC 
values for the various LAs against E.coli, K.aerogenes and 
P.aeruginosa (Gram-negative) are essentially of the same 
order, though K.aerogenes was particularly resistant to 
procaine. B.megaterium (Gram-positive), however, was more 
sensitive to the LAs than were the other organisms. 
Table 3.2 shows the influence of inoculum size (E.coli) 
on the MIC of amethocaine. The MIC is virtually unchanged 
for increases in cell number from 2.66 x 10 8 to 0.89 x 10 9 
cells.ml-1 and increases only slightly as the E.coli cell 
concentrations ranged from 0.89 x 10 9 to 4.05 x 10 9 cells.ml-1 • 
Table 3.3 shows the effect of Mg c1 2 concentration on 
the MIC of amethocaine against E.coli. The MIC remains 
M 
constant up to about 1000 , after which increases in the 
Mg c1 2 content of the medium, up to 1 ~0 , increase the MIC 
value. 
Figs 3.1 to 3.16 inclusive are growth curves pptical 
density vs time) for E.coli (Figs. 3.1 to 3.4); K.aerogenes 
(Figs 3.5 to 3.8); P. aeruginosa (Figs 3.9 to 3.12)and 
B.megaterium (Figs 3.13 to 3.16) growing in the absence or 
presence of different concentrations of amethocaine,procaine, 
Table 3.1 Minimum inhibitory concentrations (MICs) in mg.ml- 1 of different LAs for 
different bacteria. 
E.coli K.aerogenes P.aeruginosa B.megaterium 
Amethocaine 0,93 ± 0.08 1.26 ± 0.09 1.1 ± 0.2 0.56 ± 0.05 
Procaine 28.3 ± 1.25 51 ± 2.94 30 ± 1. 5 15 ± 2 
Cinchocaine 0.8 ± 0.13 0.9 ± 0.15 0.9 ± 0.10 0.3 ± 0.1 
Lignocaine 18.6 ± 0.94 26.3 ± 1.24 25 ± 1 8.6 ± 0.94 
Table 3. 2 Minimum inhibitory concentrations (MICs) and minimum bactericjCJofconcentrations 
(MBCs) of amethocaine (mg.ml- 1 ) for E.coli cells when different cell 
concentration was used 
Cell No. -1 2.66 108 5.2 x 1 o8 0.89 X 109 2.01 X 10 9 4.05 X 109 ml X 
MIC -1 (mg.ml ) 0.93 ± 0.08 0,93 ± 0.08 0.93 ± 0.08 1 • 1 ± 0.06 1 • 1 ± 0.08 
MBC -1 (mg.ml ) 7.5 7.5 7.5 7.5 7.5 
Table 3,3 MICs and MBCs of amethocaine (mg.ml- 1 ) for E.coli cells suspended in media 
containing different concentrations of Mg Cl2 
Mg++ M M M M M 
10,000 2,000 1000 200 100 
MIC _
1 (mg.ml ) 0.93 0.93 0.93 1.1 1 • 3 
MBC _
1 (mg.ml ) 7.5 7.5 7.5 7.8 7.8 
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cinchocaine or lignocaine. 
Essentially all curves show similar patterns. The 
graphs for untreated and treated suspensions with LA 
concentrations lower than MIC (see Table 3.1) are linear. 
The rate of increase in OD in these cultures is exponential 
at a rate dependent on LA concentration, i.e. increasing the 
concentration of LA causes a reduction in growth rate, the 
extent of reduction produced by equal increments in LA 
concentration becoming progressively larger at higher 
concentrations• For example,growth.rate of E.coli in the presence 
-1 
of amethocaine concentrations ranging from 0.25 mg.ml to 
-1 1.0 mg.ml (Fig 3.1) decreases gradually. In each case 
increasing the LA concentration, above the MIC (Table 3.1), 
causes a decrease with time in the turbidity of cultures. 
For example, concentration of 1.25 mg.ml- 1 ameth~caine 
acting on E.coli (Fig 3.1), causes a reduction in the OD~the 
extent of which increases.with time. Higher concentration 
-1 (1.5 mg.ml amethocaine) causes a further decrease in the 
turbidity of bacterial cultures. However, there is an 
exception with cinchocaine concentrations higher than MIC 
(Table 3.1).Such concentrations still reduce culture 
turbidity, but the extent of turbidity change is less than 
that caused by lower concentrations. For example, a culture 
treated with 1.5 mg.ml- 1 cinchocaine (Fig 3.3) shows less 
decrease in turbidity than those treated with 0.5 or 0.6 
mg.ml- 1 cinchocaine, although both cause marked decreases in 
the OD compared with the control. 
Comparing MICs of LAs acting on different bacteria, 
using two different methods, tube dilution (Table 3.1) and 
direct assessment (Figs 3.1 to 3.16), it can be deduced that 
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except with cinchocaine, all the LAs have either higher 
or equal MICs using the shaking method than with the tube 
dilution method. For example, MICs of amethocaine for E.coli 
are 0.93 ± 0.08 mg.ml- 1 (Table 3.1) and 1.25 mg.ml- 1 
(Fig 3.1), using tube dilution method and direct assessment 
respectively. In the case of cinchocaine the direct assess-
ment 
(0.8 
gives lower MIC (0.5 mg.ml- 1 ) than tube dilution 
-1 
± 0 • 1 3 mg. ml ) • 
Fig 3.17 shows the effect of LA concentration on the 
percentage inhibition of growth of E.coli,K.aerogenes, 
P.aeruginosa and B.megaterium, 70 min after addition of 
glucose. It is based on data derived from the appropriate 
growth curves, assuming the increase in the OD of the control 
after 70 min to be 100%. Concentrations of LAs which cause 
50% growth inhibition for the organisms are given in Table 3.4. 
From that the order of LAsconcentration which cause 50% growth 
inhibition for the organisms are: 
Cinchocaine < Amethocaine < Lignocaine < Procaine 
The growth rate constants of exponentially growing 
cultures of E.coli in the presence of LAs (Figs3.1 to 3.4) 
were calculated (Stanier et al., 1980) and are shown in 
Fig 3.18 as a function of LAs concentration. Increasing the 
concentrations of LAs causes a reduction in the growth rate, 
the extent of the reduction produced by equal increments in 
LA concentration becoming progressively larger at 
concentrations. At very low concentrations (e.g. 
higher 
-1 0.1 mg.ml ) 
amethocaine and cinchocaine have nearly the same effects on 
E.coli, though at higher concentrations cinchocaine is more 
effective in inhibiting growth than equivalent concentrations 
of amethocaine. Lignocaine, at all concentrations, is more 
- 76 -. 
Table 3.4 Concentrations of LAs which cause 50% inhibition 
of growth of different organisms, 70 min after 
the addition of glucose 
~ ) Amethocaine Procaine Cinchocaine Lignocaine ~in 
E.coli 0.66 28 0.37 14.0 
K.aerogenes 1.0 28 0.39 12.5 
P.aeruginosa 1.0 18 0.45 10.0 
B.megaterium 0.39 13 0.17 2.5 
Table 3.5 Concentrations (mg.ml- 1 ) of local anaesthetic causing 
an 80% reduction in cell viability in bacteria 
suspended in CFM at 22°C. Initial cell optical 
density 0.30, contact time 10 min. 
~ Amethocaine Procaine Cinchocaine Lignocaine ~in 
E.coli 5.5 > 100 2 > 50 
K.aerogenes 4 > 100 2 > 50 
P.aeruginosa 5 > 50 2 > 50 
B.megaterium 0.64 40 0.25 15 
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effective in inhibiting growth than procaine. 
(ii) Growth.inhibition of division-inhibited cells 
Fig 3.19 shows the changes in the log OD which 
occurred after the addition of glucose (2 mg.ml- 1 ) and 
ampicillin (2.0 ~g.ml- 1 ) to resting suspensions of E.coli 
containing different concentrations of amethocaine in CFM at 
37°C. Growth in the presence of concentration of 
amethocaine up to about 1. 0 mg .ml-1 was. exponential but 
occurred at a slower rate than the control suspension. This 
preliminary experiment was performed to determine the 
concentrations of amethocaine required to partially inhibit 
the growth of E.coli in the presence of 2.0 ~g.ml- 1 
ampicillin which prevent cellular division without having 
significant effect upon the rates of increase in the optical 
density. 
Fig. 3.20 compares the size distributions (threshold 
units) of amethocaine treated E.coli cells .(0.5 mg.ml- 1 ) and 
those of control (untreated) suspension before and at inter-
vals following the addition of glucose and ampicillin to the 
cells and incubation at 37°C. These results show that the 
size distribution patterns for amethocaine treated and 
untreated cells at different times are similar, except that 
as the bacterial growth continued, the size distribution 
curves shifted to the higher size range accompanied with 
broadening of the peak. For example after about 60 min, in 
both cultures very few cells were left in the smallest 
size ranges. 
(iii) Reversibility of growth inhibition 
Evidence that the inhibition of growth of E.coli 
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caused by amethocaine, procaine, cinchocaine and lignocaine 
in concentrations up to the relevant MICs is reversible is 
shown in Figs 3.21 to 3.24 respectively. In each case the 
cultures were initially treated with sufficient concen-
trations of LA to significantly alter the growth rate. 
Resuspension and incubation of the cells in fresh growth 
medium, resulted in cultures that exhibited growth curves 
that are linear over much of their range and having 
approximately the same slope as the control, or which are 
initially convex with time becoming linear. The latter case 
was most notable with cultures initially treated with 
concentration of LA that were about the MIC. 
The reversibility of the growth inhibitory 
properties of amethocainewas also investigated by diluting 
cultures inhibited partially or totally by this agent with 
an equal volume of fresh complete growth medium. The 
results (Fig 3.25) show that amethocaine inhibited cultures 
up to about 0.75 mg.ml- 1 , on dilution immediately resume 
growth at a rate characteristic of the new amethocaine 
concentration. The growth rate for cultures initially 
treated with higher concentrations of the agent either 
increases gradually (1.25 mg.ml- 1 on dilution 0.625 mg.ml- 1 ) 
or show no growth (1.5 mg.ml- 1 on dilution 0.75 mg.ml- 1). 
(iv) Diauxic growth 
Figs 3.26 to 3.32 show the effect of amethocaine, 
procaine, cinchocaine, lignocaine, chloramphenicol, 
ampicillin and cetylpyridinium bromide respectively, on the 
growth of E.coli under diauxic conditions. The carbohy-
drates present were glucose (0.15 mg.ml- 1 ) and galactose 
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-1 {0.15 mg.ml ). In each case the control showed the antici-
pated growth curve with a diauxic lag indicating cessation 
of glucose utilization and the onset of the use of galactose. 
All growth curves obtained in the presence of LAs are 
essentially similar (Figs 3.26 to 3.29), and following the 
diauxic lag phase, the cells treated with subinhibitory 
concentrations of each LA continued to grow in the presence 
of secondary carbon source (galactose) , though the growth 
rate depended on LA concentration. As the concentration of 
LA was increased, the length of the diauxic lag phase was 
increased. In the presence of LA concentrations which 
approximate to the MIC,as determined previously (Table 3.1), 
the characteristic diauxic curves were disrupted. For 
example, amethocaine treated cells of E.coli growing on 
glucose as the sole carbohydrate during shake-incubation at 
37°C (Fig 3.1) showed 
concentrations of 1.0 
some growth up to amethocaine 
-1 
mg.ml When glucose and galactose 
were present, amethocaine at 0.75 mg.ml-1 permitted only a 
short period of cellular growth, after which a decrease in 
culture turbidity was observed. However, with concentration 
of LAs more than MICs (Table 3.1) the growth was completely 
inhibited and in fact a decrease in culture turbidity was 
observed. 
In the presence of subinhibitory concentrations of 
chloramphenicol (Fig 3.30), the length of the diauxic lag 
phase was considerably increased, the extent of the increased 
lag depending on chloramphenicol concentration. 
Fig. 3.31 shows the effect of ampicillin on the 
diauxic growth of E.coli. Concentrations up to about 7.5 
-1 ~g.ml gave rise to curves with a shorter diauxic lag than 
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the control, but nearly the same length as each other. 
The cells continued to grow after the diauxic lag, though 
-1 
with concentrations of 2.5 ~g.ml or more the optical 
density decreased within a few min of commencement of 
utilization of galactose. 
When cetylpyridinium bromide (CPB) was present (Fig 
3.32), the effect on growth was markedly dependent on CPB 
concentration. Concentration of more· tha~ 6 ~g .ml-1 
completely inhibited growth and in fact caused a decrease in 
culture turbidity; with 6 ~g.rnl-1 CPB the growth was 
inhibited for about 70 min, after which the culture turbidity 
increased.Sub-inhibitory concentrations permitted growth on 
both glucose and galactose with a very slight increase in 
the diauxic lag phase with increasing the CPB concentration. 
Figs 3.33 to 3.39 show the effect of the addition of 
the various antimicrobial agents (amethocaine, procaine, 
cinchocaine, chloramphenicol, puromycin, ampicillin and 
cetylpyridinium bromide respectively) to E.coli cells 
already growing under the diauxic conditions. In each case 
the drug was added after approximately 28 min incubation in 
the presence of both glucose and galactose. In comparison 
with results from experiments on diauxic performed with the 
drug present from the onset of incubation (Figs 3.26 to 3.32) 
effects on the.diauxic lag are essentially similar and 
relatively easier to observe. 
When the LAs were present (Figs 3.33 to 3.35) the 
length of diauxic lag phase increased as the concentration 
increased. This increase in lag phase was greater, when 
cells were growing in the presence of chloramphenicol 
(Fig. 3.37) or puromycin (Fig 3.38), and with these drugs no 
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decrease in culture turbidity was observed even at high 
-1 -1 
concentration (25 ~g.ml chloramphenicol and 600 ~g.ml 
puromycin) • 
Ampicillin (Fig 3.38), up to about 10.0 ~g.ml- 1 
decreased the length of the diauxic lag; concentrations 
between 5.0 and 10.0 ~g.ml- 1 permitted only brief growth at 
a rate similar to ·the lower concentrations (1.0 and 2.5 ~g. 
ml- 1), followed by decreases in culture turbidity. Even 
higher concentrations of ampicillin (15-20 ~g.ml- 1 ) 
inhibited growth and eventually caused decreases in culture 
turbidity. 
Cetylpyridinium bromide (Fig 3.39) gave curves 
qualitatively very similar to those for the local anaesthetics 
(particularly amethocaine and cinchocaine) and basically as 
described previously. 
3.2 Cell Via~ility 
Figs 3.40 to 3.43 illustrate the effect of procaine, 
lignocaine, amethocaine and cinchocaineon the percentage 
viability of cells of E.coli (Fig 3.40), K.aerogenes 
(Fig 3.41), P.aeruginosa (Fig 3.42) and B.megaterium (Fig 
3.43) suspended in CFM, after 10 min contact time at 22°C. 
As a group, all curves are essentially similar, 
though B.megaterium (Fig 3.43) was more sensitive to procaine 
and lignocaine than were the Gram-negative organisms. All 
curves in which losses of viability were eventually 
significant, exhibit thresholds below which little or no 
change in percentage viability is apparent (e.g. in Fig 3.40, 
-1 2.0 and 1.0 mg.ml of amethocaine and cinchocaine 
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respectively for E.coli). Above this value, small increases 
in LA concentration, produces large reductions in cell 
viability. This reduction is generally greater per unit 
concentration for cinchocaine comparing with amethocaine. 
There is no or very little decrease in cell viability 
of E.coli and K.aerogenes treated with procaine over the 
wide concentration range used (Figs3.40-3.41). However this 
is no.t the case when P.aeruginosa or B.megaterium 
(Figs3.42-3.43) weretreated with procaine. With B.megaterium 
there is threshold of about 15 mg.ml- 1 procaine below which 
little or no change in cell viability occurs, and above which 
it decreases considerably, falling to 20% at about 40 mg.ml- 1 
procaine. With P.aeruginosa, however, the length of this 
threshold region is longer (up to 20 mg.ml- 1 procaine) and 
after that percentage cell viability decreases, reaching 
-1 
about 85% at 50 mg.ml procaine. 
In the case of lignocaine, (Figs 3.40 to 3.43) there 
are thresholds of about 30, 30, 20 and 8 mg.ml- 1 for E.coli, 
K.aerogenes, P.aeruginosa and B.megaterium respectively, 
above which increases in lignocaine concentration cause 
decreases in percentage cell viability. With B.megaterium 
% viability drops to zero at 20 mg.ml- 1 lignocaine. Other 
organisms were not so sensitive and at a concentration of 
50 mg.ml- 1 lignocaine,typically about 70% of the cells are 
viable. 
For amethocaine, however, effecting on E.coli, 
K.aerogenes, P.aeruginosa and B.megaterium (Figs 3.40 to 
3.43), the minimum bactericidal concentrations (MBCs)are 
-1 7.5, 6.0, 7.5 and 1.5 mg.ml respectively. The MBCs of 
cinchocaine for these organisms are 2.5, 2.5, 4.0 and 0.60 
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mg.ml- 1 respectively. (Figs 3.40 to 3.43) • 
. 
Generally all organisms were sensitiv~ to the local 
anaesthetics in the order: cinchocaine >amethocaine >. 
lignocaine > procaine. Concentrations causing 80% 
reduction in cell viability are summarized in Table 3.5. 
Table 3.2 shows the effect of inoculum level (E.coli) 
on the MBC of amethocaine. Variations in cell number from 
2.66 x 10 8 to 4.05 x 10 9 cells.ml-1 did not give any 
detectable difference in MBC. 
Similarly Table 3.3 suggests that increasing the 
M M Mg c1 2 content of cell suspending medium from 10000 to 1000 
did not have detectable change on the MBC of amethocaine for 
E.coli. Higher Mg c1 2 concentrations, however, did cause a 
small increase in the MBC. 
Table 3.6 shows the effect of contact time on the 
influence of amethocaine and cinchocaine on the viability of 
E.coli suspended in CFM. Increasing the contact time of 
amethocaine (5.0 mg.ml- 1 ) on E.coli from 5 to 25 min reduced 
the cell viability from 55% to 0%, but with 7.5 mg.ml- 1 
amethocaine even after 5 min contact time 100% reduction in 
cell viability was observed. Similarly with cinchocaine 
(1.0 mg.ml- 1), increase in contact time from 10 to 25 min, 
reduced the cell viability. from about 100% to about 56%. 
-1 However, 2.5 mg.ml was bactericidal even after 5 min 
contact time. 
3.3 Leaka9:e of Intracellular Haterials 
. 32p (i) Effect of LAs on labelled bacterial cells 
Fig 3.44 shows the effect of various concentrations 
of LAs ( 1 0 min) on the release of 32p labelled components 
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Table 3. 6: Effect of contact time on the P.ercentage cell 
viability of E.coli treated with LAs in CFN 
LA ~Time 0 5 10 15 20 b _1 l:it- (miti (mg.ml l ~
Amethocaine 5.0 100 '55±5 36±3 9±1 2±0 .2 
Amethocaine 7.5 100 0 0 0 0 
Cinchocaine 1.0 100 100 100 80±8 65±5 
Cinchocaine 2.5 100 0 0 0 0 
25 
0 
0 
5:±6 
0 
Table 3.7 The partition coefficients of LAs between chloroform, 
n-heptane, octanol and CFM (pH 6.4) Temp. 22°C 
~ Chloroform n-Heptane Octanol A 
Amethocaine 79 0.34 17 
Procaine 1 0.015 0.18 
Cinchocaine 100 1 • 2 100 
Lignocaine 10.90 0. 16 5.23 
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from cells of E.coli pulse labelled with 32P and suspended 
in CFM at 22°C. 
\~hi le procaine and lignocaine, in the concentration 
range used, had no effect on 32P release, amethocaine and 
cinchocaine caused the leakage of 32P and showed a similar 
pattern of activity. In initial part of the curve there is 
either a small decrease or no change in 32P release as the 
LA concentration is slightly increased. This is followed 
by . 32 a phase of increased P release with increasing LA 
concentration. This approaches a maximum release at about 
-1 10 mg.ml amethocaine and is approximately equal to 90% of 
the 32P content released by cold trichloroacetic acid (TCA) • 
With cinchocaine the maximum release occurred at about 7.5 mg. 
ml-1 , and was approximately equal to the amount of 32P 
labelled compounds released by cold TCA. 
(ii) Voltammetric determination of inorganic phosphate 
The loss of inorganic phosphate from E.coli cells 
suspended in LPM containing different concentrations of LA at 
22°C for 10 min is shown in Fig. 3.45. 
Procaine and lignocaine did not inftiate the release 
of inorganic phosphate from the cells. Amethocaine and 
cinchocaine, however, caused a linear increase in the amount 
of phosphate released up to about 8 mg.ml- 1 amethocaine and 
5 mg.ml- 1 cinchocaine after which the release reached a 
maximum level. The maximum inorganic phosphate release from 
cinchocaine treated cells was higher than that. due to 
amethocaine. 
(iii) Estimation of pentoses 
The leakage of pentoses from E.coli cells treated with 
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LAs is illustrated in Fig. 3.46. 
Procaine and lignocaine in the concentration range 
used, did not cause the release of pentose from E.coli with 
amethocaine and cinchocaine, however, leakage of pentose 
occurred linearly as LA concentration was increased up to 
-1 -1 7.5 mg.ml and 5.0 mg.ml 
trations of amethocaine (up 
respectively. 
-1 to 10 mg .ml ) 
Higher concen-
caused slight 
increase in leakage. Further increase in concentration 
caused slight reduction in the total amount of pentose released. 
becoming constant at about 20 mg.ml- 1 Concentrations in 
excess of 5.0 mg.ml- 1 cinchocaine caused nearly the same 
(maximum) release of pentose. The maximum pentose released 
for amethocaine and cinchocaine was equivalent to ea 8.0 and 
7.4 \lg ribose per mg dry Height of bacteria. 
These results are also illustrated in plates 3.1 to 
3.4 for amethocaine, procaine, cinchocaine and lignocaine 
respectively.Increasing pentose concentrations cause colour 
changes from yellow to green. With procaine and lignocaine 
there is no colour change (all solutions are yellow, i.e. no 
pentosemleased). Both sets of tubes for amethocaine and 
cinchocaine show colour changes from yellow (nopentose) to 
green (maximum pen to se} and to yellowish-green (less pentose) • 
Fig. 3.47 shows the release ofpentose from E.coli 
cells after treatment with LA for different time intervals 
at 22°c. 
Procaine (50 mg.ml- 1 ) and lignocaine (40 mg.ml- 1 ) 
did not cause detectable leakage of pentose up to about 3 hr. 
After that, however, increasing the contact time caused 
minor release. Amethocaine and cinchocaine caused the 
release of pentose at rates that dependent on the concentration 
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of LA used, Relatively low concentration of either drug 
(10 mg.ml- 1 amethocaine or 5 mg.ml- 1 cinchocaine) caused an 
initial rapid release ofpentosefollowed by a sl6wer 
secondary phase that continued for up to 5 hr. Higher 
concentrations, however, (30 mg.mi- 1 amethocaine or 
20 mg.ml- 1 cinchocaine) only showed the rapid primary 
release. This was followed up to 5 hr contact time. Fig 3.48 
shows the release ofpentose from E.coli cells treated with 
LA for different time intervals at 1°c, After about 10 min 
contact time amethocaine and cinchocaine caused considerable 
release ofpentose from E.coli cells at rates depending on 
LA concentration. However, increasing the contact time did 
not increase the amount of leaked material. 
(iv) Leakage of 260 nm absorbing substances 
Fig. 3.49 shows the leakage of 260 nm absorbing 
material at 22°c from E.coli cells suspended in CFM contain-
ing different concentrations of amethocaine, procaine, 
cinchocaine or lignocaine. 
Procaine and lignocaine did not cause any leakage of 
260 nm absorbing material in the concentration range used. 
With both amethocaine and cinchocaine the leakagejconcentra-
tion curve is diphasic, an approximately linear increase in 
-1 leakage occurs up to about 7.5 and 6.0 mg.ml of amethocaine 
and cinchocaine respectively. With higher concentrations, 
however, the total amount of material released is slightly 
reduced. 
3,4 Uptake of LAs by Bacterial cells 
The uptake isotherms for amethocainel procaine, 
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cinchocaine and lignocaine (corrected for leakage of 260 nm 
absorbing material and. also the influence of cell volume) 
after 30 min contact by cultures of E.coli at 37°c are shown 
in Figs 3.50 to 3.52. 
For the correction because of the influence of bacterial 
cell volume, the method of Lang and Rye (1972) was followed. 
The LA uptake was obtained by calculating K, the ratio of 
the concentration of drug within the cells to the concentra-
tion in the suspending medium. K may be derived as follows: 
( 1 ) 
(2) 
( 3) 
(4) 
( 5) 
cone. in cells K = cone. in supernatant 
Cone. in cells = Wt. in cells cell volume 
Wt. 
= Wt. 
in control -
in supernatant. 
cell volume 
K = Wt. in control - Wt. in supernatant 
Cell volume x Con. in supernatant 
K = 
VC - C' !V-v) 
V X C' 
K 1 + V {c ~.c•} = V 
Where: 
V = total volume of reaction mixture. 
V = volume occupied by the cells 
c = drug concentration in the supernatant 
the control mixture 
C' = drug concentration in the supernatant 
from the treated cell suspension. 
liquids from 
liquids 
Using calibration curve, the optical density measure-
ments were related to the concentrations, and from that and 
the other data, the uptake isotherms were constructed. 
The average intracellular: extracellular concentration 
ratio (K) were 0.8, 1.2, 6.4 and 13.6 for procaine, lignocaine, 
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amethocaine and cinchocaine respectively. 
As the K values or the uptake isotherms show, while 
the uptake of procaine (Fig 3.50) and lignocaine (Fig 3.52) 
with E.coli cells is very low, the amount of amethocaine 
(Figs 3.50 and 3.51) or cinchocaine (Fig 3.52) taken up by 
the cells is considerably greater. Throughout the 
concentration ranges studied the cellular uptake was directly 
proportional to the concentration of LA remai~ing in the 
suspending medium. With amethocaine, however, the uptake 
isotherm eventually flattens out at an uptake of approximately 
200 mg.ml- 1 amethocaine and an equilibrium concentration of 
about 80 mg.ml- 1 amethocaine. 
3.5 Determination of Critical Micelle Concentration(CMC) 
(i) Dye solubilization 
Fig 3.53 shows the extent of solubilization of Sudan 
Black B by solutions of LAs in CFM and distilled water. From 
these graphs, values for the CMC of amethocaine in the two 
t . t d 10 5 mg.ml- 1 ( F ) d 31 5 1-1 systems were es J.ma e as • C M an • mg.m 
(water). In the case of cinchocaine these values were 7.5 
mg.ml- 1 (CFM) and 23.5 mg.ml- 1 (water). Procaine and ligno-
caine did not show any coloured solutions in the presence 
of Sudan Black B up to about 40 mg.ml- 1 in CFM and in water. 
(ii) Surface tension measurement 
Figure 3.54 shows the surface tension changes occuring 
in relation to LA concentration in both CFM and doubled 
distilled water. From these curves, value for the CMC of 
amethocaine was found to be 10 and 30 mg.ml-1 in CFM and 
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doubled distilled water respectively. Procaine did not 
cause any significant change in surface tension measurement 
at air-water interface. 
3.6 LAS'Partition Coefficients 
The partition coefficients of LAs used between 
chloroform or n-heptane or octanol and CFM at 22°C are shown 
in Table 3.7. 
The order of LA solubility in these organic solvents 
is: Cinchocaine > Amethocaine > Lignocaine > Procaine 
3.7 Effect of LAs on the Changes in the Turbidity of 
Non-Growing Cultures 
Figs 3.55 to 3.58 inclusive show the effect of 
different LAs (amethocaine, procaine, cinchocaine and 
lignocaine) on the turbidity (650 nm, 1 cm) of non-growing 
cells of E.coli (Fig 3.55), K.aerogenes (Fig 3.56) ~ 
P.aeruginosa (Fig 3.57) and B.megaterium (Fig 3.58) suspended 
in CFM at 22°C, after 10 min contact. 
In all Gram-negative cell suspensions, procaine and 
lignocaine produced little or no change in turbidity over 
the concentrations range studied. With B.megaterium, 
however, increasing lignocaine concentration from about 
-1 25 mg.ml , caused a minor increase in turbidity. For 
amethocaine and cinchocaine, a general pattern of activities 
emerges. Curves show three main regions. A primary region 
in which little or no variation in turbidity is detected as 
LA concentration is increased, and a secondary region in 
which small concentration changes induce large increase in 
turbidity. This phase of activity terminates either in a 
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plateau (Fig 3.58, B.megaterium) or reaches a maximum after 
which turbidity decreases (Figs 3.55 to 3.57, Gram-negative 
bacteria). However, the maximum OD value induced by 
amethocaine was not as high as that induced by cinchocaine in 
the case of all bacterial cultures used. Maximum OD was 
reached at about 20 and 10 mg.ml- 1 for amethocaine and 
cinchocaine respectively for all the organisms used. The 
extent of the first region depends on both the bacteria and 
the LA. In the case of the Gram-negative bacteria used in 
this project (Figs. 3.55 to 3.57) the primary region ends for 
amethocaine and cinchocaine, at about 5 and 2.5 mg.ml-1 
respectively. For B.megaterium (Fig 3.58) this region is 
only detected as an initial 'S' shape to the curves. 
Fig 3.59 shows the influence of contact time on the 
induced turbidity changes in non-growing cells of E.coli 
suspended in CFM containing different LAs. 
Procaine (50 mg.ml-1 ) and lignocaine.(40 mg.ml- 1 ) which 
did not normally induce marked turbidity changes over the 
normal short contact time (10 min) 1 by extending the contact 
time for up to 5 hr caused a slight decrease in turbidity. 
-1 -1 With both amethocaine (10 mg.ml ) and cinchocaine (5 mg.ml ) 
the increase in culture turbidity is very rapid, being 
complete after approximately 10 min. Longer contact time 
resulted in a slight fall in turbidity in both cases. Higher 
concentrations showed little variation in turbidity after the 
initial large and rapid increase. 
Figs 3.60 to 3.62 show the effect of LAs (10 min 
contact) on the turbidity of E.coli cells suspended in various 
media. 
tvhen the cells were suspended in distilled water 
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containing various concentrations of amethocaine, and 
cinchocaine (Fig 3.60), at low concentrations a large 
increase in turbidity was observed. Then it approached a 
maximum with concentration in excess of approximately 5 mg.ml-1 
for both LAs. Moreover, the maximum OD value induced by 
amethocaine was not as high as that induced by cinchocaine. 
Fig 3.61 shows the effect of LA concentration on the 
turbidity of E.coli cells suspended in 0.2 M phosphate buffer 
(pH 6.4). The shape of curves is essentially similar to that 
reported earlier for the E.coli/CFM/LA system (Fig 3.55), 
except that the extent of first region is much shorter. 
Fig 3.62 shows the effect of increase in amethocaine 
concentration on the turbidity of E.coli cells suspended in 
CFM of increased Mg Cl2 concentration. The shape of the 
curves is basically similar to that reported earlier for 
E.coli cells suspended in CFM (Fig 3.55). However, the first 
region of the curve is extended, the maximum slope of each 
curve and the height of the final plateau is reduced as the 
Mg Cl2 content of the medium is increased. 
Changes in the OD (650nm) of the soluble intracellular 
material released from sonicated E.coli cells and of the 
remaining cell "ghosts" in the CFM containing different 
concentrations of amethocaine, procaine and cinchocaine, 
lignocaine are shown in Figs 3.63 and 3.64 respectively. 
Procaine and lignocaine did not have significant effect 
on OD of either cell, envelope or intracellular material in CFM, 
though at higher concentrations (30 mg.ml- 1 lignocaine) the 
OD of intracellular material showed minor increase. 
Amethocaine and cinchocaine induced turbidity increases 
in both cell envelope and cell contents fractions-, the effect being 
most marked with cell contents. The changes can be divided 
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into three regions: A short initial phase of nearly no 
change in optical density, followed by large changes as the 
concentration of LA is increased and finally a plateau after 
which the OD remains virtually constant with further increases 
in LA concentration. The initial short part of the curves 
relating to cell contents ends at approximately 5 mg.ml-1 and 
2.5 mg.ml .... 1 for both amethocaine and cinchocaine respectively. 
The second phase ends at higher concentration for amethocaine 
(25 mg.ml- 1 ) comparing with cinchocaine (10 mg.ml- 1). The 
maximum OD value induced with cinchocaine was higher than that 
with amethocaine. 
Amethocaine and cinchocaine showed a slight increase in 
the OD of the cell envelope preparations with concentration in 
excess of 5 mg.ml- 1 and 2.5 mg.ml- 1 respectively. This 
-1 increase reached a maximum at 20 mg.ml amethocaine and 
10 mg.ml- 1 cinchocaine. 
Figs 3.65 and 3.66 show, respectively, the effect of 
10 min contact with different LAs on the optical density (650 
nm) of both lipid depleted cells of E.coli and the cell free 
lipids dispersed in CFM at 22°c. 
With procaine and lignocaine no large change in 
turbidity of lipid depleted cells of E.coli was detected, 
although a small increase was noted with concentrations of 
lignocaine in excess of 20 mg.ml-1 (Fig 3.65). For 
amethocaine and cinchocaine, however, increases in concen-
tration establish curves similar to that reported earlier for 
E.coli cells/CFM/LA system (Fig 3.55). The primary phase 
ends at about 1.25 mg.ml-1 for both amethocaine and 
cinchocaine and the plateau commences with approximately 20 
mg.ml-1 amethocaine and 15 mg.ml-1 cinchocaine. 
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Fig 3.66 shows that amethocaine and cinchocaine have 
similar pattern of activity on the dispersed lipid extracts. 
The curves consist of several regions. The initial part, in 
which turbidity increases markedly with increase in LA 
concentration, followed by a maximum or plateau region. The 
OD then decreases to zero as the LA concentration is further 
-1 -1 increased (~ 30 mg.ml amethocaine, ~ 15 mg.ml 
cinchocaine). No further changes were observed and the 
optical density remains at zero as the LA concentration is 
increased. 
Procaine did not increase the turbidity of lipids 
extracted from E. coli cells up to about 25 mg.ml- 1 (Fi.g 3.66). 
Further increase in concentration caused a slight increase in 
turbidity. With lignocaine, however, the curve consists of 
three phases (Fig 3.66). The initial part which extends to 
-1 
about 7.5 mg.ml shows no change in OD. The second part in 
which increases in lignocaine concentration, causes an 
increase in the OD and a final plateau which commences at about 
-1 20 mg.ml • 
3.8 Effect of LAs on Respiration 
(i) Reduction of triphenyltetrazolium chloride (TTC) 
Figs 3.67 to 3.71 show the effect of amethocaine, 
procaine, cinchocaine and lignocaine concentration on the rate 
of reduction of TTC (changes in OD at 490nm) by E.coli cells, 
suspended either in CFM (Fig 3.67) or in phosphate buffer 
(Figs 3.68 to 3.71). Substrates were either glucose (Figs 
3.67 and 3.68), succinate (Fig 3.69), malate (Fig 3.70) or 
lactate (Fig 3.71). 
There is a general common pattern of variation in 
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reduction rates dependent on concentration of LA. With 
glucose as a substrate, however, very low LA concentration 
often stimulated the rate of reduction of TTC by bacterial 
cells, at least for the first 30 min (e.g. 0.25 mg.ml -1 
amethocaine, 4 and 10 mg.ml- 1 procaine, 0.10 and 0.25 mg.ml- 1 
cinchocaine, 2 and 10 mg.ml- 1 lignocaine, Fig 3.67). However, 
with all different substrates, as the concentration of LA 
increased, the rate of TTC reduction decreased by an 
amount dependent on the LA concentration. Concentrations of 
amethocaine and cinchocaine approximately equal to the MBC 
virtually inhibited TTC reduction (7.5 mg.ml-1 amethocaine and 
2.5 mg.ml-1 cinchocaine, Fig 3.67), while with 50 mg.ml-1 
procaine or 20 mg.ml- 1 lignocaine formazan production 
continued. However, succinate~malate or lactate utilization 
was particularly sensitive (Figs 3.69 to 3.71) the rate of 
reduction of TTC decreasing more for the same increase in LA 
concentration than when glucose (Figs 3.67 and 3.68) was used 
as substrate. 
(ii) Measurement of oxygen uptake 
The rate of oxygen uptake by cells of E.coli in the 
presence of different concentration of amethocaine, 
procaine, cinchocaine and lignocaine is shown in Fig 3.72 
(glucose as substrate) or Fig 3.73 (succinate as substrate). 
Overall the curves are similar. Very low concentrations 
of LA stimulated or had no effect on the rate of oxygen 
-1 -1 
comsumption (e.g. 0.25 and 0.5 mg.ml amethocaine, 10 mg.ml 
procaine, 0.1 and 0.25 mg.ml- 1 cinchocaine, 2 and 10 mg.ml- 1 
lignocaine, in Fig 3.72). Further increases in the LA 
concentration caused a reduction in the rate of oxygen uptake, 
-.96-
the extent of which depends on the LA concentration, until 
at higher concentration it reached to the level of 
endogenous respiration (e.g. 6.5 mg.ml amethocaine, 2.0 
mg.ml- 1 cinchocaine in Figs 3.72 and 3.73). However, 
complete inhibition of respiration was not observed in the 
presence of procaine or lignocaine. Comparing Fig 3.72 and 
3.73, it can be seen that, for approximately the same 
decrease in the rate of oxygen comsumption, a higher 
concentration of LA is required with glucose as substrate 
than with succinate. For example, 1.5 mg.ml- 1 amethocaine 
caused about 56% reduction in oxygen consumption after 1 hr 
1.;hen glucose was the substrate (Fig 3. 72), while this 
concentration of amethocaine caused,when succinate was the 
substrate, about 79% reduction in oxygen uptake (Fig 3.73). 
3.9 Electron Microscopy 
Plates (3.5 to 3.15) are scanning electron micrographs 
of untreated and LA treated cells of E.coli. Both treated 
and untreated cells appear rod-shaped. Some of the cells 
grown in the presence of low concentrations of LAs are 
elongated without having any apparent surface damage, i.e. 
the cell surface appears smooth (Plates 3.6, 3.10 
3.14 •and 3.15), and some appear as a clump (Plates 
3.7 and 3.10). Higher concentrations (about MBC of 
LA) did not induce elongation, and some surface damage is 
apparent (Plates 3.8, 3.9 and 3.13). 
Plates 3,16 to 3.19 show the electron micrographs of 
ultra thin sections of E.coli in the absence or presence of 
LAs. Sections 
In plates 3.16 
had not been post stained prior to viewing. 
-1 (control) and 3.17 (50 mg.ml procaine) the 
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cell envelope can be seen to be continuous and apparently 
undamaged, the intracellular material is stained faintly and 
uniformly. The white region in the section could be the 
nuclear region. -1 In plates 3.18 (10 mg.ml amethocain~ and 
3.19 (20 mg.ml- 1 amethocaine) the cytoplasm is heavily and 
non-uniformly stained. In some parts it is contracted away 
from the cell envelope and the outer membrane appears less 
well defined. 
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Fig 3.1 Changes with time in the optical density 
(650 nm) of suspension of E.coli in CFM containing 
different concentrations of amethocaine after the 
addition of glucose at zero time. Initial contact 
time 10 min. Initial cell concentration 3.8 x 10 8 
-1 0 
cells.ml • Incubation temp 37 c. 
-1 Amethocaine concentration (mg.ml ): •---•, 0.0: 
x--x, 0.25;o----c, 0.50: o---o, 0.75: +-+, 1.0; 
~--~. 1.25: 0--0, 1.5. 
Fig 3.2 Changes with time in the optical density 
(650 nm) of suspensions of E.coli in CFM containing 
different concentrations of procaine after the addition 
of glucose at zero time. Initial contact time 10 min. 
Initial cell concentration 3.8 x 10 8 cells.ml-1 • 
Incubation temp 37°C. 
-1 Procaine concentration (mg.ml ): •--•, 0.0: x--x, 
10.o;c-o, 20.0: o-o, 25.0: +-+, 30.0: ~--~, 35.0: 
0-0, 40.0: !--!, 50.0. 
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Fig 3.3 Changes with time in the optical density 
(650 nm) of suspension of E.coli in CFM containing 
different concentrations of cinchocaine after the 
addition of glucose at zero time. Initial contact time 
10 min. Initial cell concentration 3.8 x 10 8 cells. 
ml-1 • Incubation temp 37°C. 
-1 Cinchocaine concentration (mg.ml ); •---•, 0.0 and 
0.10; e--a, 0.25; o-o, 0.30; +-+, 0.40; 
1:1-I:J., 0.50; 0-0, 0.60; A-A, 1.50. 
Fig 3.4 Changes with time in the optical density 
(650 nm) of suspension of E.coli in CFM containing 
different concentrations of cinchocaine after the 
addition of glucose at zero time. Initial contact 
time 10 min. Initial cell concentration 3.8 x 10 8 
-1 0 
cells.ml • Incubation temp 37 c. 
Lignocaine concentration (mg.ml-1); •-•, 0.0; x--x, 
10.o;cr-a, 15.0; o-o, 20.0; +-+, 25.0; 
tJ.-tJ., 30.0; 0-0, 40.0. 
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Fig 3.5 Changes with time in the optical density 
(650 nm) of suspensions of K.aerogenes in CFM contain-
ing different concentrations of amethocaine after the 
addition of glucose at zero time. Initial contact 
time 10 min. Initial cell concentration 0.12 mg.ml- 1 • 
Incubation temp 37°c. 
Amethocaine concentration (mg.ml-1 ): •-•, 0.0; x--x, 
0.5o;o--o, 1.00; o-o, 1.25; +-+, 1.50; 6.-!J., 2.00; 
,_,, 3.00. 
Fig 3.6 Changes with time in the optical density 
(650 nm) of suspensions of K.aerogenes in CFM contain-
ing different concentrations of procaine after the 
addition of glucose at zero time. Initial contact 
time 10 min. Initial cell concentration 0.12 mg.ml- 1 • 
Incubation temp 37°c. 
Procaine concentration (mg.ml-1); •---•, 0.0; x--x, 
10.0; o---o, 20.0; o-o, 30.0; +-+, 40.0; 
6.-!J., 50.0; , __ ,, 60.0. 
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Fig 3.7 Changes with time in the optical density 
(650 nm) of suspension of K.aerogenes in CFM contain-
ing different concentrations of cinchocaine after the 
addition of glucose at zero time •. Initial cell 
concentration 0.12 mg.ml- 1 • Initial contact time 
10 min. Incubation temp 37°c. 
Cinchocaine concentration (mg.ml-1 ) •-•, 0.00; 
x--;x:, 0.25;c-c, 0.50; o-.-o, 0.75; +-+, 1.00; 
t:,--t:., 2.00. 
Fig. 3.8 Changes with time in the optical density 
(650 nm) of suspension of K.aerogenes in CFM contain-
ing different concentrations of lignocaine after the 
addition of glucose at zero time. Initial cell 
concentration 0.12 mg.ml-1 • Initial contact time 
10 min. Incubation temp 37°c. 
Lignocaine concentration (mg.ml- 1 ) •--•, 0.0; 
x--x, 10.0;o--o, 15.0; o-o, 20.0; +-+, 25.0; 
/::,-/:;., 30.0. 
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Fig 3.9 Changes with time in the optical density 
(650 nm) of suspension of P.aeruginosa in CFM contain-
ing different concentrations of amethocaine after the 
addition of glucose at zero time. Initial cell 
-1 
concentration 0.125 mg.ml Initial contact time 
10 min. Incubation temp 37°c. 
-1 Amethocaine concentration (mg.ml ) •-•, 0.0; 
x-x, 0.25;o--o, 0. 75; !J.-!J., 1.0; o-o, 1. 5; 
+ - +, 2 • 0 ; ·-• , 2 • 5 • 
Fig 3.10 Changes with time in the optical density 
(650 nm) of suspension of P.aeruginosa in CFM 
containing different concentrations of procaine after 
the addition of glucose at zero time. Initial cell 
concentration 0.125 mg.ml- 1 • Initial contact time 
10 min. Incubation temp 37°c. 
-1 Procaine concentration (mg.ml ) •-•, 0.0; 
x--:K, 10.0;0--0, 20.0; !J.-!J., 30.0; o--o, 40.0; 
+-+, 50.0. 
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Fig 3.11 Changes with time in the optical density 
(650 nm) of suspension of P.aeruginosa in CFM contain-
ing different concentrations of cinchocaine after the 
addition of glucose at zero time. Initial cell 
concentration 0.125 mg.ml- 1 • Initial contact time 
10 min. Incubation temp 37°c. 
Cinchocaine concentration (mg.ml- 1 ), •---•, 0.001 
x---x, 0.251o--c, 0.501 1!.---IJ., 0.751 o-o, 1.001. 
Fig 3.12 Changes with time in the optical density 
(650 nm) of suspension of P.aeruginosa in CFM contain-
ing different concentrations of lignocaine after the 
addition of glucose at zero time. Initial cell 
-1 
concentration 0.125 mg.ml 
10 min. Incubation temp 37°c. 
Initial contact time 
Lignocaine concentration (mg.ml-1 ), •-•, 0.01 
x---x, 10.010-- c, 15.01 fi-t., 20.01 o-o, 25.01 
+-+, 30.0. 
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Fig 3.13 Changes with time in the optical density 
(650 nm) of suspension of B.megaterium in CFM contain-
ing different concentrations of amethocaine after the 
addition of glucose at zero time. Initial cell 
-1 
concentration 0.070 mg.ml • Initial contact time 
10 min. Incubation temp 37°c. 
-1 Amethocaine concentration (mg.ml ): •-•, 0.0; 
x-x, 0.25;0-- a, 0.30; !J.-!J., 0.40; A- A, 0.50; 
+-+, 1.0. 
Fig 3.14 Changes with time in the optical density 
(650 nm) of suspension·of B.megaterium in CFM contain-
ing different concentrations of procaine after the 
addition of glucose at zero time. Initial cell 
-1 
concentration 0.070 mg.ml • Initial contact time 
10 min. Incubation temp 37°C. 
Procaine concentration (mg.ml-1), •-•, 0.0; 
x- x, 5.0;0-- c, 10.0; !J.--!J., 15.0; A-A, 20.0; 
+-+, 25.0. 
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Fig 3.15 Changes with time in the optical density 
(650 nm) of suspension of B.megaterium in CFM 
containing different concentrations of cinchocaine 
after the addition of glucose at zero time. Initial 
-1 
cell concentration 0.070 mg.ml • Initial contact 
time 10 min. Incubation temp 37°C. 
-1 Cinchocaine concentration (mg.ml ) , •-•, 0.0; 
x-x, 0.15;0--o, 0.20; t.--t., 0.25; A--A, 0.50. 
Fig 3.16 Changes with time in the optical density 
(650 nm) of suspension of B.megaterium in CFM contain-
ing different concentrations of lignocaine after the 
addition of glucose at zero time. Initial cell 
-1 
concentration 0.070 mg.m. 
min. Incubation temp 37°c. 
Initial contact time 10 
Lignocaine concentration (mg .ml-1 ) , •-•, 0. 0; 
x-x, 2.0; a-c, 2.5; t,--t., 4.0; A--A, 8.0; 
+- +, 10.0. 
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Fig 3.17 Effect of LAs concentration on the % 
inhibition of growth of E.coli (A); K.aerogenes (B); 
P.aeruginosa (C) and B.megaterium (D) 70-min after_ 
the - addition of glucose. Temp 37°c. 
o-o amethocaine, +-+ procaine, •-• cinchocaine, 
A---A lignocaine. 
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Fig 3.18 Exponential growth rate constants of E.coli 
in cultures partially inhibited by (A) o---o amethocaine 
and e--e cinchocaine; 
lignocaine. 
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Fig 3.19 Changes in the optical density (650 nm) of 
E.coli cell suspension in CFM after the addition of 
glucose (2•0 mg.ml- 1 ) and ampicillin (2.0 ~g.ml- 1 ) in 
the presence or absence of different concentrations of 
amethocaine. Temp 37°C. Contact time 10 min. Cell 
8 -1 
concentration 1.3 x 10 cells.ml • 
Amethocaine concentrations (mg.ml- 1 ) •---•, 0.0; 
x-x, 0.2o;c-c, 0.40; o--o, 0.50; +-+, 0.60; 
1:!.-1:!., 1.00; 0---0, 1.50. 
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Fig 3.20 The size distributions 
untreated and amethocaine treated 
(threshold units) 
-1 (o.50 mg.ml ) 
cells of E.coli growing in complete growth medium 
-1 
containing 2.0~g.ml ampicillin. 
•--•, control at zero time; !-!, control 60 min 
after the addition of glucose (2.0 mg.ml-1 ) and 
ampicillin; o--o, amethocaine treated cells at zero 
time;o----o, amethocaine treated cells after 20 min 
of 
growth; 0-e,amethocaine treated cells after 40 min 
growth; !J.-!J., amethocaine treated cells after 60 min 
growth»--<>, amethocaine treated cells after 90 min 
growth. 
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Fig 3,21 Changes with time in the optical density 
(650 nm) of cultures of E.coli initially suspended in 
CFM containing different concentrations of amethocaine, 
after the addition of glucose (at zero time) and after 
resuspension in the same volume of the complete growth 
medium (at 80 min). Initial contact time (prior to 
addition of glucose) 10 min. Incubation temp 37°C. 
-1 Cell concentration 3.8 x 10 8 cells.ml • 
Amethocaine concentration (mg.ml- 1): 
·-· o-o' 0.0; 
x--x 
+-+' 
0 5 
·--· 
· ic--e' o. 75; ,_" ·-· v--v , 1. o 1<>-o , 1. 2 5 ; 
A-A A-A' 1.50 (the lower symbol represents changes measured 
after resuspension)• 
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Fig 3.22 Changes with time in the optical density 
(650 nm) of cultures of E.coli initially suspended in 
CFM containing different concentrations of procaine 
after the addition of glucose at zero time and after 
resuspension in the same volume of the complete 
growth medium (at 80 min), Initial contact time (prior 
to addition of glucose) 10 min. Incubation temp 37°C. 
Cell concentration 3.8 x 10 8 cells.ml-1 • 
-1 ·-· Procaine concentration (mg.ml ): 0 ___ 0 , 0.0; 
x-x --• 
+-+' 10.o;• , 20.o; f-T 30 o•--• 40 o o -- o v---v, . ;~--<>' . ; 
~===~· 50.0 (lower symbol represents changes measured 
after resuspension). 
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Fig 3.23 Changes with time in the optical density 
(650 nm) of cultures of E.coli initially suspended in 
CFM containing different concentrations of cinchocaine 
after the addition of glucose at zero time and after 
resuspension in the same volume of the complete growth 
medium (at 80 min). Initial contact time (prior to 
addition of glucose) 10 min. Incubation temp 37°C. 
a -1 Cell concentration 3.8 x 10 cells.ml • 
-1 ·--· Cinchocaine concentration (mg.ml ) : 0 _ 0 , o.o; 
x--x 0 20 •--• 0 30 ,--,, 0 40 +--+ 0 60 +-+' · ;o-o ' · ; • ; ' • • v-v ~ ~ 
(lower symbol represents changes measured after 
resuspension). 
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Fig 3.24 Changes with time in the optical density 
(650 nm) of cultures of E.coli initially suspended in 
CFM containing different concentrations of lignocaine 
after the addition of glucose at zero time and after 
resuspension in the same volume of the complete growth 
medium (at 80 min). 
Initial contact time (prior to addition of glucose) 10 min. 
Incubation temp 37°c. Cell concentration 3.8 x 10 8 cells. 
-1 
ml • 
-1 Lignocaine concentration (mg.ml ): •---•, 0.0; x---x, 
o-o +-+ 
·-· ,_, ·--· 10.0; 0 _ 0 , 15.0; V-V' 20.0;<> <>' 25.0. 
(lower symbol represents changes measured after resuspension). 
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Fig 3.25 Changes with time in the optical density 
(650 nm) of cultures of E.coli initially suspended in 
CFM containing different concentrations of amethocaine, 
after the addition of glucose (at zero time) and after 
the dilution with an equal volume of complete growth 
medium (at 55 min). Initial contact time (prior to 
addition of glucose) 10 min. Temp 37°C. Cell 
a -1 
concentration 3.8 x 10 cells.ml • 
Initial amethocaine concentrations (mg.ml- 1 ): ~:::~· 
o.o; +x=+x' o.5o:•--• , o. 75; ,-,, 1.0o:•-. -•, 1.25; 
e--a v-i/ o-o 
!---!, 1.50 (lower symbol represents changes measured 
f::,_f::, 
after dilution}. 
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Fig 3,26 Diauxic growth of 
containing glucose-galactose 
E.coli in growth medium 
(0,15 mg,ml-1 ) with 
amethocaine added 10 min before the addition of 
carbohydrates. Initial cell concentration 3.8 x 10 8 
-1 0 
cells.ml • Temp 37 c. 
Amethocaine concentration (mg.ml- 1) o---o, 0.0; 
x-x, 0.25;o--o, 0.50; !J.--!J., 0.75; :-:, 1.00; 
+-+, 1.50. 
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Fig 3.27 Diauxic growth of 
containing glucose-galactose 
E.coli in growth medium 
(0.15 mg.ml- 1 ) with 
procaine added 10 min before the addition of carbohy-
drates. Initial cell concentration 3.8 x 10 8 cells.ml-1 • 
Temp 37°c. 
Procaine concentration (mg.ml- 1 ) o--o, 0.0; x-x, 10.0; 
o--0• 20.0; I:J.-I:J., 25.0; :-: 1 30.0; +-+, 35.0; 
,_,, 40.0;••--•, 50.0. 
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Fig 3.28 Diauxic growth of E.coli in growth medium 
-1 
containing glucose-galactose (0.15 mg.ml ) with 
cinchocaine added 10 min before the addition of 
carbohydrates. Initial cell concentration 3,8 x 10 8 
-1 0 
cells.ml • Temp 37 c. Cinchocaine concentration 
-1 (mg.ml ) : o..,....-o, 0.0; 1-1, 0.20; x----x, 0.30; 
o-o, 0.40; I:J.-I:J., 0.60; :--:, 0.80; T--T, 1.00. 
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Fig 3.29 Diauxic growth of E.coli in growth medium 
-1 
containing glucose-galactose (0.15 mg.ml ) with 
lignocaine added 10 min before the addition of carbohy-
drates. Initial cell concentration 3.8 x 10 8 cells.ml-1 • 
0 -1 Temp 37 c. Lignocaine concentration (mg.ml ) : 
o--o, 0.0; x-x, 10.0;o--c, 15.0; tJ.-!J., 20.0; 
:-:, 25.0; ,_,, 30.0; +-+, 40.0. 
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Fig 3.30 Diauxic growth of 
containing glucose-galactose 
E.coli in growth medium 
(0.15 mg.ml- 1 ) with 
chloramphenicol added 10 min before the addition of 
carbohydrates. Initial cell concentration 3.8 x 10 8 
-1 0 
cells.ml • Temp 37 c. Chloramphenicol concentration 
-1 ()Jg.ml >:o-o, 0.0; x-x, 2.0;o-o, 4.0; 
!J.-!J., 8. 0; :-: , 1 0. 0. 
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Fig 3.31 Diauxic growth of E.coli in growth medium 
containing glucose-galactose (0.15 mg.ml- 1) with 
ampicillin added 10 min before the addition of 
carbohydrates. Initial cell concentration 3.8 x 10 8 
-1 0 -1 
cells.ml • Temp 37 c. Ampicillin concentration (~g.ml ): 
o-o, 0.0; x-x, 1.0;0--0, 2.5; D.-D., 3.0; 
:--:, 4.0; T-Tr 5.0; +-+, 7.5. 
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Fig 3.32 .Diauxic growth of E.coli in growth medium 
containing glucose-galactose (0.15 mg.ml- 1) with 
cetylpyridinium bromide (CPB) added 10 min before the 
addition of carbohydrates. Initial cell concentration 
8 -1 3.8 x 10 cells.ml • 
-1 CPB concentration (~g.ml ): o---o, 0.0 and 2.0; 
x- x, 3. 0 ;o-- o , 4. 0; 1:!. -ll, 6. 0; :-: , 1 0. 0; 
,_,, 15.0. 
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Fig 3.33 Diauxic growth of 
containing glucose-galactose 
caine added 28 min after the 
Initial cell concentration: 
0 Temp 37 c. 
E.coli in growth medium 
(0.15 mg.ml- 1) with ametho-
addition of carbohydrates. 
-1 3.8 x 10 8 cells.ml • 
Amethocaine concentration (mg .ml-1 ) o-o, 0. 0 ,· 
x--x, 0.25;o-o, 0.5; !J.--!J.1 0.75; :--:,1.0; +-+, 1.5. 
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Fig 3.34 Diauxic growth of E.coli in growth medium 
containing glucose-galactose (0.15 mg.ml- 1 ) with procaine 
added 28 min after addition of carbohydrates. Initial cell 
concentration: 3.8 x 10 6 cells.ml-1 • Temp 37°C. 
Procaine concentration (mg.ml- 1): o-o, 0.0; x--x, 10.0; 
o-o, 20.0; .l-.l, 25.0; :--:, 30.0; +-+, 35.0. 
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Fig 3.35 Diauxic growth of 
containing glucose-galactose 
E.coli in growth medium 
( 0. 1 5 mg. ml - 1 ) with 
cinchocaine added 30 min after addition of carbohydrates. 
Initial cell concentration: 3.8 x 10 8 cells.ml-1 • Temp 
37°C. Cinchocaine concentration (mg.ml- 1 ): o-o, 0.0 
and 0.10; x-x, 0.30;c--o, 0.40; 6-6 0.50; :-:, 
0.60. 
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Fig 3.36 Diauxic growth of E.coli in growth medium 
-1 
containing glucose-galactose (0.15 mg.ml ) with 
chloramphenicol added 30 min after the addition of 
carbohydrates. Initial cell concentration: 3.8 x 10 8 
. -1 0 
cells.ml • Temp 37 c. Chloramphenicol concentration 
-1 (IJg.ml ) : o-o, 0.0; x-x, 2.5;c--o 5.0; t;-t; 7.5 
and 1 0 • 0 ; : -: , 1 5 • o, 2 0 • 0 and 2 5 • 0 • 
Fig 3.37 Diauxic growth of E.coli in growth medium 
containing glucose-galactose (0.15 mg.ml-1 ) with puromycin 
added 30 min after the addition of 
Initial cell concentration: 3.8 x 
-1 Puromycin concentration (1Jg.ml ): 
carbohydrates. 
8 -1 10 cells.ml • 
o-o,O.O; 
x-x; 100; c- o, 200 and 300; t;-{;500; :-: 600, 
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Fig 3.38 Diauxic growth of E.coli in growth medium 
containing glucose-galactose (o.15 mg.ml-1 ) with 
ampicillin added 28 min after the addition of carbohydrates. 
Initial cell concentration: 3.8 x s -1 10 cells.ml • Temp 
-1 Ampicillin concentration (~g.ml ) : o-o, 0.0; 
X-X, 1.0;0---C, 2.5; 6-6 1 5.0; :--:, 7.5; l--l, 
10.0;•-•, 15.0; •-•, 20.0. 
Fig 3.39 Diauxic growth of E.coli in growth medium 
containing glucose-galactose (0.15 mg.ml-1 ) with cetyl-
pyridinium bromide added 28 min after the addition of 
carbohydrates. Initial cell concentration: 3.8 x 10 8 
-1 0 
cells.ml • Temp 37 c. 
-1 Cetylpyridinium bromide concentration (\Jg .ml ) : o- o, 
0.0 and 2.0; x-x, 3.0;c-o, 4.0; 6-6, 5.0; :-:, 6.0. 
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Fig 3.40 The effect of (A) procaine l!.-l!. and lignocaine 
1.--1.; (B) amethocaine, o-o and cinchocaine •-• 
concentration on the percentage viability of cells of 
E.coli suspended in CFM. Cell concentration 3.8 x 10 8 
-1 0 
cells.ml • Contact time 10 min. Temp 22 c. 
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Fig 3.41 The effect of (A) procaine t:.-t:. and lignocaine 
!- !: (B) amethocaine o-o and cinchocaine •-• 
concentration on the percentage viability of cells of 
K.aerogenes suspended in CFM. Initial cell concentration 
-1 0 0.12 mg.ml • Contact time 10 min. Temp 22 c. 
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Fig 3.42 The effect of (A) procaine D.-D. and lignocaine 
i-i; (B) amethocaine o-o and cinchocaine •-•, 
concentration on the percentage viability of cells of 
P.aeruginosa suspended in CFM. 
-1 0.125 mg.ml • Contact time 
Initial cell concentration 
10 min. Temp 22°c. 
- 129 -
loo 
so 
so 
>. 4 0 
.... 
.... 
.... 
.... 
..0 
"' .... 
:> 20 
l----~------~--~~~--~4~0~--~~---------30 oo lo 2o -1) 
( mg.rnl Cone 
>. 60 
.... 
.... 
.... 
.... 
..0 
"' 
•.-1 4 0 
:> 
2o 
(B) 
f f~ OL_--~~~--~~4·--~~~~)~6~~~S~ 
o 2 Cone (mg .ml 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
j 
Fig 3.43 The effect of (A) procaine ~---~ and lignocaine 
A---A; (B) amethocaine, o-o and cinchocaine, •-•; 
concentration on the percentage viability of cells of 
B.megaterium suspended in CFM. Initial cell concentration 
-1 0 0.070 mg.ml • Contact time 10 min. Temp 22 c. 
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Fig 3.44 The effect of treatment with local anaesthetics 
for 10 min at 22°C on the 32P content of labelled cells of 
E.coli suspended in CFM. Cell concentration 3.8 x10 8 cells. 
-1 
ml • 
(A) o---o Amethocaine; A---A Procaine 
(B) •---• Cinchocaine; A---A Lignocaine 
radioactivity released from the cells exposed to 5% 
trichloroacetic acid. 
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Fig 3.45 The release of inorganic phosphate from E.coli 
cells suspended in LPM after 10 min exposure to different 
concentrations of local anaesthetics. Cell concentration 
3.8 X 10 9 -1 cells.ml • 
(A) o---o Amethocaine; 
(B) e---e Cinchocaine; 
Procaine 
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Gl 
u 
~ 
"tJ 
tO 
E 
= ~0 
Gl 
... 
ftl 
i 
tl) 7·5 
0 
..c 
Q. 
0 
0 
- 132 -
(A) 
5 IO 
(B) 
·-·-· ..... ( 
• I 
• I 
5 10 
IS 
20 
30 
_,) 
cone (mg·ml 
30 
Conc.(mg.mi1) 

Fig 3.46 The release of pentose from E.coli cells 
suspended in CFM after 15 min exposure to different 
concentrations of local anaesthetics. Cell concentration 
-1 0 3.8 x 10 9 cells.ml • Temp 22 C. 
(A) o--o Amethocaine 1 t::.--t::. Procaine 
(B) e---e Cinchocaine, !--! Lignocaine 
Pentose released from the cells after boiling the 
cells for 10 min. 
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Plate 3.1 
Plate 3.2 
Effect of amethocaine on pentose release 
from E.coli cells after 15 min contact time 
0 
at 22 c, as a change in colour from yellow to 
green and greenish yellow, corresponding to 
increase and then decrease in.released 
pentose. Cell concentration: 3.8 x 10 9 
-1 
cells.ml • Concentration of amethocaine 
(mg.ml- 1), from left to right: 
0.0, 1.25, 2.5, 5.0, 7.5, 10.0, 15.0, 20.0, 
25.0. 
Effect of procaine on pentose release from 
E.coli cells after 15 min contact time at 
22°C, no colour chang'es can be observed, 
i.e. no pentose released. Cell concentra-
tion: 3. 8 x 
of procaine 
10 9 cells.ml-1 • concentration 
-1 (mg.ml ) , from left to right: 
o.o, 10.0, 20.0, 25.0, 30.0,35.0, 40.0, 50.0 
- 1 34 -

Pl ate 3 . 3 
Plate 3 . 4 
Effect of cinchocaine on pentose release 
from E . coli cell s after 15 min contact time 
0 
at 22 c , as a change in colour from yellow to 
green and gr eenish yellow , corresponding to 
increase and t h en decrease in the r e l eased 
pentos e . Cell concentration : 3 . 8 x 10 9 
-1 
cells . ml . Concentration of c inchocaine 
- 1 (mg . ml ) from l e ft to right : 
0 . 0 , 1 . 25 , 2.5 , 5 . 0 , 7 . 5 , 10 . 0 , 15 . 0 , 20 , 0 , 
25 . 0 . 
Effect of lignocaine on p entose release from 
E . col i cel l s after 1 5 min cont act time at 
22°c . No col our changes were observed , i . e . 
no pentose r e l eased . Cel l concentration: 
-1 3 . 8 x 10 9 cells . ml . Concentration of 
lignocaine (mg . ml - 1 ) from l e ft to right : 
0.0 , 5 . 0, 10 . 0 , 15.0 , 20 . 0 , 25 . 0 , 30 . 0 , 35 . 0 . 
- 13 5 -
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Fig 3.47 The effect of LA concentration on the release of 
penbose from E.coli cells suspended in CFM after different 
contact times at 22°c. Cell concentration, 3.8 x 10 9 cells. 
ml-1 • 
(A) 
o-o 10 mg.ml -1 amethocaine 
D--!J 30 mg.ml -1 amethocaine 
0-0 50 mg.ml -1 procaine 
(B) 
·-· 
5 mg.ml -1 cinchocaine 
·-· 
20 mg.ml -1 cinchocaine 
·-· 
40 mg.ml -1 lignocaine 
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Fig 3.48 The effect of LA concentration on the release of 
pentose from E.coli cells suspended in CFM after 
different contact times at 1°C. Cell concentration 
9 -1 3.8 x 10 cells.ml • 
(A) 
o-o 5 mg.ml -1 amethocaine 
o-o 10 mg.ml -1 amethocaine 
o-<> 25 mg.ml -1 amethocaine 
(B) 
·-· 
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·-· 
10 mg.ml -1 cinchocaine 
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20 mg.ml -1 cinchocaine 
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Fig 3.49 The leakage of 260 nm absorbing material from 
E.coli cells, suspended in CFM after 30 min exposure to 
different concentration of LA. Cell concentration 3.8 x 10 9 
-1 0 
cells.ml • Temp 22 c. 
(A) o---o, Amethocaine; 6---6 Procaine 
(B) e---e Cinchocaine; !---! Lignocaine 
Amount of 260nm released after boiling of the cells 
for 10 min. 
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Fig 3.50 Uptake of amethocaine (o---o) and procaine (~---A) 
by E.coli suspended in CFM plotted as a function of 
equilibrium concentration. Contact time 30 min; Temp 37°C, 
cell concentration 3.8 x 10 10 cells.ml-1 • 
Fig. 3.51 Uptake of amethocaine by E.coli cells suspended 
in CFM plotted as a function of equilibrium concentration. 
Contact time 30 min, temp 37°C, cell concentration 3.8 x 10 10 
-1 
cells.ml • 
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Fig 3.52 Uptake of Cinchocaine (e---e) and lignocaine 
(!---!) by E.coli suspended in CFM plotted as a function 
of equilibrium concentration. 
37°c. Cell concentration 3.8 
Contact time 30 min, 
-1 
x 10 10 cells.ml • 
temp 
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Fig 3.53 Solubilization of Sudan Black B by 
amethocaine in water +---+ and CFM x---x, cinchocaine 
in water 
Fig 3.54 
. . 
.. --.. and in CFM 
Plot of surface tension <Yl at air-liquid 
interface for amethocaine in water +---+ and CFM x---x 
against concentration (mg.ml- 1 ) at 22°c. 
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Fig 3.55 Turbidity changes (optical density at 650 nm) 
in cells of E.coli suspended in CFM containing different 
LA as a function of LA concentration. Cell number 
3.8 x 10 8 cells.ml-1 • Temp 22°c, contact time 10 min. 
(A) o-o Amethocaine; 6-6 Procaine 
(B) •-• Cinchocaine; A- A Lignocaine 
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Fig 3.56 Turbidity changes (optical density at 650 nm) 
in cells of K. aerogenes suspended in CFM containing 
different LA as a function of LA concentration. Cell 
concentration 0.12 mg.ml-1• Temp 22°c, contact time 10 
min. 
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Fig 3.57 Turbidity changes (optical density at 650 nm) 
in cells of P.aeruginosa suspended in CFM containing 
different LA as a function of LA concentration. Cell 
concentration 0.125 mg.ml-1 • Temp 22°c. Contact time 
10 min. 
(A) o- o Amethocaine; t:.-1::. Procaine 
(B) •-• Cinchocaine; '_, Lignocaine 
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Fig 3.58 Turbidity changes (optical density at 650 nm) 
in cells of B.megaterium suspended in CFM containing 
different LA as a function of LA concentration. Cell 
-1 0 
concentration 0.070 mg.ml • Temp 22 C. contact time 
10 min. 
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Fig 3.59 Influence of time on the induced turbidity 
changes in cells of E.coli suspended in CFM containing 
LAs. 
Cell number 3.8 x 10 8 -1 cells .ml • 0 Temp 22 c. 
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10 -1 amethocaine a-a mg.ml 
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Fig 3.60 Turbidity changes (OD 650 nm) in LA treated 
cells of E.coli suspended in distilled water. Cell 
concentration 4.0 x 10 8 cells.ml-1 , temp 22°c, contact 
time 10 min 
o-o amethocaine, and •-• cinchocaine, 
Fig 3.61 Turbidity changes (OD 650 nm) in LA treated 
cells of E.coli suspended in phosphate buffer (pH 6.4, 
0. 2M) • 8 -1 0 Cell concentration 4.0 x 10 cells.ml , temp 22 c, 
contact time 10 min. 
o -o amethocaine, and •-• cinchocaine. 
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Fig 3.62 Turbidity changes (OD 650 nm) in amethocaine 
treated cells of E.coli suspended in CFM containing 
different concentrations of Mg++. Cell concentration 
3.8 x 10 8 cells.ml-1 • Temp 22°c, contact time 10 min. 
Mg++ concentration: V- V' M 10,000' x--x 
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Fig 3.63 The effect of amethocaine and procaine on 
optical density (650 nm) of E.coli cell envelope preparation 
( o-- a, amethocaine; 'V -'i/, procaine) and intracellular 
material (o-o, amethocaine; t:.--t,.,procaine) in CFM. 
Cell concentration ea. 3.8 x 10 8 cells.ml-1 • contact 
time 10 min. Temp 22°c. 
Fig 3.64 The effect of cinchocaine and lignocaine on 
optical density (650 nm) of E.coli cell envelope preparation 
( •-- •,cinchocaine; T--T ,lignocaine) and intracellular 
material (e-e,cinchocaine; !--&,lignocaine) in CFM. 
Cell concentration ea. 3.8 x 10 8 cells.ml-1 • contact 
time 10 min. Temp 22°c. 
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Fig 3,65 Turbidity changes (650 nm) of lipid depleted 
cells of E.coli suspended in CFM as a function of LA 
concentration. Contact time 10 min, Temp 22°c. 
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Fig 3.66 Turbidity changes (650 nm) of lipids, extract~d 
from E.coli cells, and dispersed in CFM as a function of 
LA concentration. Contact time 10 min, Temp 22°C. 
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Fig 3.67 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the 
reduction of TTC by a suspension of E.coli cells 
in CFM using glucose as substrate. Cell 
9 -1 
concentration 3.8 x 10 cells.ml . 0 Temp 37 c. 
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Fig 3.68 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the 
reduction of TTC by a suspension of E.coli 
cells in phosphate buffer (pH 6.4, 0.20M) 
using glucose as substrate. Cell concentration 
3.8 x 10 9 cells.ml-1 • Temp 37°C. 
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Fig 3.69 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the 
reduction of TTC by a suspension of E.coli cells 
in phosphate buffer (pH 6.4, 0.20M) using 
succinate as substrate. Cell concentration 3.8 x 
10 9 cells.ml-1 • Temp 37°C. 
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Fig 3.70 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the 
reduction of TTC by a suspension of E.coli cells 
in phosphate buffer (pH 6.4, 0.20M) using 
malate as 
3.8 X 10 9 
substrate. Cell concentration 
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Fig 3.71 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the 
reduction of TTC by a suspension of E.coli cells 
in p~osphate buffer (pH 6.4, 0.20M) using lactate 
as substrate. Cell concentration 3.8 x 10 9 
cells.ml-1 • Temp 37°c. 
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3.72 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the· rate of 
oxygen uptake of E.coli suspended in CFM using 
glucose as substrata. 
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Fig 3.73 The effect of amethocaine (A), procaine (B), 
cinchocaine (C) and lignocaine (D) on the rate 
of oxygen uptake of E.coli cells suspended in 
CFM using succinate as substrate. Cell 
concentration 3.8 x 10 8 cells.ml-1 • Temp 37°c. 
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Plate 3.5 Scanning electron micrograph of E.coli 
shake-incubated in complete growth medium 
at 37°C. Bar indicates 1.0 ~m. 
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Plate 3.6 
Plate 3.7 
Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the 
presence of 0.5 mg.ml- 1 amethocaine 
(£e ~ MIC) at 37°C, showing some 
filamentous forms with smooth surface 
X10,000. 
Scanning electron micrograph of E.coli shake 
shake-incubated for 15 min in the 
-1 presence of 1.0 mg.ml amethocaine 
(~ MIC) at 37°C, showing cells similar to 
the untreated one. However, clumps of 
cells in some parts can be observed. 
Bar indicates 1.0 ~m. 
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Plate 3.8 
Plate 3.9 
Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the presence 
of 7.5 mg.ml- 1 amethocaine (MBC), at 37°C 
Showing surface damages without any 
filamentous forms •. Bar indicates 1.0 ~m. 
Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the presence 
-1 0 
of 12 mg.ml amethocaine at 37 c. Show-
ing surface damages without any 
filamentous forms. Bar indicates 1.0 ~m. 
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Plate 3.10 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the presence 
of 30 mg.rnl- 1 procaine (~MIC) at 37°c, 
showing some filamentous forms and some 
clumps of cells. Bar indicates 1.0 11m. 
Plate 3.11 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the presence 
-1 0 
of 50 rng.ml procaine at 37 C. The cells 
surface are smooth and they appear as un-
treated cells. Bar indicates 1.0 11m. 
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Plate 3.12 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the 
presence of 1.0 mg .ml-1 cinchocaine 
(~MIC) at 37°c. Showing smooth 
surface. Bar indicates 1.0 ~m. 
Plate 3.13 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the 
presence of 5.0 mg.ml- 1 cinchocaine 
(ea 2 x MBC) at 37°C. Surface damages 
can be observed. Bar indicates 1.0 ~m. 
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Plate 3.14 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the 
presence of 10 mg.ml-1 lignocaine 
(sub-inhibitory concentration) at 37°C, 
showing some filamentous cells. X10,000. 
Plate 3.15 Scanning electron micrograph of E.coli 
shake-incubated for 15 min in the 
-1 presence of 30 mg.ml lignocaine 
(~ MIC) at 37°C, showing some filamen-
tous cells. Bar indicates 1.0 ~m. 
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Plate 3.16 Electron micrograph of an ultra thin 
section of E.coli suspended in CFM for 
15 min at 22°c, showing the usual feature 
of a bacterial cell. X60,000. 
Plate 3.17 Electron micrograph of an ultra thin 
section of E.coli suspended in CFM in 
the presence of 50 mg.ml- 1 procaine 
for 15 min at 22°c. The section does not 
show any visible change comparing with 
control. X37,500. 
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Plate 3.18 Elec~ron micrograph of an ultra thin 
section of 
presence of 
E.coli suspended in CFM in the 
-1 
amethocaine (10 mg.ml ) for 
15 min at 22°C. The section shows heavily 
and non-uniformly stained cytoplasm 
which in some parts is contracted away 
from the cell envelope. The outer membrane 
appear less well defined. X67,500. 
Plate 3.19 Electron micrograph of an ultra thin 
section of E.coli suspended in CFM in the 
presence of amethocaine (20 mg.ml- 1 ) for 
15 min at 22°C. The section shows 
heavily and non-uniformly stained 
cytoplasm which in some parts is 
contracted away from the cell envelope. 
The outer membrane appears less well 
defined. X45,000. 
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CHAPTER 4 
D I S C U S S I 0 N 
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Local anaesthetics (LAs) affect bacterial cells in 
many different ways. Their effects range from growth 
inhibition and stimulation/depression of respiration to 
leakage of cellular constituents, gross cytological changes 
and cell death. Not all the anaesthetics studied, however, 
gave rise to the same effects. For example procaine had 
little effect on cell viability. 
LAs are generally more effective against Gram-positive 
cells than Gram-negative in terms of minimum inhibitory 
concentrations (Fig 3.1 to 3.16 and Table 3.1). This 
variation is probably due to combinations of (a) the 
differences in the lipid content of the cell envelope, (b) 
the presence of a capsule or (c) the production of a slime 
layer. Indeed a quantitative comparison of the LA 
concentrations required to produce a 50% inhibition of 
growth of the different Gram-negative organisms (Table 3.4) 
with those producing a similar effect with B.megaterium 
produced ratios greater than one. This indicates the 
significance of the"outer membrane" of the Gram-negative 
cells in the protection of the cell from the influx of the 
drug (Chopra and Shales, 1981). The local anaesthetics are 
not equally effective as antibacterial agents and consider-
ing them as esters or amides, amethocaine is more effective 
than procaine and cinchocaine is more effective than 
lignocaine. These differences probably reflect structural 
differences in these LAs (Figs 2.1) which though 
only slight for amethocaine and procaine gives rise to a 
marked increase in the lipophilicity of amethocaine. 
Similarly with cinchocaine and lignocaine. 
Slightly different values were obtained for MICs 
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using the tube dilution or the shaken culture techniques 
indicating the significance of adequate aeration during 
growth. The amount of capsule or slime formation is 
influenced by oxygen concentration (Meadow, 1978) and of 
course there is a marked effect on the cellular growth rate 
which approaches the maximum possible under the shaken 
conditions. The formation of clumps of cells (Sykes, 1965) 
was also noted with LA treated cells (Plates 3.7 and 3.10) 
and this would be more likely to occur under the static 
conditions of the tube dilution method. 
Growth of bacteria in the presence of LAs 1~as followed 
as mass increase (absorbance, 650 nm). This technique was 
suggested for bacterial cells which increase in size 
rather than numerically during the incubation in the 
presence of drug (Lang and Rye, 1972). As the presence of 
subinhibitory concentration of LA in the growth medium 
caused some changes in cell size for E.coli cells (Plates 
3.6, 3.10, 3.14 and 3.15), the measurement of mass 
increase rather than cell counts was adopted. 
When the bacterial cultures were grown in the 
presence of different concentrations of LA using the 
shake culture method, the reduced growth rate depended on 
the drug concentration. The extent of the reduction 
produced by equal increments in LA concentration became 
progressively larger at higher concentrations, and complete 
inhibition was observed at higher concentrations still. 
Even higher concentrations caused a reduction in turbidity. 
The inhibitory pattern of LA which also is shown in Fig 3.18 
are unlike those which have been reported by Garrett and 
Miller (1965) and Garrett et al (1966) for inhibitors of 
protein synthesis such as chloramphenicol and tetracycline 
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and by Mielck and Garrett (1970) for spectinomycin on 
E.coli cells. With these agents cell growth is slowly 
inhibited to a new steady state with a new rate constant 
which is linearly dependent on drug concentration. In 
these situations they suggested that only a small fraction 
of the receptor sites are required to be blocked before 
totally inhibition of bacterial growth occurs. The 
inhibitory patterns reported for erythromycin (Garrett et al, 
1970) and for lincomycin (Mielck and Garrett , 1969) with 
E.coli cells, however, show that the growth rate decreases 
on increasing the inhibitor concentration and that the 
rate constant, approaches zero asymtotically at higher 
concentrations. Mielck and Garrett (1969) suggested that 
this shape of curve, indicates the presence of some 
saturable processes such as binding of drug to a limited 
number of essential receptor sites and the generation rate 
is proportional to or dependent upon the number of free 
receptor sites. The plots of rate constants against. 
concentration of LAs (Fig 3,18) are similar to the growth 
rate patterns of benzyl and phenethyl alcohols reported by 
Lang and Rye (1972), who showed that these compounds 
altered cellular permeability in a non-specific 
reversible manner. 
The observed restriction of growth of bacteria 
produced by many compounds could be due to either a 
partial uniform inhibition of growth or to a non-uniform 
inhibition of the cells. Garrett and Miller (1965) in the 
kinetic studies of the effect of chloramphenicol and 
tetracycline on partially inhibited culture of E.coli 
found that the total and viable cell counts coincided and 
- 171 -
they suggested that this resulted from a general inhibition 
of growth of all of the cells rather than only some of the 
cells. Rye and Wiseman (1968) suggested that this approach 
was not entirely satisfactory as organisms which are not 
multiplying under the conditions of the experiment may do so 
under the changed conditions used for detecting viability. 
They suggested another method based on the effect of 
subinhibitory concentration of drugs on E.coli cells 
and the measurement of the cell-size distribution, after 
growth had occurred in the presence of sufficient ampicillin 
to suppress cellular division. In the culture treated with 
amethocaine, however, the size distribution, in terms of 
threshold units, (Fig 3.20) shows a single distribution of 
cell sizes developing in the presence of the agent which is 
similar in shape to that of the untreated cultures. The 
subinhibitory concentration of the LA used, however, 
causes no loss in cell viability (Fig 3.40) and the 
observed restriction of growth in the partially inhibited 
cultures is probably due to a general and uniform 
inhibition of growth rather than to a selective inhibition 
of some of the cells. A uniform inhibition of growth which 
is due to an even distribution of a highly effective agent 
amongst the cells can be achieved if only a small 
proportion of the antibacterial agent is adsorbed by the 
cells at the concentration used (Rye and Wiseman, 1968). 
Indeed as the uptake of LAs by E.coli cells was so low, 
the number of bacterial cells was increased about a 
hundred times to get a measurable uptake. 
To investigate the reversibility of action of LAs on 
the growth of E.coli, two different methods were used 
(Figs 3.21 to 3.25). Cultures treated with sub-MIC levels 
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of LA, (for example up to 1.0, 2 0, 0.4 and 10 mg.ml for 
amethocaine, procaine, cinchocaine and lignocaine, 
respectively, which cause about 85, 30, 85 and 32% growth 
inhibition) on resuspension or dilution with fresh growth 
medium, grow rapidly at a rate very similar to that of the 
untreated culture or the relevant new concentration of drug. 
However, higher concentration showed, on resuspension or 
dilution with the fresh growth medium, an initial lag 
period, after which the growth continued with the growth 
rate similar to the corresponding new concentration of LA. 
This lag phase may be attributed to a possible need for the 
cell to recover or undergo repair before restablishment of 
the new growth rate, or to a consequence of the shock of 
dilution (Garrett et al 1970). However, the results do 
show that the inhibition of growth of the bacteria in the 
presence of varying concentration of LA up to the MIC is 
reversible. 
The extent of loss in viability of the bacteria is 
governed by three principal factors: drug concentration, 
bacterial cell density and time of contact (Figs 3.40 to 
3.43 and Tables 3.2 and 3.6). The results of these 
determinations show that, with the exception of the 
effect of procaine on the Gram-negative organisms, the 
number of viable organism was reduced by these LAs within 
a short period of time (10 min). While amethocaine and 
cinchocaine have significant bactericidal capacity, 
lignocaine has much less, and procaine is even less 
effective. The order of bactericidal activity was found 
to be cinchocaine > amethocaine > lignocaine > procaine. 
Also comparing the bacteria affected by LAs, B.megaterium 
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(Gram-positive) was the most sensitive organism. The 
viability curves (Figs 3.40 to 3.43) show threshold 
concentrations about the MIC for the system, below which 
cell viability is virtually unaltered. Above this 
threshold as the LA concentration increases, so does the 
bactericidal activity. Both amethocaine and cinchocaine 
have similar MBCs for each of the different Gram-negative 
organisms. Table 3.6 also shows that the bactericidal 
action of amethocaine and cinchocaine is rapid, as there 
is an appreciable drop in viable number of E.coli cells 
almost immediately after the addition of the LAs. Further-
more the results show that increasing the contact time of 
E.coli with a1nethocaine and cinchocaine decreases the number 
of viable cells considerably (Table 3.6). Surprisingly 
increasing the bacterial cell density over the range of 
2.66 x 10 8 to 4.05 x 10 9 , did not have a significant 
effect on the MBC of amethocaine on E.coli (Table 3.2). 
Neither procaine nor lignocaine are effective 
bactericidal agents especially against Gram-negative 
organisms. This may reflect the inability of the active 
agent to achieve an effective concentration at its sitgs) 
of action; since the drug must first penetrate the 
various permeability and structural barriers that separate 
the target site from the external environment before 
exerting its affect. In the case of bacterial cells the 
difference in the properties of these permeability 
barriers among the various genera and species play an 
important role in determining the antibacterial spectrum 
of a drug (Brown, 1975). Target sites e.g. membranes, 
ribosomes, DNA, enzymes, etc. isolated from different 
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groups of bacteria, are frequently found to have comparable 
sensitivities to an antibacterial agent and yet the intact 
cells have very different sensitivities. In many cases it 
is the differences in the composition of the bacterial 
cell envelopes which affect the ease of penetration of 
drugs to the intra-·or peri-cellular target sites. 
In the viable count method of assessing bactericidal 
activity, the method of recovery of microorganism is very 
important. There is a possibility that cells, although 
not killed within the period of drug treatment, are 
damaged during the dilution stages to such an extent that 
recovery becomes impossible. The experiments on the 
reversibility of growth inhibition (Figs 3.21 to 3.25) 
suggest that this is unlikely with local anaesthetics. 
Morever experiments in which the recovery media contained 
1% Tween 80, gave no detectable improvement in the % 
recovery from amethocaine treatment. This does not, 
however, mean that any degree of non-lethal damage to 
cell can not be reversed by other methods. 
The MIC/MBC data obtained in this study, confirms 
the findings reported by previous authors (Murphy et al., 
1955; Kleinfeld and Ellis, 1966 and 1967; Schmidt and 
Rosenkranz, 1970; Weinsteinetal,1975;Zaidi and Healy, 1977; 
Leung and Rawal, 1977; Salt and Traynor, 1979). 
Significant antibacterial activity of amethocaine and 
cinchocaine, but not procaine and lignocaine against 
E.coli, K.aerogenes, P.aeruginosa and B.megaterium was 
observed. 
There are some observations, however, that are at 
variance with previously reported data. Schmidt and 
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Rosenkranz (1970) found that P.aeruginosa was the only 
Gram-negative organism resistance to lignocaine and 
-1 procaine, even at 20 mg.ml • While in this study it was 
found that these LAs have nearly the same effect on E.coli, 
K.aerogenes and P.aeruginosa, and lignocaine was more 
effective than procaine. This difference could be due to 
differences in the bacterial strains and the techniques 
used. Leung and Rawal (1977) reported the MBC of 
-1 
amethocaine for P.aeruginosa to be 1.5 mg.ml , while in 
this work it was found to be 7.5 mg.ml- 1 The difference 
is due to different contact times, inoculum levels and the 
media. Zaidi and Healy (1977) reported much lower MBCs 
of procaine against E.coli and P.aeruginosa. In addition 
to the variation in media and inoculum level etc., their 
results would certainly be influenced by the presence of 
0.2% chlorocresol as preservative in the procaine contain-
ing ointment which they evaluated. 
Results so far mentioned on the evaluation of both 
bacteriostatic and bactericidal activity of LAs in 
conjunction with other authors' results, confirm that LAs 
are active against a wide range of bacteria. This 
perhaps, suggest that the mode of action of LAs might 
involve a sys.tem or systems that is or are common in, or 
to, a wide variety of microorganisms, and (or) that LAs 
might have more than one mode of action and, therefore, 
may affect many different microorganisms but in different 
ways. 
The result of present study shows that LAs are 
capable of reducing dehydrogenase activity as interpreted 
via oxygen uptake and TTC reduction depending on the 
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concentration and the structure of the compound. 
Amethocaine and cinchocaine were found to be more effective 
than procaine and lignocaine (Figs 3.67 to 3.73) and LA 
effectiveness was influenced by medium composition. For 
example, with glucose as substrate, TTC reduction was 
affected to a greater extent when the experimental medium 
was phosphate buffer rather than CFM. This indicates the 
significance of the ions in the environment stablizing 
the bacterial cell membrane and or its enzymes (McQuillen, 
1960; Morris and Russell, 1970; Salt and h'iseman, 1970) 
and competing with the LA so that a higher concentration 
of the drug is required to produce the same effect. 
Very low concentrations of LAs either stimulated or 
had no effect on the cellular respiration. This was more 
detectable when glucose was used as substrate. For example 
-1 
concentration of 0.25, 10, 0.25 and 10 mg.ml , amethocaine, 
procaine, cinchocaine and lignocaine respectively stimulated 
the oxygen consumption when glucose was utilized by E.coli 
cells (Fig 3.72), while these concentrations had an 
inhibitory effect when succinate was metabolised (Fig 3.73). 
Such a stimulation has been reported by Hugo (1956), Hugo 
and Bloomfield (1971b)and Bloomfield (1974) lvith other 
antibacterial agents. Hugo and Bloomfield (1971b)deduced 
that an increase in the total oxygen comsumption with low 
drug concentrations was typical of the action of energy 
uncouplers. Whether the LAs acts as uncoupler or not 
requires further investigation, particular as others have 
reported no stimulation of oxygen consumption by LAs in 
other cell systems (Fink et al, 1969). 
Hugo and Street (1952) however suggested that this 
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stimulation could be due to an increase in the permeability 
of the cell, thus facilitating the access of substrate to 
the enzymes which are localized within the cells. The 
marked inhibition of lactate or malate or succinate activity 
could be interpreted if the enzymes responsible for their 
oxidation were located at or near the cell surface. 
Salton (1971) proposed that the mechanism of an increase in 
permeability must involve the "solubilization" or "opening 
up" of the membrane bound enzyme, so that its active site 
is available to substrate. solubilization of lipophilic 
components of the membrane would be facilitated by the 
presence of drug micelles. This seems unlikely with LAs, 
as the concentration which stimulates the respiration is 
far less than the CMC value and unless localized concentra-
tion effects due to adsorption permit 'limited' micelle 
formation, colloidal aggregateswould not be present. 
Cellular respiration, as reflected by TTC reduction 
and oxygen uptake, is affected by all LAs studied at 
concentrations below the MIC suggesting that the inhibition 
of respiration is at least partially involved in growth 
inhibition. 
If a critically sensitive enzyme exist, its activity 
is affected by small amounts of LA, it would be expected 
that increasing the concentration of LA would soon give an 
excess capable of altogether blocking metabolic activity. 
Results show that, once the concentration of the agent 
was high enough to inhibit respiration to a very low level, 
it did not reduce the oxygen consumption to zero. TTC 
reduction did, however, become effectively zero. The true 
meaning of this apparently total inhibition is difficult to 
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interpret as the technique involves an extraction procedure 
which is itself inevitably an equilibrium state. Therefore 
it seems unlikely that there is an enzyme of key importance 
that is very sensitive to LAs. So it seems reasonable to 
assume that LAs, at this level of concentration, dis-
organize not an enzyme protein but rather some component 
in the bacterial cell membraneJchanges in which would then 
influence enzyme activity. 
Since damage is presumably caused only by adsorbed 
drug, the first stage of antibacterial activity by any 
cytotic agent is its adsorption by bacterial cells. The 
study of drug uptake can yield information about the site 
of action of the drug but does not necessarily provide 
direct evidence for a proposed mode of action (Russell et 
al, 1973). 
It is unlikely that adsorption of antibacterial 
drugs by a cell is, itself, a fatal event. After the 
adsorption process, however, secondary process can be 
shown to occur and these contribute to the inhibition of 
the reproductive and metabolic processes of the cell 
(bacteriostatic effect) or even to a rapid loss of 
viability (bactericidal effect). 
As the uptake isotherms illustrate (Figs 3.50 to 
3.52); at equilibrium in treated cell suspensions, the 
concentration of cinchocaine or amethocaine on or within 
the cell is much greater than the external medium. On the 
other hand lignocaine and procaine are taken up to a much 
lesser extent, indicating that the cells have a greater 
affinity for amethocaine and cinchocaine than for procaine 
and lignocaine. Since amethocaine and cinchocaine are 
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relatively lipophilic (partition data, Table 3.7, shows 
that o;w partition coefficient of amethocaine and 
cinchocaine is higher than procaine and lignocaine) it 
seems reasonable to assume that cellular LA is largely 
present in the lipid containing region of the cell, which 
in E.coli is the cell envelope. 
A comparison of the relative activities of these 
LAs when present within the cell can be made by combining 
the uptake data of Figs 3.50 to 3.52 with the growth 
inhibitory patterns shown in Fig 3.17(A) or 3.18. Table 
4.1 shows the total concentrations and calculated 
extracellular and intracellular concentrations of LAs 
which reduce the growth rate by 50%. It seems that 
approximately the same concentration of amethocaine and 
cinchocaine is present within the cell, although this 
value for the latter is a little less than for the former. 
Lignocaine and procaine are both present at much greater 
concentrations. The greater uptake of procaine and 
lignocaine required for 50% growth inhibition could be due 
to the presence of a significant proportion of the 
intracellular molecules in the aqueous biophase and 
consequently not at the (lipophilic) site of action. An 
approximate correction can be made for this by calculating 
the effective intracellular LA concentrations. It is 
assumed that the concentration of the compound in the 
aqueous biophase is the same as in the external medium 
(Lang and Rye, 1973) and the water content of E.coli to be 
73-78% (Luria, 1960). The total amount of LA present in 
the aqueous regions of the cell can be calculated and 
substracted from the overall intracellular uptake to get 
Table 4.1 
LA 
Cinchocaine 
Amethocaine 
Lignocaine 
Procaine 
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The total, extracellular and intracellular 
LA concentrations required to reduce 
the growth rate of E.coli by 50"'· 
Total Cone. Cone. in Overal Effective 
(mg .ml-1) medium inter a- intracellular 
(mg .ml-1) cellular cone. 
cone. 
(mg.ml-1) mg.ml-1 % of 
total 
0.37 0.025 0.345 0.31 86 
0.66 0.088 0.572 0.49 75 
14 6.4 7.7 2.82 20 
28 15.55 12.44 0.84 3 
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what would probably be the intracellular LA associated with 
the cell envelope. This effective intracellular concen-
tration is shown as both the % of the total LA concentra-
tion and as mg.ml..,. 1 (Table 4.1). This shows a closer 
agreement between the amount of each LA in the cell which 
is effective in reducing growth rate by 50%. These 
results together with others suggest that the apparent 
differences in the antibacterial activities of these 
compounds are due not just to'the differences in their 
uptake properties but additionally to their mode of 
intracellular.distribution. 
Although the uptake isotherms show the differences 
in the amount of different LAs taken up by the cells, it 
is difficult to specify the similarity of these isotherms 
to any one of the uptake isotherm reported by Giles et al 
(1960) and Giles and Smith (1974). The uptake isotherm 
shows a straight line, which is generally characteristic of 
the constant partition of LA between solution and substrate 
(bacteria), corresponding to the "C" curve of Giles et al 
(1960). However, some "L" uptake isotherms are linear 
over much of their range (Giles et al, 1960), and "C" and 
"L" isotherms can be difficult to differentiate. 
LA molecules are amphipathic and it seems likely 
that they would be absorbed by cellular membranes, the 
lipophilic part penetrating by hydrophobic interactions 
within the phospholipid region, and the polar group 
remaining associate with the polar region of the membrane. 
A disturbance in the membrane phospholipids could be 
responsible for an alteration in the protein-lipid 
hydrophobic interactions with a consequent effect on 
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membrane bound enzymatic activity. 
It is thus relevant to briefly outline the possible 
mechanisms for the interaction of LAs with the 
phospholipid membranes of other cells that have been 
proposed by Feinstein (1964); Ohki (1970); Papahadjopoulos 
(1972) and Papahadjopoulos et al (1975); common processes 
may be identified with cellular uptake. It is suggested 
that LAs interact with polar groups as well as the hydro-
carbon phase of the nerve phospholipid membrane. The 
former may be both dipole-dipole interaction as well as 
electrostatic interaction (Fig 4.1). This would cause 
the LA to exhibit an effect similar to that of ea++ which 
interac~with the polar groups on the surface of the 
membrane (Feinstein, 1964 and Papahadjopolous, 1968). 
glycerol 
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Fig 4.1 Proposed model for the mechanism of complex 
formation between·acidic phospholipids and 
LAs. (After Feinstein, 1964). 
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The latter interaction lvould be hydrophobic interaction 
between non-polar groups of the LAs and of the phospho-
lipids, which suggests that some part of the LA can 
penetrate into the hydrocarbon phase of the membrane. 
This would provide a greater degree of freedom for the 
lipid chains and to lessen van der Waals interaction 
forces (Feinstein et al, 1975). Any resulting increase 
in disorder of the lipid molecules would cause a 
conformational change in proteins intimately associated 
with the lipid (Johnsori and Miller, 1970; Seeman, 1972 and 
Lenaz et al 1978). 
" Buchi and Perlia (1972) suggested that LAs are 
bound to the nerve membrane by fe1v types of bonds, which 
are illustrated in Fig 4.2. They also pointed out that 
D H 
E 
EDA Electron donor-acceptor binding 
V van der waals binding 
D Dipole attraction 
E Electrostatic binding 
H Hydrogen bond 
Fig 4.2 Binding of LA to the site of action 
" (After Buchi and Perlia, 1972) 
- 184 -
the substituent R is an electron donating group, which 
causesan increase in the density of electrons at carboxyl 
oxygen with a consequent increase in the attachment of the 
anaesthetic to the receptor. Therefore amethocaine having 
H 9 C~-NH- instead of -NH 2 in procaine will have more binding 
power to attach to the receptor site, and will be more 
effective than procaine. 
The spectrophotometric method for determination of 
uptake of LAs by bacteria used in this study is not very 
sensitive. As the overall extent of the uptake was very 
low, dense cell suspensions were used to get a detectable 
difference from the corresponding control concentration. 
Other experiments were performed using lower cell concen-
trations, thus making comparison difficult. The amount of 
absorbed drug is not measured directly, but by calculation 
from the differences between the drug concentration of the 
suspending medium before and after contact with the cells. 
The accuracy of values of K (the ratio of concentration of 
LA taken up by the cell to the concentration in the medium) 
depends on the accuracy of C (drug concentration in the 
supernatant liquids from the control mixture), C' 
(concentration of drug remaining in the supernatant after 
uptake has taken place), V(the bacterial cell volume) and 
V (the total volume of reaction mixture). The main source 
of error is in dilutions of C and C' in order to get a 
measurable OD, and the need for correction due to the 
leakage of intracellular material (260 nm absorbing 
material). Therefore, the use of radioactive LA, would be 
expected to give a more accurate result. 
Experimental results so far mentioned, show the 
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higher antibacterial activity of amethocaine than procaine, 
and of cinchocaine than lignocaine. This reflects the 
structural differences between the members of each group, 
and is apparently related to a number of differences in 
physical properties, such as solubility, miscibility, 
micellisation, surface and interfacial tension. Indeed 
Seeman (1972) is of the opinion that the narcotic activity 
of anaesthetics correlates much better with the non-aqueous-
aqueous partition coefficient than with any other parameter 
of the anaesthetic molecule. The partition coefficients of 
LAs used (Table 3.7) are in general agreement with the 
antibacterial activity of these LAs. It therefore seems 
likely that the difference in the antibacterial activity 
of the LAs is related to their lipid solubility, the more 
lipophilic cinchocaine and amethocaine showing a greater 
antibacterial effectiveness than lignocaine and procaine. 
Similarly in a homologous series the surface anaesthetic 
activity of these agents has been shown to be parallel to 
their lipid solubility, degree of ionization, diffusion 
" coefficient, surface and interfacial activity (Buchi et al 
1964) • 
The correlation of anaesthetic potency and 
antibacterial potency of LA to the non-aqueous/aqueous 
partition coefficient supports the idea that membrane 
anaesthetic interaction is lipophilic in nature 
(Schneider, 1968; Seeman et al 1971; Machleidt et al 
1972 and Seeman, 1972). The hydrophobic region of a membrane 
may consists of 1) non-polar portions of lipid molecule, 
2) the non-polar interfaces between lipid and protein 
molecules; or 3) the hydrophobic regions of protein 
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molecules. Amethocaine and cinchocaine being more 
lipophilic than procaine and lignocaine would be expected 
to have stronger hydrophobic binding with the membrane 
components and therefore exert a greater antibacterial 
activity. 
There is a similarity between the action of the LAs 
and that of the cationic antibacterial agents (e.g. CTAB). 
Such compounds usually have a marked surface activity and 
form colloidal aggregates (Salt and Wiseman, 1970). 
Consequently the micellar formation of these agents was 
investigated. Amethocaine lowered the surface tension 
of both water and CFM whereas procaine did not have any 
significant effect. Any surface activity inherent in the 
LA will of course contribute to its antibacterial 
effectiveness by aiding its concentration at the bacterial 
cell surface and this again reflects the difference between 
amethocaine and procaine. Similarly in his adsorption 
expansion hypothesis Schneider (1968) reported that 
anaesthetics would adsorb to a cell membrane, altering the 
amount of water in contact with each side of the membrane, 
and consequently altering the interfacial tension at the 
membrane-water interface. The net result of these effects 
would be for membrane to undergo extension. 
Such an effect would be difficult to imagine in a 
bacterial cell with its rigid/semi-rigid cell wall unless 
such extension occurred into the cytoplasm. Certainly 
intracellular changes do occur in LA treated cells (Plates 
3.18 and 3.19) but direct membrane intrusion into the 
cytoplasm was not observed. 
The formation of micelles causes abrupt changes 
- 187 -
in many physical properties of a surface active agent 
provided that the aggregation number is fairly large 
(Grindley and Bury, 1929). Measurement of the concentra-
tion at which these changes take place is generally taken 
as indicative of coalescence of the monomers and CMC 
values obtained by different methods have been found to be 
comparable. The CMC's (dye solubilization) of amethocaine 
and cinchocaine (Fig 3.53) are in agreement with those 
reported by previous workers (Eckert et al, 1966; Farhadieh 
et al 1967; Salt and Traynor, 1979), and have values of 
31,5 and 23.5 mg.ml-1 for amethocaine and cinchocaine 
respectively in water. These values were lowered to 1~5 
and -1 7.5mg.ml when CFM was used instead of water. This 
again favours a comparison with the cationic surfactants 
(Salt and Wiseman, 1970). In the concentration ranges 
studied, no detectable CMC values were observed for 
procaine or lignocaine. Farhadieh et al (1967), however, 
reported that procaine forms small ionic micelles, though 
they did not reported any value for the CMC of this compound. 
Antibacterial activity increases with decrease in 
the CMC values. This is to be expected, the smaller the 
CMC value of the LA, the more hydrophobic is the compound. 
The uptake of the compound will thus occur more easily from 
aqueous solution, and most of it will accumulate in the 
lipid region of the cell. 
The cytoplasmic membrane of the bacterial cell 
plays a dual role: it forms an osmotic barrier to the free 
diffusion of small molecules, and controls the internal 
concentration of metabolites by specific transport mechanism. 
Destroy either of these roles and the cell is no longer able 
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to function as an effective metabolic unit. The barrier 
action of the membrane lies in the organization of the 
lipoproteins that compose it. Distortion or dissociation 
of the lipoprotein structure leads to the leakage of intra-
cellular material. The level of the leakage depends on 
the extent of damage to the membrane. However, although 
membrane damage and loss of cytoplasmic constituents 
might be expected to result in the inhibition of cellular 
growth, loss of viability may only occur when the membrane 
damage is irreversible. 
Procaine and lignocaine did not cause any leakage 
of intracellular material from E.coli cells after 10 to 30 
min contact (Figs 3.44 to 3.46 and 3.49, Plates 3.2 and 
3.4). Also SEM (Plates 3.10, 3.11, 3.14 and 3.15) and 
TEM (Plate 3.17) show no surface or intracellular damage 
due to the action of procaine or lignocaine on E.coli 
cells. Amethocaine and cinchocaine, however, caused the 
leakage of considerable quantities of intracellular 
materials, including 260 nm absorbing material, pentoses 
and inorganic phosphate (Figs 3.44 to 3.49). Low concen-
trations of amethocaine and cinchocaine induced little or 
no leakage, but as the concentration increased, the 
leakage also increased reaching a maximum at about 10 and 
5 mg.ml- 1 for amethocaine and cinchocaine respectively. 
SEM (Plates 3.8, 3.9 and 3.13) also show some surface 
damages which could be due to the effect of these LAs on 
the bacterial cell surface. Prolonged contact, however, 
between drug and cell (Fig 3.46 and 3.49) produced a 
different pattern in the leakage profile. After the 
maximum release was reached at about 10 mg.ml- 1 amethocaine 
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-1 
and 5 mg.ml cinchocaine, the extent of leakage was 
reduced as the LA concentration was increased. Further-
more when the rate of loss of pentoses was followed (Fig 
3.47), concentrations of amethocaine and cinchocaine 
about those causing peak leakage showed very rapid initial 
release which was completed within 10 min. This was 
followed by a secondary slower release of material; with 
higher concentrations of LA, however, only the rapid 
initial release was observed. 
Such a pattern of leakage was reported by Leung 
and Rawal (1977) for the action of amethocaine on 
P.aeruginosa and by Silva et al (1979) for chlorpromazine, 
nupercaine and amethocaine on B. cereus. This leakage 
profile is described as diphasic and can be compared to 
that of chlorhexidine (Rye and Wiseman, 1964 and 1965; 
Hugo and Longworth, 1964). This reduction in the leakage 
at higher drug concentration could be due to sealing of the 
cells by one of a number of mechanism. For example Hugo 
and Longworth (1964) suggested that high concentrations 
of chlorehexidine brought about the coagulation of protein 
which would prevent leakage by the simple mechanism of 
blockage. However, when the effect of LAs on the induced 
changes in the turbidity of cell-free cytoplasmic material 
was investigated (Figs 3.63 and 3.64), increase in LA· 
concentration (amethocaine or cinchocaine) caused increase 
in turbidity which could be due to the precipitation of 
cytoplasmic material (proteins and nucleic acids). At 
higher drug concentrations no further increase in turbidity 
was observed, probably as all the cytoplasmic material had 
been coagulated at lower concentration of drug. These 
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results are also substantiated by the TEM (Plates 3.18 and 
3.19), which show ultra thin sections of E.coli cells 
pretreated with 10 mg.ml- 1 amethocaine (Plate 3.18) which 
caused nearly maximum leakage (Figs 3.44 to 3.46 and 3.49). 
The cell have intensely stained interiors recalling the 
"dense blocks" reported by S il va et al ( 1979) • Such 
sections were not subjected to post-sectioning staining 
and had only been pre-washed with uranyl acetate. Intra-
cellular staining must therefore be due to the infiltration 
of stain through the cell membrane. Higher concentration 
(20 mg.ml- 1 amethocaine) give rise to similar micrographs 
(Plate 3.19) in which the contraction of cytoplasmic 
constituents from the cell envelope is more detected. 
An alternative explanation for the reduction of 
leakage at high drug levels was put forward by Hugo and 
Longworth (1964). They suggested that cytoplasmic 
membrane was "sealed off" by a surface film of chlorhe-
" xidine. Buchi and Perlia (1972) suggested the obstruc-
tion of membrane surface by LA bases as one of the modes 
of action of these agents on the nerve membrane, though 
no evidence of this sealing effect can be seen in the 
electron micrographs of E.coli cells treated by high 
concentrations of amethocaine (Plates 3.18 and 3.19). 
Salton (1951) pointed out, that a decrease in 
cellular leakage could be due to the readsorption of 
leaked material by the drug saturated cells. This 
possibility was not examined in this study. 
Another possible explanation is that if the 
leakage is due, at least in part, to the activity of 
autolytic anzymes following cellular damage, this 
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enzymatic activity could be. inhibited at higher drug 
concentrations (Hugo and Longworth, 1964; Rye and >Viseman, 
1964 and 1965). The two phenomena may be distinguished by 
conducting the experiment at 1°-4°C, as the autolytic 
enzyme activity is inhibited and resulting leakage level 
represents only material from metabolic pool (Rye and 
Niseman, 1965). Indeed when thepentose release >vas followed 
at 1°C, increasing the contact time did not increase the 
amount of released material, i.e. this secondary release 
could be due to the break-down of large molecules (such 
as ribonucleic acids) by the action of autolytic enzymes 
which were inhibited at low temperature. 
The amount of 32P released by exposure of E.coli 
cells for 10 min to amethocaine and cinchocaine was 
comparable to that released when the cells were treated 
with cold TCA, which extracts the metabolic pool 
(Britten and McClure, 1962). The amount of 260 nm 
absorbing material or pentoses released, however, was 
for both amethocaine and cinchocaine less 
than the amount released when the cells were boiled for 
10 min. 
While the exposure of E.coli for 10 min to 
procaine and lignocaine did not cause any significant 
leakage, a longer exposure time (5 hr), did cause minor 
release of intracellular material (Fig 3.47). Similarly 
Silva et al (1979) reported that procaine (100 mM)caused 
a minor release of K+ from B.cereus. 
Although the leakage of 260 nm absorbing material 
and pentoses by LAs occurred over a comparatively longer 
period of time than 32P, a comparison of experimental 
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results suggest that it is the loss of intracellular 
materials in general that has an effect on the viability 
of the organism. These substances, together with some 
others, such as amino acids, have been shown to be 
important to osmo~egulation (Tempest, Meers and BrO\m, 
1970) and one of the effects of their loss is the 
reduction in internal osmotic pressure. Apart from osmo-
regulation, the small molecular weight substances leaked 
by LAs treatment form the basic materials from which 
complex molecules like structural proteins and nucleic 
acids are forilled. The formation of these complex 
molecules required en~ymatic activity but it is possible 
that some enzymes are also lost through the action of 
LA on the cell membrane. The results of the leakage of 
these materials therefore is that, the organism loses 
compounds necessary to manufacture complex molecules. 
This will bring about the cessation of growth, and if the 
materials lost are .not replaced, lead to the death of the 
organism. 
Gross leakage has been related both to cell death 
(Sal ton, 1951) and to the bacteriostasis action (Huge and 
Longworth, 1964; woodroffe and Wilkinson, 1966). Salton 
(1968) reported that in many cases with cationic 
detergents it is possible to show quantitative correspon-
dence betw.een killing and release of solutes, so that 
disruption of the membrane can safely be taken to be the 
lethal event. LA induced leakage appears to be related 
to the bactericidal rather than bacteriostatic activity. 
Thus bacteriostatic concentrations of LA induce little 
or no leakage of intracellular material whereas, as the 
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concentration increases, there is a relationship between 
% loss of viability and % of metabolic pool material 
released. -1 Concentrations of about 7.5 mg.ml amethocaine 
and 5 mg.ml- 1 cinchocaine which produce considerable loss 
of metabolic pool material within 10 min, causes 99.9% 
loss of viability over the same period. The difference 
in the MBC and the concentration that cause maximum 
leakage might be due to a carry over of bactericide which 
continues to exert its cytotic effect during the dilution 
and incubation period necessary for plate count. Another 
possibility is that, as the most immediate effect of a 
membrane active compound on the cell is the leakage of 
K+ (Hugo, 1977), therefore it might be possible if the K+ 
leakage was investigated, a bette.r relation to cell 
death could be observed. However, although the loss of 
viability and leakage are caused by similar LA concentra-
tions, the autolytic release which occurs comparatively 
slowly probably accompanies and follows, rather than 
causes, the observed loss of viability. 
The optical density of non-growing cell 
suspensions of E.coli, K.aerogenes, P.aeruginosa and 
B.megaterium was influenced by amethocaine and 
cinchocaine treatment, but not by procaine or lignocaine 
in the concentration range studied (Figs 3.55 to 3.58). 
While low concentration of amethocaine and cinchocaine 
did not change the turbidity, higher concentrations 
.caused a rapid and significant increase in culture 
turbidity. 
Increase in turbidity of bacterial cell suspen-
sion can be attributed either to an increase in effective 
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(reflecting) surface area of the cell or to an increase 
in refractive index of the cell or both (Hugo and 
Longworth, 1964). The change in the effective reflecting 
surface of the cell would be accompanied by a change in 
the size or shape of the cell. A comparison of drug 
adsorption (Figs 3.50 to 3.52) and turbidity of bacterial 
suspensions in the presence of LAs (Fig 3.55) suggests 
that the first increase in turbidity may be caused by 
changes in the reflecting surface of the cells due to the 
presence of the adsorbed drug, or to a drug induced 
physical alteration of the cell surface. Furthermore 
when the effect of amethocaine and cinchocaine on turbidity 
changes was followed by time (Fig 3.59), concentration of 
-1 -1 10 mg.ml amethocaine and 5 mg.ml cinchocaine, which 
cause peak leakage, caused reduction in turbidity. This 
suggests that gross cytological damage is linked with a 
well-marked change in optical density of the cell, 
possibly caused by reduction in size of the cell. The 
rise or nearly no change in turbidity at higher LA 
concentrations, may suggest complete precipitation of 
cell constituents. 
The effect of drugs on the cell wall, has been 
shown to be one of the factors contributing to the 
increase in optical density of bacterial cell suspension 
(Munton and Russell, 1970; Lamikanra and Allwood, 1977b) • 
However, when the effect of LAs on the cell envelope 
preparation of E.coli was investigated (Figs 3.63 and 
3.64), only minor OD increase in the presence of 
amethocaine and cinchocaine was observed. This possibly 
corresponded to the increase light scattering properties 
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of walls as caused by other adsorbed drug (Hugo and 
Longworth, 1966). Also Plates 3.8, 3.9 and 3.13 show 
that amethocaine and cinchocaine caused some surface 
damages on E.coli cells. This could be either due to 
the direct effect of drug, or perhaps because of vacuum 
collapse (indirect effect of drug, which makes the cell 
wall weak). 
lvhen the effect of LAs on the isolated cell contents 
was investigated (Figs 3.63 and 3.64), the turbidity 
increased, reaching a maximum at higher LA concentration, 
perhaps due to the complete coagulation of the cytoplasmic 
contents. Similar results were obtained when the effect 
of LAs (amethocaine and cinchocaine) on lipid depleted 
cells of E.coli investigated (Fig 3.65). Confirming 
that the integrity of the cell is not essential for these 
effects ofthe drug. 
However, because of the lipophilic character of 
some of the drugs used in this study an attempt was made 
to correlate culture turbidity 1~ith the effect of these 
LAs on the turbidity of a cell-free dispersion of 
extracted lipids (Fig 3.66). Dispersion turbidity 
initially increased as LA concentration was increased. 
This OD increase could account for the small increase 
in OD of the isolated E.coli cell envelope preparation 
described earlier. However, this increase was followed 
at higher LA concentration, by a decrease in dispersion 
turbidity to zero optical density. This decrease is 
probably due to the solubilization of the lipids in the 
hydrophobic core of the LA micelles which formed at 
concentration above the CMC (Fig 3.53). The amount of 
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reduction in OD induced by these high amethocaine 
concentrations was less than that for cinchocaine. This is 
probably because the latter is a more effective solubilizing 
agent for the bacterial cell envelope lipids. Such a 
drastic decrease in turbidity was not observed for the 
effect of LAs on E.coli cells suspended in distilled water 
(Fig 3.60). As the CMC of LAs in distilled water is much 
higher than in CFM, no solubilization of lipid component of 
bacterial cell envelope had occurred in the concentration 
range studied. When the effect of procaine on the dispersed 
lipid v.'as investigated no change in turbidity occurred (Fig 
3.66). While with lignocaine concentrations in excess of 
7.5 mg.ml-1,turbidity increased, which suggests this drug 
is perhaps more lipophilic than procaine. 
Salt (1976) suggested that changes in turbidity 
are indicative of post mortem changes in the cells following 
penetration of the cell membrane. Comparing LA concentra-
tions having measurable effects on culture viability, 
cellular leakage and culture turbidity, confirms the above 
statement •. Concentrations of LA about and higher than the 
MIC, change the membrane permeability. This causes the 
release of cytoplasmic constituents which in turn causes 
cell death. The cytoplasmic constituents interact with 
the agent, perhaps both within and without the cell and 
are the significant cause of the turbidity increase. 
Further evidence which support the view that, 
induced changes in turbidity might be the result of post 
mortem changes comes from a comparison of the changes in 
turbidity of E.coli cells suspended in distilled water 
with that of cells suspended in other media (Figs 3.60 to 
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3.62). The extent of the first region of little or no 
change in turbidity, is increased, probably due to the 
presence of ions in the suspending medium. As the metal 
ions will stabilize the membrane (McQuillen, 1960; 
Morris and Russell, 1970; Salt and Wiseman, 1970), and 
compete with the similarly charged drug during adsorption 
(Salt and Wiseman, 1970), a higher concentration of LA is 
necessary to increase membrane permeability. Leakage, 
cell death and increase in turbidity lvill thus occur at 
different concentrations in the various media. 
Induced increases in turbidity of non-growing 
cells by LAs (amethocaine and cinchocaine) therefore seem 
to be due to the action of LA on the cytoplasmic constitu-
ents following penetration of the cell membrane and to a 
lesser extent to a direct effect on the cell envelope 
components. Higher concentrations, however, may cause a 
reduction in turbidity due to the partial solubilization 
(fluidizing effect) of the cell surface l.ipids which 
are present in Gram-negative bacteria. 
Most previous investigations of the inhibition of 
protein synthesis by antibacterial agents have been carried 
out by studying the uptake of radiolabelled amino acids. 
Schmidt and Rosenkranz (1970) showed that procaine and 
lignocaine inhibit the synthesis of DNA, RNA and protein 
to the same extent. An alternative method was developed 
and used in this study. 
Bacterial cells, when growing in a medium containing 
certain pairs of compounds as carbon sources, undergo 
diphasic growth, if the presence of one of the carbon 
compounds represses enzymes anc;/or permeases needed to 
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utilize the other(Monod,1949).Such growth curves consist of 
two exponential phases separated by a distinct lag phase, 
marking the switch over from one carbon source to the 
other. It is during this enforced lag period that 
de-repression occurs and the cells commence de-novo 
synthesis of the necessary enzymes and/or permeases specific 
for the second carbon source. Normally when sufficient 
protein has been synthesised, the cells return to 
logarithmic growth. Any inhibition of this specific protein 
synthesis would result in the cells having a reduced 
capacity to use or being unable to use the second (now sole) 
carbon source in which case the lag should extend into a 
pseudo-stationary phase. 
In the glucose-galactose containing medium, as was 
used for this series of experiments the bacteria utilize 
glucose exclusively during the initial growth phase. Upon 
depletion of glucose, the cells utilize galactose giving 
rise to the second growth phase. As expected the growth 
of E.coli when glucose is being used as a carbon source 
shows a faster growth rate than when galactose is used 
(Figs 3.26 to 3.39). 
During the studies of the effect of the addition of 
antibacterial agents to E.coli growing under diauxic 
conditions two approaches, differing only in the timing of 
the drug addition, were used. Drug added at the start of 
growth (Figs 3.26 to 3.32) was deemed to be not a very ideal 
method for the evaluation of antimicrobial agents by the 
diauxic growth technique, as the early presence of anti-
bacterials at sub-MIC values influenced the cell growth 
rate sufficiently to make the prediction of the diauxic 
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lag and the interpretation of the curves complex. So 
mostly the results obtained from experiments in which the 
drugs were added just prior to the onset of the diauxic lag 
will therefore be discussed. 
The antibacterial agents used were, chloramphenicol and 
puromycin as examples of inhibitors of protein synthesis 
(Franklin and Snow, 1975), ampicillin, an inhibitor of cell 
wall synthesis (Gale et al, 1972) and CPB which is membrane 
active agent (Sykes, 1965). 
Both chloramphenicol and puromycin gave similar 
patterns of inhibition, not permitting the use of the 
secondary carbon source at concentrations approaching, but 
less than, the relevant MIC. Lower concentration of these 
agents, however, permitted growth to continue at a reduced 
rate; the extent of the diauxic lag phase, however, 
depended on the ability of the cells to synthesize protein 
de-novo, and this in turn will be affected by drug 
concentration. Both drugs caused a marked extension of the 
diauxic lag. For example it increased from 10 min (control) 
to ea 50 min (7.5~g.ml- 1 chloramphenicol) and ea 60 min 
(600 ~g.ml- 1 puromycin) after which the cells continued to 
grow but at very low rate (Figs 3.36 and 3.37). 
Ampicillin and CPB gave essentially similar curves 
at low concentration (Fig 3.38 and 3.39) and did not inhibit 
the appearance of the second logarithmic growth phases, 
though they gave rise to curves of various slope indicat-
ing inhibition probably not involving direct suppression 
of protein synthesis. With CPB the extent of the lag 
-1 . 
phase was from 10 (control) to 25 min (S~g.ml ) and 
after that the cells continued to grow. Ampicillin at 
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concentration more than 2.5].lg.Ihl-1 ,~after a time depending on 
drug concentration,caused reduction in cell turbidity due 
to the cell lysis (Rye and Wiseman, 1967). Similarly, 
higher concentration of CPB > 6 \lg .ml-1 ) caused a reduction 
in cell turbidity (Fig 3.32). 
Diauxic growth of E.coli in the presence of LAs 
(Figs 3.27, 3.29, 3.33 and 3.35) showed a lag phase, the 
extent of which depended on the LA concentration, it 
increased from ea 10 min to 30 min (0.75 mg.ml- 1 
amethocaine), 30 min (0.3 mg.ml- 1 cinchocaine),50 min 
(25 mg.ml- 1 procaine) and 55 min (10 mg.ml- 1 lignocaine) 
and after which the cells continued to grow at a reduced 
rate as compared with the control. The overall shape of 
these curves indicates that LAs, especially amethocaine and 
cinchocaine have much more in common with CPB than with 
chloramphenicol or. puromycin.· The increase in the 
concentration of CPB or LA cause relatively small increase 
in the lag phase (although it is longer for LAs) perhaps 
reflecting an overall reduction in cell metabolism, after 
which the bacteria continue to utilize the second carbon 
source at a rate relating to the initial degree.of growth 
inhibition. Specific inhibitors of protein synthesis do not 
normally cause cell lysis as an immediate part of their 
mode of action and though results indicate that LAs may 
inhibit protein synthesis to a small extent, it seems 
likely that this is not the prime mode of action. Such an 
inhibition is probably a result of a general reduction in 
the efficiency of the cell following structural chanqes in 
membrane causing a reduction in metabolic effectiveness. 
Furthermore electron micrographs (Plates 3.6, 3.10, 
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3.14, 3.15) show that in the presence of low concentrations 
of LAs (up to about MIC) some E.coli cells in a growing 
state form filaments, indicating an interruption of the 
division process. The concentration range which induced 
filaments, is comparable with the concentrations that cause 
DNA synthesis inhibition (Schmidt and Rosenkranz, 1970). 
DNA replication and cell division are intimately inter-
connected (Slater and Schaechter, 1974) and a wide variety 
of chemical treatments which inhibit DNA synthesis also 
inhibit cell division. Cells in which DNA synthesis has 
been inhibited often elongate without division, eventually 
forming very long cells (Stanier et al 1980). 
The inhibition of protein or DNA synthesis could have 
been caused by loss of essential molecules through a 
damaged cytoplasmic membrane (Tvoodside, 197 3) • With LAs, 
however, this is not the case, as the concentration that 
inhibits protein or DNA synthesis is lower than the concen-
tration that cause release of cytoplasmic constituents. 
Therefore, it seems reasonable to assume that inhibition 
of protein or DNA synthesis may ~~ell be secondary to a 
change in the association of DNA with the cell membrane 
during replication (Ryter, 1969; Garland and Highton, 1973) 
due to LA induced changes in membrane structure. 
Thus local anaesthetics do possess some antibacterial 
properties. However, although all LAs studied affected 
respiration and inhibited cellular growth in a reversible 
manner, significant differences in effectiveness are 
apparent between the individual drugs. Neither lignocaine 
or procaine were bactericidal agents against Gram-negative 
organisms, nor did they induce turbidity increases in non-
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growing cell suspensions, or increase the loss of cellular 
constituents. Both amethocaine and cinchocaine are active 
antibacterial agents and appear to have much in common with 
the cationic antibacterial surfactants, though in 
concentration terms they are much less effective. Their 
effects reflect gross changes in cellular structure and 
may therefore be related to the general toxicity of these 
drugs, suggesting the possible use of bacterial cell 
suspensions as an alternative in the assessment of tissue 
toxicity. 
It must, however, be emphasized that all four drugs 
are effective local anaesthetics. Taking them as a 
single group it seems probable that the effects on growth 
inhibition give a more realistic indication of relative 
LA effectiveness than the induced turbidity changes or effects 
on cell viability, which may well be reflecting. the potential 
tissue toxicity of the drugs concerned. 
The physical properties of LAs are of great importance 
in their role both as local anaesthetics and as anti-
microbial agents. The hydrophilic-lipophilic balance of 
an individual molecule will influence not only its cellular 
uptake but also its intracellular distribution and 
consequent location at or near its site of action. 
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